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Summary 
“Prevention is better than cure” and when it comes to human health, this strategy translates 
into many socioeconomic benefits. Practically all the cellular processes, including every step in 
the flow of genetic information from gene expression to protein synthesis and degradation, can be 
affected by diet and lifestyle. Similar to the role of pharmaceuticals, nutrients contain a number of 
different compounds that act as modifiers of network function and stability. However, the level of 
complexity in nutrition studies is further increased by the simultaneous presence of a variety of 
nutrients, with diverse chemical structures that can have numerous targets with different affinities 
and specificities. Obviously, this differentiates the nutritional from the pharmacological studies, 
where single elements are used at low concentrations and with a relatively high affinity and 
specificity in a small number of thoroughly selected targets. Our need for fundamental 
understanding of the building blocks of the complex biological systems had been the main reason 
for the reductionist approach that was mainly applied in the past to elucidate these systems. 
Nowadays, it is widely recognized that systems and network biology has the potential to increase 
our understanding of how small molecules affect metabolic pathways and homeostasis, how this 
perturbation changes at the disease state, and to what extent individual genotypes contribute to 
this. A fruitful strategy in approaching and exploring the field of nutritional research is, therefore, 
to borrow methods that are well established in medical and pharmacological research. 
In this thesis, we use advanced data-mining tools for the construction of a database with 
available, state-of-the-art information concerning the interaction of food and its molecular 
components with biological systems and their connection to health and disease. The database will 
be enriched with predicted interactions between food components and protein targets, based on 
their structural and pharmacophore similarity with known small molecule ligands. Further to this, 
the associations of bioactive food components with metabolic pathways will be investigated from 
a chemical-protein network perspective, while their effects in network robustness will be further 
confirmed by proteome analyses and high-throughput genotype-phenotype characterization.  
The first chapter of the thesis is about the development of our data resource. In this work, 
we applied text mining and Naïve Bayes classification to assemble the knowledge space of food-
phytochemical and food-disease associations, where we distinguish between disease 
prevention/amelioration and disease progression. We subsequently searched for frequently 
occurring phytochemical-disease pairs and we identified 20,654 phytochemicals from 16,102 
plants associated to 1,592 human disease phenotypes. We selected colon cancer as a case study 
and analyzed our results in three directions; i) one stop legacy knowledge-shop for the effect of 
food on disease, ii) discovery of novel bioactive compounds with drug-like properties, and iii) 
discovery of novel health benefits from foods. 
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This works represents a systematized approach to the association of food with health effect, and 
provides the phytochemical layer of information for nutritional systems biology research. The 
paper also shows as a proof-of-concept that a systems biology approach to diet is meaningful and 
demonstrates some basic principles on how to work with diet systematic. 
The second chapter of this thesis we developed the resource NutriChem v1.0. A food-
chemical database linking the chemical space of plant-based foods with human disease 
phenotypes and provides a fundamental foundation for understanding mechanistically the 
consequences of eating behaviors on health. Dietary components may act directly or indirectly on 
the human genome and modulate multiple processes involved in disease risk and disease 
progression. The database has been created from text mining. The database and its content have 
been made available to the public from our webserver NutriChem: 
http://cbs.dtu.dk/services/NutriChem-1.0 
The third chapter of the thesis is on developing a molecular roadmap of drug-food 
interactions. Our main hypothesis in the current work is that the complex interference of food on 
drug pharmacokinetic or pharmacodynamics processes is mainly exerted at the molecular level 
via natural compounds in food that are biologically active towards a wide range of proteins 
involved in drug ADME and drug action. Hence, the more information we gather about these 
natural compounds, such as molecular structure, experimental and predicted bioactivity profile, 
the greater insight we will gain about the molecular mechanisms dictating drug-food interactions, 
which will help us identifying, predicting and preventing potential unwanted interactions between 
foods and marketed- or novel drugs. Unlike drug bioactivity information that has already been 
made available for system-level analyses, biological activity data and source origin information of 
natural compounds present in food are scarce and unstructured. To this end, we integrate protein-
chemical interaction networks, gene expression signatures and molecular docking to provide the 
foundation for understanding mechanistically the effect of eating behaviors on therapeutic 
intervention strategies. 
The fourth chapter of the thesis is a case study on diet-colon cancer through candidate 
molecular interaction networks. The study shows a holistic examination of the dietary 
components for exploring the mechanisms of action and understanding the nutrient-nutrient 
interactions. In this paper we used colon cancer as a proof-of-concept for understanding key 
regulatory sites of diet on the disease pathway. We propose a framework for interrogating the 
critical targets in colon cancer process and identifying plant-based dietary interventions as 
important modifiers using a systems chemical biology approach. 
  
Summary 
 
9 
 
The fifth chapter of the thesis is on discovering of novel anti-ovarian cancer compounds 
from our diet.  Ovarian cancer is the leading cause of death from gynecological disorders with an 
increasingly high incidence, especially in the western world. Epidemiological studies suggest that 
some dietary factors may play a role in the development of ovarian cancer; so far most studies 
have shown up inconclusive. In the present study we disclose novel anti-ovarian cancer 
compounds from our diet with activity against ovarian cancer, through text mining and a system-
wide association of phytochemicals, foods and health benefits on human ovarian cancer. We 
selected several compounds that where predicted to have anti-ovarian cancer activities, using 
chemoinformatics approaches and evaluated and confirm their activities in vitro.

Summary 
 
11 
Resumé (Dansk) 
"Forebyggelse er bedre end helbredelse", og når det kommer til menneskers sundhed, 
udmønter dette sig i mange samfundsøkonomiske fordele. Stort set alle de cellulære processer, 
herunder alle trin i strømmen af genetisk information fra gen udtryk til proteinsyntese og 
nedbrydning, kan påvirkes af kost og livsstil. Svarende til lægemidler indeholder næringsstoffer en 
række forskellige forbindelser, der virker som modifikatorer for funktion og stabilitet. Imidlertid er 
graden af kompleksitet i ernæring studier yderligere påvirket af den samtidige tilstedeværelse af en 
række næringsstoffer, med forskellige kemiske strukturer, der kan have mange størrelse med 
forskellige tilhørsforhold. Det er klart, dette adskiller den ernæringsmæssige studier fra 
farmakologiske studier, hvor enkelte elementer anvendes ved lave koncentrationer og med en 
relativ høj affinitet og specificitet i et lille antal omhyggeligt udvalgte mål. Vores behov for 
grundlæggende forståelse af byggestenene i de komplekse biologiske systemer havde været den 
vigtigste årsag til den reduktionistiske tilgang, der blev primært anvendt i førhen for at belyse disse 
systemer. I dag er det almindeligt anerkendt, at systemer og netværks biologi har potentiale til at 
øge vores forståelse af, hvordan små molekyler påvirker metaboliske veje og homeostase, hvordan 
disse perturbationsmetoder påvirker sygdomstilstand, og i hvilket omfang de enkelte genotyper 
bidrage til dette. En frugtbart strategi til ernæringsmæssige forskning er derfor at låne metoder, 
der er godt etableret i medicinsk og farmakologisk forskning.  
I denne afhandling, bruger vi avancerede data mining-værktøjer til konstruktion af en 
database med tilgængelige, state-of-the-art oplysninger om samspillet mellem mad og dets 
molekylære komponenter med biologiske systemer og deres forbindelse til sundhed og sygdom. 
Databasen vil blive beriget med forudsete vekselvirkninger mellem fødevare-komponenter og 
proteinerne i vores krop, baseret på deres strukturelle og pharmacophore lighed med kendte 
ligander. I forlængelse af dette, vil de sammenslutninger af bioaktive fødevarer komponenter med 
metaboliske veje undersøges ud fra et kemisk-protein-netværk perspektiv, mens deres virkninger i 
netværk robusthed vil blive yderligere bekræftet af proteom analyser og high-throughput 
genotype-fænotype karakterisering. 
Det første kapitel i denne afhandling handler om udviklingen af vores datagrundlag. I dette 
arbejde anvender vi tekst mining og Naïve Bayes klassifikation til at samle viden om af 
fytokemikalier i plantefødevarer og deres fødevare-sygdom sammenhænge, hvor vi skelner 
mellem sygdomsforebyggelse/forbedring og sygdomsprogression. Vi søger efterfølgende 
forekomsten af fytokemikalie-sygdoms par og vi identificerede 20.654 fytokemikalier fra 16.102 
planter, der er forbundet til 1.592 humane sygdomsfænotyper. 
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Vi valgte tyktarmskræft som case og har analyseret vores resultater i tre retninger; i) et one-stop 
videns punkt for effekten af ernæring på sygdom, ii) opdagelsen af helt nye bioaktive forbindelser 
med stof-lignende egenskaber, og iii) opdagelse af nye sundhedsmæssige fordele fra fødevarer. 
Dette arbejde repræsenterer en systematiseret tilgang til forståelsen af fødevarer og deres 
sundhedseffekt, og giver et fytokemikalie lag af oplysninger til brug inden for ernæringsmæssig 
systembiologisk forskning. Dette arbejde virker også som et proof-of-concept, at en 
systembiologisk tilgang til forskning inden for ernæring er meningsfuldt og demonstrerer nogle 
grundlæggende principper om, hvordan man arbejder med ernæring systematisk. 
Det andet kapitel i denne afhandling er en database publikation. Vi udviklede ressourcen 
NutriChem v1.0. En fødevare-kemisk database der forbinder kemi fra plante-baserede fødevarer 
med humane sygdomsfænotyper og giver et grundlæggende fundament for at forstå 
konsekvenserne af spiseadfærds virkning på sundhed mekanistisk. Kostbestanddele kan fungere 
direkte eller indirekte på det menneskelige genom og modulere processer involveret i risiko for 
sygdom og sygdomsprogression. Databasen er udarbejdet ved brug af tekst mining. Databasen og 
dens indhold er blevet gjort tilgængelige for offentligheden via vores webserver NutriChem: 
http://cbs.dtu.dk/services/NutriChem-1.0 
Den tredje kapitel i denne afhandling handler om udvikling af en molekylær køreplan for 
lægemiddel-fødevare interaktioner. Vores vigtigste hypotese i det aktuelle arbejde er, at den 
komplekse indblanding af fødevarer på lægemidlers farmakokinetiske eller farmakodynamiske 
natur hovedsageligt udøves på det molekylære plan via de naturlige stoffer der findes i fødevarer. 
Disse stoffer er biologisk aktive mod en bred vifte af proteiner involveret i ADME og 
lægemiddelvirkning. Derfor, jo flere oplysninger, vi indsamler om disse naturlige forbindelser, 
såsom molekylær struktur og bioaktivitets profil, jo større indsigt, får vi om de molekylære 
mekanismer dikteret af lægemiddel-fødevarer interaktioner, som vil hjælpe os med at identificere, 
forudsige og forebygge potentielt uønsket samspil mellem mad og markedsførte- eller nye 
lægemidler. I modsætning til lægemidlers bioaktivitets oplysninger, der allerede er gjort 
tilgængeligt for system-niveau analyser, biologiske aktivitetsdata og kilde oprindelsesoplysninger 
af naturlige forbindelser til stede i fødevarer er begrænsede og ustruktureret. Til dette formål har 
vi integreret protein-kemiske interaktions netværk, gen-ekspression signaturer og anvendt 
molekylær docking for at give et grundlag for at forstå effekten af spise adfærd på terapeutisk 
interventions strategier. 
Det fjerde kapitel i denne afhandlingen er et casestudie om diæt og tyktarmskræft gennem 
kandidat molekylærer interaktion netværk. Undersøgelsen viser en holistisk gennemgang af kost 
komponenter for at udforske de virkningsmekanismer og forstå samspillet af næringsstoffer. I 
denne artikel har vi brugt tyktarmskræft som et proof-of-concept for at forstå vigtige regulatoriske 
komponenter i kosten. 
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Vi foreslår en ramme for undersøgelse af kritiske mål i tyktarmskræfts proces og identificere 
plantebaserede diætinterventioner som vigtige modifikatorer ved hjælp af en system-kemisk 
biologi tilgang. 
Det femte kapitel i denne afhandling handler om opdagelsen af nye anti- kræft i 
æggestokkene stoffer fra vores kost. Kræft i æggestokkene er den førende dødsårsag fra 
gynækologiske lidelser med en stadig høj forekomst, især i den vestlige verden. Epidemiologiske 
undersøgelser tyder på, at nogle kost faktorer kan spille en rolle i udviklingen af kræft i 
æggestokkene. I den foreliggende undersøgelse afslører vi nye potentielle anti- kræft i 
æggestokkene stoffer fra vores kost, via tekst mining og et system af fytokemikalier, fødevarer og 
sundhedsmæssige fordele på menneskers kræft i æggestokkene. Vi valgte flere stoffer, der blev 
forudsagt til at være aktive fra vores analyse, afprøvede deres aktivitet i celle linje studier og 
kunne heraf bekræfte den forudsagte aktivitet for flere af stofferne. 
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Introduction 
 
The structure of the thesis is illustrated in Figure 1. In the following we will walk through 
the basic principles of the thesis, and provide an overview of the theoretical background of its 
content. First we define the basic principles of nutritional systems biology that govern our 
research. Following this, we introduce our data resource, PubMed/MEDLINE, and the main 
concepts behind data extraction. Finally we present publicly available chemical and biological 
data sources that we have integrated in our work. 
 
 
Figure 1: In the first and second chapter we develop the data infrastructure and define the basic 
principles of our research. In the following three chapters we explore our data 
warehouse in respective case studies on drug-food interactions and effects of food and 
its components on colon and ovarian cancer. 
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Nutritional systems biology 
 
Similar to the role of pharmaceuticals, nutrients contain a number of different compounds 
that act as modifiers of network function and stability. However, the level of complexity in 
nutrition studies is further increased by the simultaneous presence of a variety of nutrients, with 
diverse chemical structures that can have numerous targets with different affinities and 
specificities. Obviously, this differentiates the nutritional from the pharmacological studies, where 
single elements are used at low concentrations and with a relatively high affinity and specificity in 
a small number of thoroughly selected targets. 
Our need for fundamental understanding of the building blocks of the complex biological 
systems had been the main reason for the reductionist approach that was mainly applied in the 
past to elucidate these systems. Nowadays, it is widely recognized that systems and network 
biology has the potential to increase our understanding of how small molecules affect metabolic 
pathways and homeostasis, how this perturbation changes at the disease state, and to what extent 
individual genotypes contribute to this. A fruitful strategy in approaching and exploring the field 
of nutritional research is, therefore, to borrow methods that are well established in medical and 
pharmacological research. Molecular interaction networks could provide a convenient and 
practical scaffold to bridge the gap between nutritional research and systems biology and to make 
possible the designing of optimal diets that would allow health maintenance and disease 
preventions for individuals. 
 
 
PubMed 
MEDLINE (Medical Literature Analysis and Retrieval System Online), the database behind 
PubMed, is a literature database of life sciences and biomedical information. It is a database 
developed by the U.S. National Library of Medicine database (NLM)(1982). Currently, there are 
5080 journals indexed as ‘Index Medicus’, which is the core content of the database. There are 
additional 575 journals not indexed in ‘Medicus’ within the following areas: 90 journals within 
dentistry, 18 within AIDS/HIV, 15 Consumer Health, 183 Nursing, 101 Health care 
administration, 85 health care technology, 80 history of medicine 
(http://www.nlm.nih.gov/bsd/num_titles.html, Accessed Feb. 28 2014). 
The first version of the database can be traced back to a collection of books in the US 
Surgeon General’s office and was in time expanded with the aim to become more complete 
within health science as the ‘Index Medicus’. It was later developed in an electronic version, 
MEDLARS, and became online in 1996 as MEDLINE (Pritchard and Weightman, 2005). 
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For many years, the U.S. National Library of Medicine (NLM) has considered MEDLINE to be 
the definitive version of its indexing data 
(http://www.nlm.nih.gov/pubs/techbull/mj04/mj04_im.html, Accessed Feb. 28 2014). Today, 
the scope of journals indexed in MEDLINE ranges from life sciences to biomedicine, 
biochemistry, behavioral sciences, chemical sciences, and bioengineering. The objective of the 
choice of journals is to provide information on relevant literature to health professionals and 
others engaged in research or education. January 2014, the database had more than 22 million 
references to journal articles within life science (2014). The development of PubMed has been 
illustrated in Figure 2A. 
The NLM, National Center for Biotechnology Information has invested huge efforts on 
indexing the literature and this has led to an extensive database with literature meta-data. The 
meta-data includes among others information on ‘genes’, ‘proteins’, ‘chemicals’ or ‘diseases’ 
related to the indexed literature. While biological sciences are moving towards a systems 
approach, meta-data has become more and more important for literature search for scientist and 
researchers. This has led to the development of the National Center for Biotechnology 
information (NCBI) E-utilities, which are a set of eight server-side programs that provide a stable 
interface into the Entrez query and database system at the NCBI (2010a). 
MEDLINE is provided in XML file-format 
(http://www.nlm.nih.gov/bsd/mms/medlineelements.html, 
http://www.w3schools.com/xml/xml_whatis.asp, Accessed Feb. 28 2014). In this file each 
journal article is listed as an xml-object with a set of associated (meta) data fields. Examples of 
such fields are ‘title’, ‘author’, ‘abstract´ and ‘journal’. However, there is an additional vast 
amount of data-fields available for each article record. MEDLINE includes some special data-
fields, which function as controlled vocabularies to ease the search within certain scientific areas. 
The MeSH term is one such term that is a controlled vocabulary of medical subject headings 
(http://www.nlm.nih.gov/bsd/mms/medlineelements.html, Accessed Mar. 2 2014). The data-
structure of MEDLINE is shown in Figure 2B. 
The MeSH term is used to provide a ‘medical’ characterization of the content of the articles. 
The substance name term is another type of meta-data that contains any of the 3 types of 
supplementary concept record data 1) MeSH SCR chemical and drug terms, 2) protocol terms 
and 3) non-MeSH rare disease terms. The gene symbol field is another meta-data that contains 
the “symbol” or abbreviated form of gene names as reported in the literature. 
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Figure 2: A) The development of PubMed/MEDLINE through time. The first version of the 
database can be traced back to an expanded version of the US Surgeon General’s 
Office named ‘Index Medicus’. The database was later developed into an electronic 
version ‘MEDLARS’ and become online in 1996 as the MEDLINE database. B) 
The MEDLINE data-structure. MEDLINE is provided in XML-file format that 
stores the articles as xml-objects. These objects have a set of properties such as ‘title’, 
‘author’, ‘abstract’, ‘journal’ and a set of biochemical meta-data with disease, genes, 
chemicals and protein annotations. 
PubMed’s secondary uses 
 
The secondary use of health information includes uses outside of direct health care delivery; 
including activities such as research, analysis and quality measurement. The secondary uses of 
health information typically aims to advance our health care knowledge or expertise (Safran et 
al., 2007). Searching and identifying literature in PubMed/MEDLINE effectively is a learned 
skill.  For some searches the large numbers of retrieved articles causes frustration because of the 
lack of overview. A search that returns thousands of articles is not comprehensive, because it’s 
hard to get an overview of the content (Jain and Raut, 2011). Therefore, scientists have begun 
exploring other means of utilizing and navigating vast amount of relevant literature. This has led 
to an increasing interest in text mining and automated information extraction methods driven by 
an increasing number of electronically available publications, stored in databases such as 
PubMed. 
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Biomedical text mining refers to text mining applied to text and literature at the edge of the 
field of natural language processing, bioinformatics, medical information and computational 
linguistics. It is related to identification of biological entities, protein and gene names in free text. 
However, automated extraction of information has also been used to extract and compile 
databases on protein-protein interactions and to develop functional concepts of genes and gene 
ontologies (http://en.wikipedia.org/wiki/Biomedical_text_mining, Accessed Mar. 2 2014). 
Protein-Protein Interaction (PPI) extraction has become an important area in biomedical 
text mining, because the PPI information has become critical in the understanding of biological 
processes (Kim et al., 2008).  Today, there is a vast amount of a variety of web-servers that 
provides PPI information. 
The web-server ‘PIE’ (Protein Interaction information Extraction) is such a web-service that 
is created to extract relevant PPI articles from MEDLINE (Kim and Wilbur, 2011; Kim et al., 
2008, 2012). Another, biomedical text-mining web-server is ‘KLEIO’. KLEIO is an advanced 
information retrieval system that provides an enriched searching for relevant literature within 
biomedicine. The web service provides searches in categories such as protein, gene, metabolite, 
disease, symptom, organ etc. and scores them based on their relevance (Nobata et al., 2008). A 
common feature for most biomedical text-mining services is that they provide ‘improved’ searches 
or structured searches. Instead of just providing another searching option, there have been some 
advances such as recognizing named entities (Rocktäschel et al., 2012). However, the more 
interesting directions biomedical text mining is when it’s used to compile databases that can be 
used for system-wide modeling of biological systems. Such as ChEMBL, STRING or STITCH 
(Kuhn et al., 2010; Overington, 2009; Szklarczyk et al., 2011). 
 
Text-mining 
The increasing amount of published literature on biomedicine represents an extremely large 
source of information (Bundschus et al., 2008). With an overwhelming amount of textual 
information on molecular biology and biomedicine, there is a need for effective and efficient 
literature mining and knowledge discovery that can help biologist to gather and make use of the 
knowledge encoded in text documents (Zhou et al., 2004a). Automatic extraction of names plays 
an important role in the increasing challenge of extracting information from free text literature. 
Traditionally, text mining is defined as the automatic discovery of previously unknown 
information by extracting information from text. However, in the community the text mining is 
often reduced to the process of highlighting small pieces of relevant information from large 
collections of raw text data (Spasic et al., 2005). 
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Text-mining can be divided into the following three categories: 1) Information retrieval, 
which gathers and filters relevant documents. 2) Information extraction, which extracts specific 
facts about predefined names or relationships. 3) Data mining, which is used to discover 
unsuspected associations between known facts, such as linking a plant to a disease (Spasic et al., 
2005). The categories are shown in Figure 3A. The most recent development of text mining 
applications aim to assist researchers in obtaining and managing additional information by 
incorporating text-mining and natural-language processing tools for the extraction and 
compilation of functional characteristics (Krallinger et al., 2005). Most natural language 
processing and text-mining applications take advantage of a range of domain-independent 
methods such as part-of-speech (POS) taggers, which label each word with its corresponding part 
of speech or stemmers, that return the morphological root of a word form (Krallinger et al., 2005). 
Although extraction of relations between the recognized entities is also possible, most work to 
date is focused on the mere detection of entities (Bundschus et al., 2008). A flow diagram 
showing the relationship between natural language processing, classification and its use is shown 
in Figure 3B. 
Text-mining applications are very powerful in their ability to integrate a broad spectrum of 
heterogeneous data resources, by transforming unlinked data into usable information and 
knowledge (Krallinger et al., 2005). All text-mining algorithms make errors when extracting facts 
from natural-language texts (Rodriguez-Esteban et al., 2006). Unfortunately, the current tools of 
information extraction produce imperfect, noisy results (Rodriguez-Esteban et al., 2006). 
Therefore, in biomedical applications it is crucial to assess the quality of individual facts – to 
resolve data conflicts and inconsistencies (Rodriguez-Esteban et al., 2006). Biomedical language 
and vocabularies are highly complex and rapidly evolving, making the identification of entities a 
cumbersome task (Krallinger et al., 2005). Among the strategies adopted to tag entities are 
methods such as ad hoc rule-based approaches, approaches using dictionaries with subsequent 
exact or inexact pattern matching, various machine-learning techniques and hybrid approaches 
that take advantage of different techniques (Krallinger et al., 2005). 
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Figure 3: A) The three categories of text mining. The first category is information retrieval that 
gathers and filters relevant documents. The second category is information 
extraction that extracts specific facts about predefined names or relationships. The 
third category is data-mining that is used to discover unsuspected associations 
between known facts, such as linking a plant to a disease. 
B) Flow-diagram showing the relationship between natural language processing, 
classification and its use. A classifier like the Naïve Bayesian classifier can be used as 
a classifier for natural language processing in order to recognize entities in textual 
data or to extraction relationships or meta-data. 
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Semantic browsing and automatic annotation (information retrieval) 
Browsing biomedical literature involves two basic tasks: 1) Finding the right literature and 
2) Making sense of its content. A lot of research has gone into supporting the task of finding the 
right literature either by means of standard literature searching or by means of semantically 
enhanced search (Guarino et al., 1999; McGuinness, 1998). Anyone who regularly reads life 
science literature often comes across names of genes, proteins or small molecules that one would 
like to know more about. Searching and retrieving information about these name entities is only 
possible if they have been annotated from the textual data. Annotation technologies allow users 
to associate meta-information with textual data, which can then be used to facilitate their 
interpretation (Kahan et al., 2001; Ovsiannikov et al., 1999; Vargas-Vera et al., 2002). While such 
technologies provide a useful way to support group-based and shared interpretation, they are 
nonetheless very limited, because the annotation is carried out manually. The quality of the sense 
making abilities of the annotations depends on the willingness of stakeholders to provide 
annotation, and their ability to provide valuable information. Annotation of literature meta-data 
is time consuming and expensive; most literature search databases such as PubMed does only 
provide annotation of named entities to some extent. This makes sematic browsing or exploration 
of the textual data complicated. 
Because of the extensive manual annotation, semantic browsing does not work well without 
a system to automatically annotate the textual data. This has brought some focus to the 
development of automatic annotations systems and lead to the pioneering of the system Cohse 
(http://cohse.cs.manchester.ac.uk/, Accessed March 14 2014) that is a system for automatic 
annotation of literature using ontologies (Goble et al.). The system enables users to choose from 
different ontologies, including those outside life science. However, the public available version of 
Cohse has only very little functionality(Pafilis et al., 2009). Another tool has recently been 
developed, Reflect (http://reflect.ws/, Accessed March 14 2014), which is an extendable 
platform that allows users to annotate documents and webpages with scientific entities. Reflect 
servers as an augmented browsing tool, broadly useful to life science (Pafilis et al., 2009). 
The idea about semantic browsing is that when browsing literature the system is capable of 
understanding the content of web pages. This is important when we are trying to retrieve the 
relevant literature within a specific field of study. The idea of the semantic browsing is to find a 
way for computers to understand the content and not just the structure. The power of semantic 
browsing becomes clear when, for example, one wishes to find the protein interactions related to 
the development of a particular disease. 
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The likelihood of knowing which keywords to search with to find all likely candidates is 
extremely low. However, with semantic browsing, it is unnecessary to know which keywords to 
search on, because the search engine automatically finds the words needed, making the search 
itself a subject area expert on every search performed. This is the fundamental principle of text 
mining and automatic information retrieval. 
 
ChemTagger 
Most of the literature has no or little annotation. Therefore, to extract useful information 
from textual data, the textual data needs first to be annotated. The automatic annotation of the 
textual data is achievable using semantic browsers such as Cohse 
(http://cohse.cs.manchester.ac.uk/, Accessed March 14 2014) or Reflect (http://reflect.ws/, 
Accessed March 14 2014). These web-services require the documents or textual data to be sent to 
a remote server through the Internet. Thus, the amount of text that can be annotated in a realistic 
time frame is limited. 
ChemTagger that has been developed within the present project 
(https://pypi.python.org/pypi/ChemTagger, Accessed March 15 2014) is a module that can be 
loaded into the python3 interpreter and incorporated into other python3 programs. The words 
from the ontologies loaded into the module and the words in the textual data are linked with a 
rule-based algorithm designed to match names of chemical compounds, therefore the name 
‘ChemTagger’. However, the module is perfectly capable of matching names and terms of any 
other types as well. Through the python-shelve technology the module allows users to upload 
‘huge’ ontologies of names and terms into virtual memory without putting pressure on the 
machine memory. This allows the user to annotate documents using ontologies at a size far 
exceeding the memory available on the machine. The technology also enables the user to do the 
annotation using several processors sharing the same virtual memory. 
Annotation of textual data has so far only been possible using huge memory machines with 
a lot of processors, where the full ontologies to be used for the annotation has to be loaded into 
the machine memory before annotation can be performed. The makes the annotation processor 
expensive and resource consuming. The ChemTagger module allows users to do the annotation 
of a resource such as PubMed/Medline in a reasonable amount of time using only few system 
resources.  
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Natural Language processing 
Initially, natural language processing (NLP) systems were based on complex sets of hand-
written rules. However, with increasing computational power and the gradual lessening of the 
dominance of Chomskyan theories of linguistics (such as transformational grammar), 
(http://en.wikipedia.org/wiki/Natural_language_processing, Accessed March 17 2014), the 
machine-learning approach to language processing has been gaining popularity. There are several 
advantages to machine-learning algorithms compared to hand-produced rules: The learning 
procedures used during machine learning automatically snap-in on the common cases, whereas 
the hand-written rules are often not at all obvious in relation to where the effort should be put 
(http://en.wikipedia.org/wiki/Natural_language_processing, Accessed March 17 2014). Another 
important advantage is that automatic learning procedures can make use of statistical inference 
algorithms to produce models that are robust to unfamiliar or erroneous input 
(http://en.wikipedia.org/wiki/Natural_language_processing, Accessed March 17 2014). 
 
Naive Bayes classifier 
When extracting information on the relationship between entities, the relationship of the 
entities depends on the context the entities. In order to make sense of textual data, the complex 
nature of natural language has to be processed (Rodriguez-Esteban et al., 2006). A means to 
process the complex nature of natural language and to extract information about the relationships 
of entities is to create a vector with text fragments for each entity relationship. These vectors can 
then be assigned a label, and a machine-learning algorithm can be trained to assign labels to new 
textual vectors (Rodriguez-Esteban et al., 2006). In text mining there can be differences in how 
the textual vectors are created as well as how they are assigned labels. Unfortunately, so far the 
current tools of information extraction still produce imperfect, noisy results (Rodriguez-Esteban et 
al., 2006). 
A popular method for assigning new labels to textual vectors is the Naïve Bayes Classifier, 
which is a machine-learning method. The Naïve Bayes classifier in based on Bayes’ theorem with 
independence assumptions between the predictors 
(http://www.saedsayad.com/naive_bayesian.htm, Accessed 15 March 2014). The model is also 
known as an independent feature model. For some types of probability models, the naïve Bayes 
classifier is easily trained and can be very efficient despite its relative simplicity. 
(http://en.wikipedia.org/wiki/Naive_Bayes_classifier, Accessed 15 March 2014). The Bayesian 
classifier assigns objects to classes if the posterior probability is greater for the class than for any 
alternative. 
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This posterior probability is computed in the following way (Rodriguez-Esteban et al., 2006): 𝑃 𝐶 = 𝑐! 𝐹 = 𝐹! = 𝑃 𝐶 = 𝑐! ×𝑃(𝐹 = 𝐹!|𝐶 = 𝑐!)𝑃(𝐹 = 𝐹!)  
When training, the probability 𝑃(𝐹 = 𝐹!|𝐶 = 𝑐!) is estimated from the training data as a 
ratio of the number of objects that belong to the class ck and have the same set of feature values as 
specified by the vector Fi to the total number of objects in class ck 
(http://en.wikipedia.org/wiki/Naive_Bayes_classifier, Accessed March 16 2014). The method 
handles a binary or a real value feature vector. While binary features are directly used in a 
frequency count for the classifier, the real value features are transformed, typically using a normal 
distribution (http://en.wikipedia.org/wiki/Naive_Bayes_classifier, Accessed March 16 2014). 
An advantage of naive Bayes is that it only requires a small amount of training data to 
estimate the parameters necessary for classification. Independent variables are assumed and only 
the variance of the variables for each class needs to be determined 
(http://en.wikipedia.org/wiki/Naive_Bayes_classifier, Accessed March 16 2014). Even through 
the naive Bayes classifier represents some oversimplified assumptions, it works quite well in many 
complex real-world situations. In 2004, an analysis of the Bayesian classification problem showed 
that there are some theoretical reasons for the apparently implausible efficacy of naive Bayes 
classifiers (Zhang, 2004). 
The main reason for choosing the naïve Bayesian classifier for natural language processing 
is that the classifier is relatively easy to train without the need of huge training sets. The 
theoretical principle behind the method is relatively simple, which makes it easy to implement 
and to debug. Due to the simplicity of the classifier results are easily reproduced. A python3 
implementation of the naïve Bayesian classifier has been made available for download at the 
Python Package Index (PyPI) (https://pypi.python.org/pypi/NaiveBayes, Accessed March 16 
2014). 
 
Training and evaluating machine learning methods 
Machine learning methods, as with all statistical models, need to be trained on an input data 
set. Training can take place either using a supervised approach, where the model fits training data 
to a specific parameter value, or unsupervised approach, where the model fits hidden structures in 
unlabeled training data (http://en.wikipedia.org/wiki/Unsupervised_learning, Accessed March 
17 2014). In both cases, evaluation of the quality model is required to ensure that there has been 
no ‘overfitting’ of data and that the parameters of the model are meaningful. Overfitting can be 
avoided by using cross-validation during training, which predicts the ‘fit’ of the model to a 
hypothetical validation set (http://en.wikipedia.org/wiki/Cross-validation_%28statistics%29, 
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Accessed March 17 2014). The most common form of cross-validation is the 10-fold cross 
validation, where the training set is divided into 10 parts. A model is then estimated (trained) on 
nine parts and evaluated on one part. The performance is measured and this is repeated 10 times 
until the model has been trained and validated on the whole set. The final performance measure 
is then calculated as the average from all 10 repeats (http://en.wikipedia.org/wiki/Cross-
validation_%28statistics%29, Accessed March 17 2014). 
The confusion matrix is a table that allows for the visualization of the performance of a 
statistical model. In this table each column of the matrix represents the instances in a predicted 
class, while each row represents the instances in an actual class: True positives (tp), false negatives 
(fn), false positives (fp) and true negatives (tn) (http://en.wikipedia.org/wiki/Confusion_matrix, 
Accessed March 17 2014). The confusion matrix is shown in Table 1. 
 
Table 1: The table illustrates the confusion matrix. The table has the ‘actual’ labels in rows and 
the ‘predicted’ labels in columns. 
 
 
Model performance can be measured in a variety of ways and different fields of science tend 
towards using specific performance measures. Accuracy is the most common performance measure 
and is calculated from the number of true positives (tp) and true negatives (tn) divided by the total 
number of instances (http://en.wikipedia.org/wiki/Accuracy_and_precision, Accessed March 17 
2014). 
Accuracy = tp+ tn
tp+ fp+ fn+ tn 
For text-mining a common performance measure is the F1-score, which considers both 
precision and recall of the model (http://en.wikipedia.org/wiki/F1_score, Accessed March 17 
2014). 𝐹! = 2 ∙ precision   ∙  recallprecision  +   recall 
 
  
P' (Predicted) N' (Predicted)
P (Actual) True positives 
(tp)
False negatives 
(fn)
N (Actual) False positives 
(fp)
True negatives 
(tn)
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The precision is the fraction of correct instances retrieved compared to the total amount of 
instances, while the recall is the fraction of correct instances that are retrieved correctly 
(http://en.wikipedia.org/wiki/Precision_(information_retrieval), Accessed March 17 
2014). 
precision = tp
tp+ fp 
recall = tp
tp+ fn 
 
Black listing of words 
There are different types of biomedical text mining and depending on the type of text 
mining one is interested in, some specific issues is relevant and should be taken into 
consideration. Text-mining were information is extracted about named entities or terms such as 
protein-protein interactions or plant-compound associations has the limitation that the ‘quality’ 
words and their meaning depends on context (Spasic et al., 2005). The words in the dictionaries 
used for this type of text mining have a ‘quality’ because the information that can be extracted 
depends on the names and terms defined in the ontology and dictionary. Even when a single 
standardized ontology is used, it is not always straightforward to link textual information with the 
ontology. The two major obstacles are 1) inconsistent and imprecise practice in the naming of 
biomedical concepts (terminology), and 2) incomplete ontologies as a result of rapid knowledge 
expansion (Spasic et al., 2005). 
Text mining of the type were information is extracted about name entities is limited to only 
recognize those names and terms that are included in the dictionary. The ‘quality’ issue of names 
and terms is not commonly addressed which we believe may be due to the fact that most of the 
dictionaries and ontologies used are curated manually (International Conference on Information 
and Knowledge Engineering and IKE ’04, 2004). However, despite of whether the dictionaries 
and ontologies are compiled or curated manually a ‘quality’ of names and terms still applies. In 
order to control the quality of our dictionaries we need to use ‘black listing’ of certain words and 
terms to ensure the outcome from our extraction. For example, the word ‘syndrome’ is a valid 
disease term. However, the term is not very specific and does not specify anything biological 
meaningful. Therefore, this word should be put on the blacklist. The same applies to the word 
‘isolated’, which is part of a synonym for the inflammatory disease of the myocardium: ‘isolated 
fielder’s’. However this term is too common to be of interest and its inclusion will yield a high 
number of false positive associations. It should therefore be either excluded our controlled during 
the text-mining process. 
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Dictionaries and ontologies 
For text mining the dictionaries define the words or named entities that we are interested in 
extracting information about. The kind of information we could be interested in extraction could 
be the relationship between two named entities. The word ontology has long been used to 
describe the branch of philosophy that deals with the study of being. In the context of text mining 
the ontology (or dictionary) refers to a formal specification of a conceptualization of words 
(Cimino and Zhu, 2006). The ontologies can range from a verity of methods; from terminologies 
that are little more than manually created hierarchical arrangements of terms, whose developers 
nevertheless consider them to be ontologies; to ontologies which are compiled semi-automatic 
(Cimino and Zhu, 2006). A concept for ontologies which have had a great impact on how we 
make dictionaries and ontologies today, is the Unified Medical Language System (UMLS) 
(Cimino and Zhu, 2006). Unified Medical Language System (UMLS) was created by US 
National Library of Medicine and identifies terminological entities at three levels: The string (any 
name for a term in a terminology), the lexical group (to which strings of identical or near-identical 
lexical structure can be mapped) and the concept (to which strings of identical meaning can be 
mapped) (Cimino and Zhu, 2006). 
Ontologies have been widely accepted as the most suitable representation model for 
conceptual information and an important building block of semantic web (International 
Conference on Information and Knowledge Engineering and IKE ’04, 2004). Ontologies have 
been developed to capture the knowledge of the real world domain as a formal and explicit 
specification of a shared conceptualization (International Conference on Information and 
Knowledge Engineering and IKE ’04, 2004). The benefits from ontologies come from the 
ontologies usage from knowledge sharing and reusability of domain knowledge (International 
Conference on Information and Knowledge Engineering and IKE ’04, 2004). As controlled 
medical terminologies develop from simple code-name-hierarchy arrangements, into rich, 
knowledge-based ontologies of medical concepts. There has been an increasing demand on both 
the developers and users of the both ontologies and terminologies (Cimino, 2001). 
 
NCBI Taxonomy 
An important source of names of organisms, plants and foods for text mining is the NCBI 
taxonomy (McEntyre and Ostell, 2003). The NCBI taxonomy is a curated database of names and 
classifications for all organisms that are represented in GenBank (McEntyre and Ostell, 2003). 
The names are derived when new sequences are submitted to GenBank, the submission is 
checked for new organism names, which are then classified and added to the taxonomy database 
(McEntyre and Ostell, 2003). In a phylogenetic classification used for the NCBI taxonomy 
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classification scheme, the structure of the taxonomic tree approximates the evolutionary 
relationships among the organisms included in the classification (McEntyre and Ostell, 2003). 
April 2003, the database had 176,890 registered taxa’s (McEntyre and Ostell, 2003). The NCBI 
taxonomy is available for download from the NCBI taxonomy website 
(http://www.ncbi.nlm.nih.gov/taxonomy, Accessed March 5 2014). The ontology is available in 
‘dmp’ format and for text-mining purpose one can use the files: ‘names.dmp’ that has the names 
of the taxa’s and ‘nodes.dmp’ which contains the taxonomic hierarchy. The file ‘names.dmp’ lists 
the scientific name and synonyms for organisms in ‘nodes.dmp’ 
(http://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/NCBI/metarepresentation.
html, Accessed March 5 2014). 
 
Human Disease Ontology 
An important source of human disease names for text mining is the human disease ontology 
developed by the Center for Genetic Medicine of Northwestern University. The human disease 
ontology project is driven to large extent by the data aggregation and analysis needs of the 
NUgene Project at the Center for Genetic Medicine (http://do-wiki.nubic.northwestern.edu/do-
wiki/index.php/Main_Page, Accessed March 5 2014). 
The human disease ontology is designed to link disparate datasets through disease concepts 
and provides a computable structure of inheritable, environmental and infectious origins of 
human disease to facilitate the connection of genetic data, clinical data, and symptoms through 
the lens of human disease (http://do-wiki.nubic.northwestern.edu/do-
wiki/index.php/Main_Page, Accessed March 5 2014). The human disease ontology is available 
for download in ‘obo’ format. The OBO flat file format is an ontology representation language. 
The format is similar to the tag-value format of the GO definitions file. ‘obo’ format is the text file 
format used by OBO-Edit, the open source, platform-independent application for viewing and 
editing ontologies (http://www.geneontology.org/GO.format.obo-1_4.shtml, Accessed March 5 
2014). 
The required tags for a human disease term on the ontology are: ‘id’ tag that is a unique id 
of the term and ‘term name’. Each term has only one name defined. The terms have several 
optional tags that can be useful for text-mining purposes.  The ‘is_a’ tag describes a sub-class 
relationship between one term and another. A term may have any number of ‘is_a’ relationships 
(http://www.geneontology.org/GO.format.obo-1_4.shtml, Accessed March 5 2014). 
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The PubChem Repository 
PubChem (https://pubchem.ncbi.nlm.nih.gov, Accessed March 5 2014) is a database where 
users deposit chemical structures. The chemical structures are then in time validated and 
standardized to comprise a non-redundant set of chemical structures. The chemical names shown 
in the PubChem compound records are a composite derived from all linked substances where the 
names are ranked by frequency of use (http://pubchem.ncbi.nlm.nih.gov/help.html, Accessed 
March 5 2014). Users deposit their own compound records in PubChem. This has the advantage 
that PubChem has an incredible high coverage of compound names and structures. However, the 
compound names and structures deposited are not always accurate and curation of PubChem is 
slow. Therefore, the compound names and structures are not always meaningful but the database 
has the advantage of high coverage. 
The PubChem database is available for download in ASN (ASN.1 formatted data), SDF 
(SDF formatted data) and XML (XML formatted data). The ANS and XML data formats 
contain the information related to the PubChem records while the SDF data format contains the 
chemical structure of the compounds 
ftp://ftp.ncbi.nlm.nih.gov/pubchem/Compound/CURRENT-Full/README-Compound, 
Accessed March 5 2014). 
 
ChEBI 
Chemical Entities of Biological Interest (ChEBI) is a freely available dictionary of molecular 
entities focused on 'small' chemical compounds. The dictionary has been compiled from a 
number of different sources were incorporated and then merged (Degtyarenko et al., 2008). For 
the first release of the database, data was drawn from three main sources: 1) The IntEnz database 
an integrated relational enzyme database of EBI. The IntEnz database contains the enzyme 
nomenclature, the recommendations of the NC-IUBMB on the nomenclature and classification of 
enzyme catalyzed reactions. 2) The compounds of the KEGG Ligand Database, the Kyoto 
Encyclopedia of Genes and Genomes (KEGG) (http://www.genome.jp/kegg/ligand.html, 
Accessed March 6 2014). 3) A chemical ontology developed by Michael Ashburner and Pankaj 
Jaiswal, the initial alpha release was merged into ChEBI (Degtyarenko et al., 2008). One 
advantage of ChEBI is that the terminology used is explicitly endorsed, where applicable, by 
international bodies such as IUPAC (http://www.iupac.org) (general chemical nomenclature) 
and NC-IUBMB (http://www.iubmb.org) (biochemical nomenclature). This provides a 
dictionary with compound terms and names of a reasonable quality. The content of the database 
is relative controlled, through curation and merging of other database (Degtyarenko et al., 2008). 
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The ChEBI dictionary is available for download in SDF and OBO data formats. The SDF 
data format contains the chemical structure of the compounds, while the OBO data format 
contains the compound names and meta-data. The OBO flat file format is an ontology 
representation language. The format is similar to the tag-value format of the GO definitions file. 
OBO format is the text file format used by OBO-Edit, the open source, platform-independent 
application for viewing and editing ontologies (http://www.geneontology.org/GO.format.obo-
1_4.shtml, Accessed March 6 2014). The required tags for the ChEBI dictionary are: ‘id’ tag that 
is a unique id of the compound term and ‘term name’. The terms have several optional tags that 
can be useful for text-mining purposes.  The ‘is_a’ tag describes a sub-class relationship between 
one term and another. A term may have any number of ‘is_a’ relationships 
(http://www.geneontology.org/GO.format.obo-1_4.shtml, Accessed March 6 2014). 
 
 
 
Figure 4: Diagram showing the three databases; ChEMBL, The Therapeutic Target database 
and DrugBank. The ChEMBL database contains compound – protein interactions 
and allows us to map external chemical structures to its compound – protein 
interaction data. The Therapeutic Target Database has information about proteins 
and their relation to diseases, including drugs and their relation to diseases. The 
database allows us to map external data to disease and drug information. The 
DrugBank database contains detailed information about drugs and similarly allows 
external data to be mapped. The database also contains information on drug effect 
targets, metabolizing enzymes, drug transporters and carriers. 
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Drug effect targets and human disease associations 
ChEMBL 
The effect of small molecule compounds can be linked to our proteome by mapping the 
small molecules to a chemical-protein interaction database.  An important database with 
chemical-protein interactions is ChEMBL, which is a database developed by the European 
Molecular Biology Laboratory (Overington, 2009). At the time of writing the ChEMBL database 
is in version 17 with 1.520.172 compound records covering 12.077.491 biological activities. The 
database contains two relevant files, a file with the chemical structures in Chemical table file SDF 
format (Dalby et al., 1992) and a file with the mapping of proteins listed in ChEMBL to UniProt 
ID’s (UniProt Consortium, 2014). The file with the chemical table file is convertible to a 
Simplified molecular-input line-entry system (SMILES) string (Weininger, 1988), which is a 
specification in form of a line notation for describing the structure of chemical molecules using 
short ASCII strings. There has since the introduction of the SMILES string been an extensive 
focus on the need of a simplified representation of chemical structures. For long the SMILES 
string has been the most dominant method of representing chemical structures in a simplified 
form. The SMILES is a trademark of Daylight Chemical Information Systems Inc. (Daylight). 
For this the development of the SMILES representation is controlled by Daylight. 
In order to provide an open alternative to the SMILES string. The International Union of 
Pure and Applied Chemistry (IUPAC) introduced the International Chemical Identifier (InChI) 
as a standard for formula representation (Heller et al., 2013). The methods are similar and solve 
the same task. The advantage of InChI is that it’s available under GNU Lesser General Public 
License and the development of the InChI is community driven. However, at the time of writing 
the SMILES still considered to have the advantage of being slightly more human-readable than 
InChI; it also has a wide base of software support with more robust implementations and 
extensive theoretical (e.g., graph theory). 
ChEMBL has four main tables which allows us to link food compounds to interactions with 
the human proteins. The first table is a ‘molecule dictionary’ where the chembl_id’s are mapped 
to molecule registration numbers (molregno). From molregno we can retrieve the activities of the 
compound using the ‘activities’ table. From the ‘activities’ table the ‘assay_id’ the target of the 
assay using the target id ‘tid’. This target id ‘tid’ is then linked to a ChEMBL id specifying the 
protein targeted. Small molecules can then be mapped to compounds in ChEMBL, using the 
SMILES representation and the outcome proteins with ChEMBL id’s can be linked to UniProt 
proteins. A diagram showing the use of the three databases ChEMBL, The Therapeutic target 
database and DrugBank is shown in Figure 4. 
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DrugBank 
DrugBank is a comprehensive database that contains information on a wide range of 
approved drug and potential bioactive molecules. The database provides an important insight into 
the use of drugs and bioactive molecules by grouping them into categories; FDA-Approved, 
Small molecules; Experimental; Nutriceutical; Illicit Drugs and Withdrawn Drugs. For each of 
these categories DrugBank contains information on which proteins has are drug effect targets; 
drug enzymes; transporters and carriers (Knox et al., 2011; Wishart et al., 2006, 2008). 
Integration of the information of known drugs is a highly valuable asset to improve our 
understanding of less studied food-compounds. The database contains 6825 drug entries including 
1541 FDA-approved small molecule drugs, 150 FDA-approved biotech (protein/peptide) drugs, 
86 nutraceuticals and 5082 experimental drugs. In addition, the database contains 4323 non-
redundant proteins. The advantage of this database is that the compounds can be linked through 
SMILES representation and the drug effect targets; absorption, distribution, metabolism, and 
excretion (ADME) proteins identified. 
 
TTD: Therapeutic Target Database 
The therapeutic target database (TTD) is a database that provides information on known 
and explored therapeutic proteins and targeted diseases. In addition, the database contains 
systematic information on drug to disease mapping which is less accessible in DrugBank (Chen et 
al., 2002; Zhu et al., 2010, 2012). Food-compounds and their interactions with human proteins, 
mapped through ChEMBL, becomes particular interesting when the interaction be linked with 
the therapeutic effects in TTD. At the time of writing, the database currently contains information 
on 2,025 targets, including 364 successful, 286 clinical trial, 44 discontinued and 1.331 research 
targets and 17.816 drugs, including 1.540 approved (Zhu et al., 2012). The therapeutic target 
database contains two important files. The first file is the main database with therapeutic target 
id’s for proteins with associated human disease names, which targeting the protein will have a 
therapeutic potential. The other file is the target information table, which maps the therapeutic 
target ids with UniProt. 
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Abstract 
Awareness that disease susceptibility is not only dependent on genetic make-up, but can be 
affected by lifestyle decisions, has brought more attention to the role of diet. However, food is 
often treated as a black box, or the focus is limited to few, well-studied compounds, such as 
polyphenols, lipids and nutrients. In this work, we applied text mining and Naïve Bayes 
classification to assemble the knowledge space of food-phytochemical and food-disease 
associations, where we distinguish between disease prevention/amelioration and disease 
progression. We subsequently searched for frequently occurring phytochemical-disease pairs and 
we identified 20,654 phytochemicals from 16,102 plants associated to 1,592 human disease 
phenotypes. We selected colon cancer as a case study and analyzed our results in three directions; 
i) one stop legacy knowledge-shop for the effect of food on disease, ii) discovery of novel 
bioactive compounds with drug-like properties, and iii) discovery of novel health benefits from 
foods. This works represents a systematized approach to the association of food with health 
effect, and provides the phytochemical layer of information for nutritional systems biology 
research. 
 
Author summary 
Until recently diet was considered a supplier of energy and building blocks for growth and 
development. However, current research in the field suggests that the complex mixture of natural 
compounds present in our food has a variety of biological activities and plays an important role 
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for health maintenance and disease prevention. The mixture of bioactive components of our diet 
interacts with the human body through complex processes that modify network function and 
stability.  In order to increase our limited understanding on how components of food affect 
human health, we borrow methods that are well established in medical and pharmacological 
research.  By using text mining in PubMed abstracts we collected more than 20,000 diverse 
chemical structures present in our diet, while by applying chemoinformatics methods we could 
systematically explore their numerous targets. Integrating the above datasets with food-disease 
associations allowed us to use a statistical framework for identifying specific phytochemicals as 
perturbators of drug targets and disease related pathways. 
 
Introduction 
The increasing awareness of health and lifestyle in the last decade has brought significant 
attention from the public media to the role of diet. Typically, specific diets or single foods are 
associated with health and disease states through in vivo studies on humans or animal models, 
where the response of selected phenotypes, e.g. up-regulation or down- regulation of certain 
genes, is being monitored (Knekt et al., 2002; Wedick et al., 2012). Observational studies on 
populations with specific food preferences may also provide statistical evidence for the absence or 
prevalence of certain diseases in connection to certain dietary habits (Ferguson and Schlothauer, 
2012). Even though these approaches have offered some useful insights for specific food types, 
they are frequently inconclusive due to small cohorts or limited focus both on the diet and the 
disease space. Most importantly, observations remain on the phenotypic layer, since diet is 
treated as a black box, when it comes to its molecular content. In the emerging field of systems 
chemical biology (Oprea et al., 2007) research is moving towards the network-based study of 
environmental exposures, (e.g. medicine, diet, environmental chemicals) and their effect on 
human health (Schadt et al., 2012). We believe that this shift in paradigm, where one considers 
the system of the molecular components of diet and their interplay with the human body, will 
build the basis for understanding the benefits and impact of diet on our health that will enable the 
rational design of strategies to manipulate cell functions through what we eat (Herrero, 2012; 
Panagiotou and Nielsen, 2009). However, to interpret the biological responses to diet, as well as 
contribute to the evidence in assigning causality to a diet-disease association, we need first to 
overcome the major barrier of defining the small molecule space of our diet. By assembling all 
available information on the complex chemical background of our diet, we can systematically 
study the dietary factors that have the greatest influence, reveal their synergistic interactions, and 
uncover their mechanisms of action.  
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In the present work we carried out text mining to collect in a systematic and high-
throughput way all available information that links plant-based diet (fruits, vegetables, and plant-
based beverages such as tea, coffee, cocoa and wine) with phytochemical content, i.e. primary 
and secondary metabolites, and human disease phenotypes. There are two reasons for focusing 
on the plant-based diet: (1) there is well established knowledge on the importance of fruit- and 
vegetable-rich diet in relation to human health e.g. nutraceuticals, antibiotics, anti-inflammatory, 
anti-cancer, just to name a few (Bravo, 1998; Colombo and Bosisio, 1996; Cowan, 1999; 
Gershenzon and Dudareva, 2007; Pandi-Perumal et al., 2006; Scalbert et al., 2005); (2) the huge 
diversity of the phytochemical space offers a fertile ground for integrating chemoinformatics with 
statistical analysis to go beyond the existing knowledge in the literature and suggest new 
associations between food and diseases. 
Our text-mining strategy, based on dictionaries from the argument browser Reflect (Pafilis 
et al., 2009), Natural Language Processing (NLP) and Naive Bayes text classification (Berry and 
Kogan, 2010; Perkins, 2010), goes beyond mere retrieval of diet - disease associations, as it further 
assigns a positive or negative impact of the diet on the disease. With this work we aim to 
demonstrate how data from nutritional studies can be integrated in systems biology to boost our 
understanding of how plant-based diet supports health and disease prevention or amelioration. 
This wealth of knowledge combined with chemical and biological information related to food 
could pave the way for the discovery of the underlying molecular level mechanisms of the effect 
of diet on human health that could be translated into public health recommendations. 
 
Results  
Mining the phytochemical space 
We extracted by text mining plant - phytochemical associations from 21 million abstracts in 
PubMed/MEDLINE, covering the period 1908-2012. We used relation keyword co-occurrences 
between plant names (both common names and scientific names) and small compound names 
and synonyms. First, the chemical name entities and plant name entities were recognized using a 
set of simple recognition rules. Then, a training set was manually compiled with abstracts 
mentioning plant - phytochemical pairs. Finally, a Naïve Bayes classifier was trained to correctly 
recognize and extract pairs of phytochemicals and plants that contain them. The performance of 
the classifier was quantitatively estimated to 88.4% accuracy and 87.5% F1-measure on an 
external test set of 250 abstracts. When the classifier was applied to the raw text of 
PubMed/MEDLINE, it associated 23,137 compounds to 15,722 plants – of which, 
approximately 2,768 are edible – through 369,549 edges. Since the total number of natural 
compounds discovered so far from all living species is estimated to be approximately 50,000 
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(Afendi et al., 2012), the retrieval of 23,137 phytochemicals solely by extraction of information 
from raw text of titles and abstracts in the PubMed domain provides a unique platform for 
obtaining a holistic view of the effects of our diet on health homeostasis. In order to collect all 
relevant available information for subsequent analyses, we integrated the data we collected via 
text mining with the Chinese Natural Product Database (Shen et al., 2003) (CNPD) and an 
Ayurveda (Polur et al., 2011) data set that we have previously curated in house. CNPD, which is 
a commercial, manually curated database, contains information on 16,876 unique compounds 
from 5,182 plant species associated through 21,172 edges. The Ayurveda data set includes 
information on 1,324 phytochemicals and 189 plants. After merging these two sources with the 
text-mined data and removing redundant information, we ended up with 36,932 phytochemicals 
and 16,102 plants. What further adds value to this pool of data is that all 36,932 compounds are 
encoded in Canonical SMILES and linked to a unique chemical structure, which allows the 
application of chemoinformatics tools for interrogating the human protein and disease space that 
these compounds may have an effect on. 
Figure 5A shows the most well studied edible plants and the number of phytochemicals 
identified in each of them. Rice has the highest number of recorded phytochemicals (4,155 
compounds), followed by soybean (4,064 compounds), maize (3,361 compounds) and potato 
(2,988 compounds). Figure 5B shows representative phytochemicals from our retrieved data that 
have made it all the way to the pharmacy shelves or have served as lead structures for drug 
development. Camptothecin is a natural compound that has led to the semi synthesis of the 
analogues irinotecan and topotecan, two antineoplastic enzyme inhibitors that are currently used 
in the treatment of colorectal and ovarian cancer, respectively. As camptothecin is highly 
cytotoxic, we have not encountered any common foods within the list of plants that contain it. 
Ergocalciferol (vitamin D2), on the other hand, has been traced in numerous plant sources, many 
of which are common foods, such as tomato, cacao and alfalfa. Ergocalciferol is an approved 
nutraceutical compound found in the market under various brand names that is used in the 
treatment of diseases related to vitamin D deficiency, such as hypocalcemia, rickets and 
osteomalacia.  
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Figure 5: A) Distribution of phytochemicals on the plant space. Rice, soybean, maize and 
potato are the plants with the most recorded phytochemicals: 4,155, 4,064, 3,361 
and 2,988 compounds respectively. B) Structures of representative phytochemicals. 
Structures that have made the way to the pharmacy shelves and their occurrence in 
respective edible sources. 
 
A
B
850 
1350 
1850 
2350 
2850 
3350 
3850 
4350 
R
ic
e 
(O
ry
za
 s
ta
tiv
e)
 
So
yb
ea
n 
(G
ly
ci
ne
 m
ax
) 
M
ai
ze
 (Z
ea
 m
ay
s)
 
Po
ta
to
 (S
ol
an
um
 tu
be
ro
su
m
) 
To
m
at
o 
(L
yc
op
er
si
co
n 
es
cu
le
nt
um
) 
Ba
rle
y 
(H
or
de
um
 d
is
tic
ho
n)
 
Sp
in
ac
h 
(S
pi
na
ci
a 
ol
er
ac
ea
) 
W
in
e 
gr
ap
e 
(V
iti
s 
vi
ni
fe
ra
) 
O
liv
e 
(O
le
a 
eu
ro
pa
ea
) 
Ka
le
/B
ro
cc
ol
i (
Br
as
si
ca
 o
le
ra
ce
a)
 
Pe
an
ut
 (A
ra
ch
is
 h
yp
og
ae
a)
 
Al
fa
lfa
 (M
ed
ic
ag
o 
sa
tiv
a)
 
R
ap
e 
(B
ra
ss
ic
a 
na
pu
s)
 
Pe
a 
(P
is
um
 s
at
iv
um
) 
Le
ttu
ce
 (L
ac
tu
ca
 s
at
iv
a)
 
In
sa
m
 (P
an
ax
 g
in
se
ng
) 
W
he
at
 (T
rit
ic
um
 v
av
ilo
vi
) 
C
ar
ro
t (
D
au
cu
s 
ca
ro
ta
) 
Su
nf
lo
w
er
 (H
el
ia
nt
hu
s 
an
nu
us
) 
Ap
pl
e 
(M
al
us
 d
om
es
tic
a)
 
C
ow
pe
a 
(V
ig
na
 u
ng
ui
cu
la
ta
) 
Th
al
e 
cr
es
s 
(A
ra
bi
do
ps
is
 th
al
ia
na
) 
C
as
to
r b
ea
n 
(R
ic
in
us
 c
om
m
un
is
) 
Fl
ax
 (L
in
um
 u
si
ta
tis
si
m
um
) 
Sa
ffl
ow
er
 (C
ar
th
am
nu
s 
tin
ct
or
iu
s)
 
Sk
ul
lc
ap
 (S
cu
te
lla
ria
 b
ai
ca
le
ns
is
) 
O
ni
on
 (A
lliu
m
 c
ep
a)
 
Ku
sh
en
in
 (S
op
ho
ra
 fl
av
es
ce
ns
) 
G
oo
se
fo
ot
 (C
he
no
po
di
um
 a
lb
um
) 
Q
ui
no
a 
(C
he
no
po
di
um
 q
ui
no
a)
 
Be
et
 (B
et
a 
vu
lg
ar
is
) 
M
ap
le
 (A
ce
r p
se
ud
op
la
ta
nu
s)
 
To
ba
cc
o 
(N
ic
ot
ia
na
 ta
ba
cu
m
) 
M
at
'-i
-m
ac
he
kh
a 
(T
us
si
la
go
 fa
rfa
ra
) 
D
af
fo
di
l (
N
ar
ci
ss
us
 p
se
ud
on
ar
ci
ss
us
) 
C
uc
um
be
r (
C
uc
um
is
 s
at
iv
us
) 
G
oo
se
fo
ot
 (C
he
no
po
di
um
 ru
br
um
) 
Pa
w
pa
w
 (A
si
m
in
a 
tri
lo
ba
) 
Am
ar
an
th
 (A
m
ar
an
th
us
 v
iri
di
s)
 
W
hi
te
 p
in
e 
(P
in
us
 s
tro
bu
s)
 
O
ld
-m
an
-in
-th
e-
Sp
rin
g 
(S
en
ec
io
 v
ul
ga
ris
) 
N
um
be
r o
f c
om
po
un
ds
 0.884 
0.886 
Accuracy F1-score 
36392 
15722 
Number of compounds Number of plants 
O
0 50 100 150 200 250 300 
Plants containing compound Common foods containing compound 
DB00742 PMID:22908558
D-mannitol Diuretics, Osmotic
Elevates blood plasma osmolality, resulting 
in enhanced flow of water from tissues, including
the brain and cerebrospinal fluid, into interstitial
fluid and plasma.
DB00936 
PMID:22309143
Salicylic acid Anti-Infective AgentKeratolytic Agent
Antifungal Agent
 It has bacteriostatic, fungicidal, and keratolytic
actions. Its salts, the salicylates, are used as analgesics.
DB00541
Antineoplastic Agent
Antineoplastic Agent
Tubulin Modulator
Indicated for the treatment of acute leukaemia, malignant
lymphoma, Hodgkin’s disease, acute erythraemia, and
acute panmyelosis.
Vincristine
PMID:20035334
PMID:22283650
DB01364
Ephedrine
PMID:19571392Vasoconstrictor Agent
Central Nervous System Stimulant
Sympathomimetic
Used in the treatment of several disorders including asthma,
heart failure, rhinitis, and urinary incontinence, and for its
central nervous system stimulatory effects in the treatment
of narcolepsy and depression. 
Camptothecin
DB04690
Inhibits the nuclear enzyme DNA topoisomerase, type I.
Semisynthetic analogs of camptothecin Irinotecan and
topotecan are used in the treatment of colorectal and
ovarian cancer.
Enzyme Inhibitor
Antineoplastic Agent, Phytogenic
DB00153 
Ergocalciferol
PMID:8934454
Antihypocalcemic Agent
Antihypoparathyroid Agent
Used in the treatment of rickets, osteomalacia, 
early renal osteodystrophy, osteoporosis.
Chapter 1: Integrated Text Mining and Chemoinformatics Analysis Associates Diet to Health 
Benefit at Molecular Level 
 
44 
Figure 5B brings also to light that natural compounds are commonly encountered in more 
than one plant, or family of plants. Previous studies have indicated that there are no consistent 
trends as to whether phytochemicals can be used as taxonomic markers or may occur in several 
unrelated plant families (Bravo, 1998; Wink, 2003). With this question in mind, we decided to 
examine how the 36,932 phytochemicals are distributed among neighboring and ancestral taxa 
and whether there are clusters of certain phytochemicals at specific parts of the taxonomy. 
Overrepresentation of phytochemicals on the taxonomy was calculated by using Fishers exact 
test, following the Benjamini-Hochberg procedure with a 5% False Discovery Rate (Yoav and 
Hochberg, 1995). Our analysis showed that only 8% of all phytochemicals are localized on 
certain parts of the taxonomy (Figure S1 and Table S1). For example the family of Fabales – 
Fabaceae – Lens, which includes lentils, and the Sapindales – Rutaceae – Citrus linkage, which 
includes orange, contain 60 out of 562 compounds and 42 out of 214 compounds, respectively (p-
value < 10-4) that are not found anywhere else on the taxonomy. On the other hand, compounds 
such as β-sitosterol, palmitic acid and catechin are spread all over the taxonomy (p-value < 10-4). 
A possible interpretation of this finding is that the synthesis of small compounds in plants is 
mainly defined by short-term regulatory than long-term evolutionary adaptation to the 
environment. 
 
Association of food with disease prevention or progression 
To systematically associate plant-based diet with health effect we extracted by text mining 
plant - disease associations from 21 million abstracts in PubMed/MEDLINE, covering the period 
1908-2012. In this manner we associated 7,106 plant species, 2,768 of which edible, with 1,613 
human disease phenotypes. The performance of the classifier was quantitatively estimated to 
84.5% accuracy and 84.4% F1-measure on an external test set of 250 abstracts. Natural Language 
Processing allowed us to add directionality to these associations, an extremely valuable feature 
for dietary recommendations. This enabled us not only to link a certain food to a disease, but also 
to characterize the association as being positive (food associated with disease prevention or 
amelioration) or negative (food associated with disease progress). Together with the temporal 
parameter that is included in the text-mined data (date of publication of articles that associate 
food to disease), one can make interesting observations as to when scientists began showing 
interest in the health effect of food and how opinion regarding a certain food has been varying 
throughout time. 
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Figure 6: A) Examples of well-studied foods in relation to positive (disease prevention 
/amelioration) and negative (disease progression) effect on health. The focus varies 
from negative effects (below 0) to positive effects (above 0) over the years. The value 
on the y-axis denotes the number of negative publications subtracted from the 
number of positive publications in a given year. B) Examples of well-studied disease 
phenotypes in relation to food consumption. Likewise, the figure illustrates a change 
in focus from negative effects (below 0) to positives effects (above 0). 
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As shown in Figure 6A, research on the health effect of food effectively began in the early 
80´s and until middle 90´s there was more research activity in relation to the negative effects of 
foods, such as their involvement in the development and progression of allergic reactions and 
asthma. However, the change of public opinion towards lifestyle and preventive strategies related 
to health in the last 15 years, resulted to an exponential growth of research papers reporting 
beneficial effects of plant-based foods against diabetes mellitus and different types of cancers (e.g. 
breast cancer, carcinoma and leukemia), not surprising since these diseases are the scourge of our 
time. Also of interest are the contradicting opinions over time on the health benefit of foods 
(Figure 6B). Until the beginning of the 21st century there were only sparse reports on the health 
benefits associated with rice consumption, while the last 10 years there are numerous reports 
describing the positive impact of a rice-based diet. The opposite trend is observed for peanuts, 
which was mainly studied for its beneficial role in cancer before a number of studies begun 
correlating its consumption with health problems, such as allergy and hypersensitivity. 
The network of Figure 7A presents the most strongly supported associations of common 
foods and health benefits in the public literature. There are only a handful of common foods that 
have been associated either only positively or negatively with disease phenotypes. Consumption 
of broccoli, blueberry and camellia-tea for example, is consistently linked positively with a variety 
of disease phenotypes including diabetes mellitus, atherosclerosis and different types of cancers 
(Figure 7B). Cassava, a good source of carbohydrates but poor in protein, which constitutes the 
basic diet for many people in the developing world, has only negative associations with 
malnutrition, and malnutrition-related phenotypes (Figure 7C). 
For the majority of cases however, a particular food is positively correlated with specific 
disease phenotypes and negatively with others, highlighting the importance of personalized 
dietary interventions; rice is one characteristic example, associated positively to hypertension, 
diabetes, colon- and breast cancer and negatively to dermatitis and hypersensitivity reactions. 
There are also several foods, including peanut, chestnut and avocado, consistently associated 
negatively with type-1 hypersensitivity and similar disease phenotypes, such as dermatitis, rhinitis 
and urticarial. Not surprisingly, a high number of publications exist for the negative effects of 
common foods such as wheat, barley and rye to celiac disease (also known as gluten intolerance). 
Figure 7 makes also evident that considerable research investments have been made in the past 
decades for enhancing our understanding of the association between diet and cancer; breast, 
prostate and colon cancers constitute the thickest edges on the network.  
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Figure 7: A) Disease phenotypes associated with common vegetables, fruits and plants of our 
diet. Foods are shown as green nodes and human disease phenotypes as purple 
nodes. Disease prevention/amelioration is depicted as a blue edge and disease 
promotion as a red edge. The size of the edge indicates the number of publications in 
support of the association. An edge is drawn between a food node and a disease 
node when there are at least five publications in support of this association. When a 
disease node has more than five edges, only the five strongest (with the most 
publication support) are shown on the network for the sake of clarity. Top left: zoom 
in the network formed between diabetes mellitus and foods that prevent/ameliorate 
the disease. Bottom left: zoom in the network formed between Type 1 
hypersensitivity and foods that promote it. B) Examples of a vegetable (broccoli), a 
fruit (blueberry) and a plant-based beverage (camellia-tea) that are only positively 
associated with disease phenotypes. C) Two examples of foods that are only 
negatively associated with disease phenotypes. 
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Molecular level association of food to human disease phenotypes 
Our main hypothesis for the molecular level association of a plant-based diet to human 
disease phenotypes is that the positive or negative effect of a certain food on human health is due 
to the presence of one or more bioactive molecules in it. Towards this end, we used Fisher´s exact 
test to systematically detect frequently occurring phytochemical - disease pairs through the 
phytochemical - food and food - disease relations that we extracted by text mining. At a 5% FDR 
we identified 20,654 phytochemicals connected to 1,592 human disease phenotypes, with 
approximately half of the disease associations being positive (Figure 8A). Some of these 
phytochemicals have been previously studied in vitro for potential biological activity. By 
integrating information from ChEMBL we find that, from the 20,654 phytochemicals that the 
above analysis suggests as bioactive, approximately 5,709 have been tested experimentally on a 
biological target. From the remaining phytochemicals, for which no experimental bioactivity data 
are available, 8,113 compounds are structurally similar to compounds with known protein targets 
(estimated with a Tanimoto coefficient > 0.85), indicating similar bioactivity, while the rest 
belong to a hitherto unexplored phytochemical space Figure 8B). 
In order to get an estimate of the performance of our approach to associate phytochemicals 
to diseases, we used the Therapeutic Targets Database to annotate the protein targets from 
ChEMBL to diseases. From the 5,709 phytochemicals that are included in ChEMBL, almost half 
are active against a biological target that is relevant for the same disease as the one we have 
predicted (Figure 8C).  Adding molecular-level information to food - disease associations allows 
us to zoom in the network of Figure 7 and generate lists of phytochemicals as promising drug-like 
candidates for subsequent target-based or cell line-based assay experiments, as we demonstrate in 
Table 2Table 2 with focus on a number of common cancer types. For example, 103 
phytochemicals from 83 common foods (Kusari et al., 2011; Miller et al., 1977; Santos et al., 
2011) that through our analysis are associated with lung cancer, are structurally similar with 23 
drugs from DrugBank that are approved for use in lung cancer treatment. In addition, by 
integrating information from ChEMBL and TTD, we identify 1,070 phytochemicals from 119 
common foods with experimental activity against a lung cancer drug target. For cancer types, 
such as endometrial cancer and adenocarcinoma, where the drugs currently available in the 
market are scarce, this approach could be of particular interest, as it provides new opportunities 
for the identification of new drug candidates. 
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Figure 8: A) In the phytochemical - food and food - disease relations that we extracted by text 
mining, there are 7,077 plants with both phytochemical and human disease 
annotation. We used Fisher’s exact test to identify statistically significant 
correlations between phytochemical and human disease phenotypes. At a 5% false 
discovery rate we identified 20,654 phytochemicals associated to 1,592 human 
disease phenotypes. B) 5,709 of the text-mined phytochemicals have been tested 
experimentally on a biological target and the activity data have been deposited in 
ChEMBL. For the remaining two thirds of the compounds, 8,113 phytochemicals 
are structurally similar to compounds with known protein targets (estimated with a 
Tanimoto coefficient > 0.85), indicating similar bioactivity. The rest of the 
compounds, 6,832 phytochemicals, are not similar to any known bioactive 
compound and belong to a hitherto unexplored phytochemical space. C) We used 
the Therapeutic Targets Database to annotate the protein targets from ChEMBL to 
diseases. From the 5,709 phytochemicals that are included in ChEMBL, 2,354 are 
active against a biological target that is relevant for the same disease as the one we 
have predicted. 
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Case study on colon cancer 
To demonstrate the full potential of our approach we selected colon (colorectal) cancer as a 
case study and analyzed our results in the three directions shown below. Colon cancer is the 
second largest cause of cancer-related deaths in western countries and various diet intervention 
and epidemiological studies suggest that diet is a vital tool for both prevention and treatment of 
the disease (Ferguson and Schlothauer, 2012; Terry et al., 2001). 
(1) One stop legacy knowledge-shop: When one embarks into studying the effect of food on 
colon cancer, it is useful first to get a systems view of the existing knowledge. This includes 
information about what types of foods and phytochemicals have already been tested in relation to 
colon cancer, which are their biological targets and how these activities affect the biological 
networks that consist the disease pathway. Such a systems view of the influence of dietary 
molecules associated to colon cancer is sketched in Figure 9A, based on the knowledge derived 
from our text mining approach that has been projected on the colon cancer pathway from the 
KEGG PATHWAY Database (http://www.genome.jp/kegg-bin/show_pathway?hsadd05210, 
Accessed May 31 2014). By surveying our data resource we found 519 plants associated with a 
health benefit towards colon cancer. Statistical analysis of the data for frequently occurring 
phytochemical - disease pairs, reveals significant associations between 6,418 phytochemicals and 
colon cancer. Among the molecules associated with a health benefit for colon cancer, 623 of them 
have experimentally verified activity against proteins involved in the colon cancer pathway 
(nodes with a grey ring in Figure 9A). Naringenin, apigenin, quercetin, ellagic acid and genistein 
are examples of such compounds. Naringenin is commonly found in barley, beans and corn and 
apigenin is found in chestnuts, celery and pear. These foods have been associated with colon 
cancer prevention in a number of studies (Chavez-Santoscoy et al., 2009; Frédérich et al., 2009; 
Madhujith and Shahidi, 2007). When tested in vivo, both compounds have been found able to 
suppress colon carcinogenesis (Leonardi et al., 2010). In addition, in in vitro experiments 
naringenin and apigenin have seven targets on the KEGG colon cancer pathway. Quercetin, 
found in artichoke, carrot and cassava, and ellagic acid, present in grapes, papaya and olives have 
seven and five targets, respectively, on the KEGG colon cancer disease pathway, while genistein, 
found in pistachio-nuts and onions, has four. In most, if not all, of these cases, interest on the 
biological activity of the phytochemicals emerged after observations that the foods that contain 
them have some health benefit in relation to colon cancer prevention and treatment (Dinicola et 
al., 2012; Al-Fayez et al., 2006; Juan et al., 2006).  
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Figure 9: A) The KEGG colon cancer disease pathway map is illustrated on the right, 
where the number of phytochemicals with experimentally measured 
bioactivity data is depicted as grey ring of varying width. Examples of 
bioactive phytochemicals are listed on the left, along with typical food source 
and biological target. B) Protein targets of typical colon cancer drugs and 
number of phytochemicals with experimental and predicted activities against 
them. C) From the 6,418 molecules associated with a health benefit for colon 
cancer, 623 have measured experimental activity against proteins from the 
colon cancer pathway or targets of colon cancer drugs. On the remaining 
phytochemical space linked to colon cancer, we can use chemoinformatics to 
predict activity based on compound structure and select the most promising 
candidates for in vitro or in vivo experimental validation. Accordingly, we 
have identified 1,415 phytochemicals with potential activity against colon 
cancer. For reasons of consistency with the disease pathway map, protein 
targets are given with their corresponding gene names. 
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Typical drugs in the market against colon cancer are listed in Figure 9B, along with their main 
protein targets. By surveying our data resource we identified a number of phytochemicals that 
have measured experimental activity against the same proteins. Riboflavin monophosphate, for 
example, which is found in many common foods such as almond, broccoli and tomato, is one 
among the 16 phytochemicals we have identified with biological activity against thymidylate 
synthase, the main target of drugs 5-fluorouracil and capecitabine (Martucci et al., 2009). 
Similarly, reserpine, a natural compound that has found applications as antihypertensive and 
antipsychotic, exhibits activity against DNA topoisomerase I (Itoh et al., 2005) - the target of the 
colon cancer drug irinotecan - which could be interesting to investigate further in the light of drug 
repurposing. 
(2) Discovery of novel bioactive compounds with drug-like properties: As we saw above, from 
the 6,418 molecules associated with a health benefit for colon cancer, only 623 have 
experimentally verified activity against colon cancer protein targets (Figure 9C). On the 
remaining phytochemical space linked to colon cancer, we can use chemoinformatics approaches 
to predict activity based on compound structure and select the most promising candidates for in 
vitro testing. By encoding the structure in 2D fingerprints and setting a Tanimoto coefficient of 
0.85 as the similarity threshold, 1,415 molecules turn up as structurally similar to a phytochemical 
or a synthetic compound from ChEMBL with activity against a protein from the colon cancer 
pathway or a colon cancer drug target (Figure 9B). The compounds listed in Table 3 are such 
examples, for which we can infer their bioactivity from experiments performed on structurally 
similar compounds. 
In regards to the remaining phytochemicals that our approach has associated to colon 
cancer, for which there exists no experimental protein target information and are not structurally 
similar with molecules that interact with colon cancer proteins, more advanced chemoinformatics 
techniques could be applied, such as pharmacophore-based similarity and docking. Alternatively, 
in vivo assays in model animals or in vitro experiments on disease cell lines could assist in 
elucidating their bioactivity. Such compounds with strong statistical support are beta-
caryophyllene (Ali et al., 2012), guaiacol (Formisano et al., 2011) and alloisoleucine (Sánchez-
Hernández et al., 2012) (p-value < 10-23). Guaiacol, for example, has been identified in 93 plants 
in total, 32 of which are associated in the literature with colon cancer. 
(3) Discovery of novel health benefits from foods: One of the key observations from our 
analysis is that the majority of phytochemicals is found in a variety of foods, even in foods that 
are distant taxonomically. Thus, information about the bioactive phytochemical content of one 
food that has been characterized as beneficial towards colon cancer could help us identify other 
foods, which contain the same bioactive phytochemicals that may have similar health benefits. 
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 For example, cauliflower has been associated with a preventive effect on colon cancer (Mas et 
al., 2007; Temple and el-Khatib, 1987). The adzuki bean shares 800 phytochemicals with it and 
could potentially have a similar effect on colon cancer as well; there exists, however, no such 
evidence in the literature. Such comparisons of phytochemical profiles could also find 
applications in the design of nutrigenomics studies, with the purpose to confirm that the study 
group follows a reference diet as different as possible from that of the control group, i.e. the two 
diets do not contain foods with similar phytochemical profiles. 
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Discussion 
Food is a complex system that has an equally complex pattern of interactions with the 
human organism. As such, it consists the ideal platform for applying a systems biology approach, 
where different heterogeneous data sources are integrated and analyzed in a holistic way. 
Ferguson and Schlothauer in a review article that was published in 2012 (Ferguson and 
Schlothauer, 2012) illustrated how information on the beneficial effect of broccoli against cancer 
is enriched by the integration of genomics, proteomics and metabolomics data. For a well-studied 
food such as broccoli there is a rich body of evidence regarding its bioactive phytochemicals. 
Nevertheless, gathering and visualizing all evidence at once offered novel insights into the 
mechanisms by which broccoli may prevent cancer or retard cancer growth and progression. 
An enormous scientific literature focusing on bioactive plant extracts and their 
phytochemicals, encompassing thousands of scientific papers, has emerged over the years. 
However, in order to utilize this wealth of information and integrate it with other types of data 
within systems biology studies, it is essential to first locate and then retrieve it in a high-
throughput manner. The approach we have demonstrated here, which relies on the text mining of 
abstracts in PubMed/MEDLINE, has associated 23,137 phytochemicals with 15,722 plants, 
including approximately 2,768 edible fruits, vegetables and plant-based beverages. Even though 
there are several ongoing efforts that aim to collect information on molecular composition of food 
in a single resource, i.e. the Danish Food Composition Database (http://www.foodcomp.dk) 
centered on well-known organic nutrients, such as vitamins, amino acids, carbohydrates and fatty 
acids; the Phenol-Explorer (Neveu et al., 2010) with information in text format for 500 
polyphenols in over 400 foods and the KNApSAcK Family Database (Afendi et al., 2012), these 
are rather limited in focus and size. For a molecular systems chemical biology approach of diet, 
the lack of chemical structures in the above databases is another significant bottleneck, as linking 
chemical names to a chemical structure in a high-throughput manner is not yet a straightforward 
process (Williams et al., 2012). The most important contribution of our study is that it uses all the 
evidence generated during the last 100 years supporting health benefits of vegetables, fruits and 
other plants for establishing associations between foods, phytochemicals and human diseases, 
where entities from all three classes are annotated with unique, standard identifiers, so that they 
can be traceable in other databases. Moreover, chemical names and synonyms of all 
phytochemicals are linked to a unique chemical structure, which, besides traceability in other 
resources, allows for the application of chemoinformatics tools and their integration in systems 
chemical biology analyses. Last but not least, food associations to disease are annotated with 
directionality, which differentiates between causative and preventive effects of the food in relation 
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to the specific disease. Nevertheless, and despite the enormous amount of information collected 
here, we should also point out that inherent bias of meta-analysis allows for further improvements 
in our text mining pipeline. For example, while PubMed/MEDLINE is the most appropriate 
database for associating dietary interventions with disease phenotypes, it is certainly lacking 
scientific journals focused on the chemical composition of plants (for example, the Springer 
journal of Metabolomics; 
www.springer.com/lifesciences/biochemistry&biophysics/journal/11306), Accessed May 31 
2014). In order to overcome other common pitfalls of meta-analysis, such as data quality and data 
independence, it is our intention in the future to investigate the use of weighting parameters on 
the retrieved associations, so that, for example, associations generated from different labs 
constitute stronger evidence than associations from the same research team. 
As we show in the case study on colon cancer, associating food, phytochemical content and 
diseases can build the basis for discovering novel bioactive compounds with drug-like properties. 
Furthermore, our analysis brought to the surface an undiscovered dietary component space of 
8,113 phytochemicals that has not been previously linked to a health benefit and bears no 
structural similarities to other bioactive phytochemicals with established molecular targets. This 
represents a forthright opportunity for biochemists and nutritionists and offers a good basis for an 
attractive drug discovery platform. At the same time, food safety authorities are concerned about 
the presence of compounds in herbal products and dietary supplements that could exert toxicity to 
humans (Singh et al., 2012). For example, myristicin, a known component of nutmeg 
(Demetriades et al., 2005) and glycoalkaloids that are present in potatoes (Mensinga et al., 2005) 
can be extremely dangerous when taken in large doses. It is thus of great value to have in silico 
tools that are able to quickly list all phytochemicals associated to a given food in the public 
literature, and subsequently interrogate databases (e.g. the Comparative Toxicogenomics 
Database, http://ctdbase.org) for experimental evidence that associates the compounds in 
question or structurally similar compounds with a toxic effect. Similar to research in the field of 
nutrition, scientists in ethnomedicine are seeking for evidence that can explain at the molecular 
level the health effect of traditional medicine. Ethnomedicine, such as Traditional Chinese 
Medicine and Ayurveda has existed and supported human health for thousands of years. A major 
barrier for developing an ethnomedicine evidence-based knowledgebase is that the current 
information related to plant substances for medicinal purposes is scattered and unstructured 
(Sharma and Sarkar, 2013). 
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We provide a solution to this problem by extracting in a structured and standardized format 
phytochemicals that are associated with a medicinal plant, either in the open literature of the last 
100 years or in the ethnomedicinal databases that we have in-house. Our approach facilitates the 
identification of novel bioactive compounds from natural sources and the repurposing of 
medicinal plants to other diseases than the ones traditionally used for, and builds a step towards 
elucidating their mechanism of action. 
 
Conclusion 
Food is a factor that exerts influence on human health on a daily basis. Modulating the 
expression and the activity of enzymes, transcription factors, hormones and nuclear receptors is 
how food and its bioactive constituents modulate metabolic and signaling processes. The aim of 
our study is to provide the molecular basis of the effect of food on health in the complete 
spectrum of human diseases and to suggest why and how diet and dietary molecules may 
represent a valuable tool to reinforce the effect of therapies and protect from relapse. Our 
systematized approach for connecting foods and their molecular components to diseases makes 
possible similar analyses as the one illustrated for colon cancer for approximately 2,300 disease 
phenotypes.  In addition, it provides the phytochemical layer of information for nutritional 
systems biology studies with the aim to assess the systemic impact of food on health and make 
personalized nutritional recommendations. 
 
Methods 
Mining the literature for plant - phytochemical pairs 
We retrieved the names of land plant species (embryophyta) and their synonyms from 
NCBI (http://www.ncbi.nlm.nih.gov/taxonomy). Chemical compound names and synonyms 
were taken from the argument browser Reflect (Pafilis et al., 2009). With these two dictionaries 
the mining of 21 million titles and abstracts of PubMed/MEDLINE (http://www.nlm.nih.gov) 
was carried out using ChemTagger (https://pypi.python.org/pypi/ChemTagger). A Naive Bayes 
Classifier (https://pypi.python.org/pypi/NaiveBayes) was trained to recognize pairs of plants 
and phytochemicals. 
A set of 200 tags, – plant and compound name entities – from 200 abstracts was compiled 
for training. As positive training set (PTS) we manually compiled a set of 75 abstracts mentioning 
plants and their phytochemical content. As negative training set (NTS) we manually compiled a 
set of 125 abstracts mentioning plants and chemical compounds, which we judged that did not 
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refer to an actual plant - phytochemical content relationship. This includes, for example, abstracts 
that associate plants with synthetic small compounds in the context of chemical extraction and 
purification of plant extracts (e.g. ecdysonoic acid, 3-acetylecdysone 2-phosphate (Isaac and Rees, 
1984). A feature vector was compiled consisting of words within the abstract that were in 
proximity of each nametag. 
The lexical features were chosen based on the term frequency–inverse document frequency 
(Wu et al., 2008) and were sorted with the most frequent feature on the top and the least frequent 
at the bottom of the list. The training of the classifier commenced with only the highest score 
feature, while features with the next higher scores were added one by one, until the accuracy of 
the classifier stabilized at 31 features. Words such as “compound”, “isolated”, “extract” and 
“concentrated” were the features with the highest tf-idf score. Training was carried out using 
leave-one-out cross validation on the shuffled training data set. The performance of the classifier 
was subsequently evaluated on an external, balanced test set of 250 positive and negative 
abstracts, and resulted to 88.4% accuracy and 87.5% F1-measure. When the classifier was applied 
to the raw text of PubMed/MEDLINE, it retrieved 23,137 phytochemicals from 15,722 land-
plant species (embryophyta) associated through 369,549 edges. 
Chemical structures of the text-mined phytochemicals were retrieved from PubChem 
(Bolton et al.), ChEBI (Hastings et al., 2013), CHEMLIST (Hettne et al., 2009), the Chinese 
Natural Product Database (Shen et al., 2003) (CNPD) and the Ayurveda (Polur et al., 2011) that 
we have previously curated in-house. Canonical SMILES were calculated with OpenBabel 
(http://openbabel.org/wiki/Canonical_SMILES) with no salts, isotopic or chiral center 
information. Edible plant names were retrieved from Plant For A Future (PFAF) 
(http://www.pfaf.org) and were mapped to NCBI IDs. 
The taxonomy of plant species was retrieved from NCBI taxonomy 
(http://www.ncbi.nlm.nih.gov/taxonomy). Overrepresentation of phytochemicals on the 
taxonomy was calculated by using Fishers exact test, following the Benjamini-Hochberg 
procedure with a 5% false discovery rate (Yoav and Hochberg, 1995). A phytochemical that is 
significantly overrepresented on a specific class, order, family or genus of the taxonomy denotes 
that it is not randomly distributed over the whole tree. Since the association of plants to their 
phytochemicals was performed on the genus level, for this analysis we projected the 
phytochemical content of a child node to the parent node. 
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Mining the literature for plant - disease associations 
The names of land plant species (embryophyta) and their synonyms were taken from NCBI 
(http://www.ncbi.nlm.nih.gov/taxonomy). We retrieved 70,005 human disease terms and 
synonyms from the Open Biological and Biomedical Ontologies (OBO) Foundry (Smith et al., 
2007). The list of 143 common, non-processed foods was retrieved from the Danish Food 
Composition Database (http://www.foodcomp.dk). Names were mapped to NCBI land plant 
species and whenever var. IDs were available, they were subsequently collapsed to the 
corresponding species ID (e.g. broccoli and kale are varieties of the same Brassica olerasea species). 
With these two dictionaries, text mining of 21 million titles and abstracts of PubMed/ 
MEDLINE (http://www.nlm.nih.gov) was carried out using ChemTagger 
(https://pypi.python.org/pypi/ChemTagger). A Naive Bayes Classifier 
(https://pypi.python.org/pypi/NaiveBayes) was trained to recognize pairs of plants and the 
associated human disease phenotypes. A set of 2,074 nametags, plants and human disease 
phenotype name entities from 333 abstracts was compiled for training. Plants and human diseases 
with a ‘preventive’ association were used as the positive training set (PTS) and plants and human 
diseases with a ‘promoting’ association as the negative training set (NTS). Name entities of plants 
and human diseases mentioned in other contextual associations were used as the ‘noise’ training 
set (OTS). 
For the training of the Naive Bayes Classifier, the lexical features were chosen based (Wu et 
al., 2008) and were sorted with the most frequent feature on the top and the least frequent at the 
bottom of the list. The training of the classifier commenced with only the highest score feature, 
while features with the next higher scores were added one by one, until the accuracy of the 
classifier stabilized at 71 features. Words such as “treatment”, “effect”, “patient”, “disease” and 
“plant” were the features with the highest tf-idf score. 
Training was carried out set using leave-one-out cross validation on the shuffled training 
data set. The performance of the classifier was subsequently evaluated on an external, balanced 
test set of 250 positive and negative abstracts, and resulted to 84.5% and an F1-measure of 84.4%. 
When the classifier was applied to the raw text of PubMed/MEDLINE, it retrieved 7,178 land-
plant species associated with 1,613 human disease phenotypes through 38,090 edges. Plant - 
disease networks were constructed in Cytoscape v.2.8.1. 
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Molecular level association of plant consumption to human disease 
phenotypes 
We performed a categorical Fisher’s exact test with the Benjamini-Hochberg procedure and 
a 5% false discovery rate (Yoav and Hochberg, 1995) to associate particular phytochemicals with 
human disease phenotypes. Our alternative hypothesis was that the proportion of plants 
associated with a particular phytochemical is higher among the plants with a specific human 
disease phenotype than among those without. Our null hypothesis was that there is no 
relationship between plants associated with a particular phytochemical and a specific human 
disease phenotype. Phytochemicals were associated to protein targets though experimental 
chemical-protein association data from ChEMBL, version 15 (Overington, 2009). Canonical 
SMILES with no salts, isotopic or chiral center information 
(http://openbabel.org/wiki/Canonical_SMILES) were used as the unique molecular identifier 
for searching for common small compound entities between the phytochemical and ChEMBL 
lists. Human proteins were associated to diseases through the Therapeutic Targets Database (Zhu 
et al., 2012) (TTD Version 4.3.02). Disease names were mapped to the OBO Foundry human 
disease ontology and ordered in disease categories. Disease pathway networks were constructed 
in Cytoscape v.2.8.1. 
 
Case study on colon cancer 
The colon cancer disease pathway was obtained from KEGG PATHWAY Database 
(http://www.genome.jp/kegg-bin/show_pathway?hsadd05210). The network was constructed in 
Cytoscape v.2.8.1. Phytochemicals were associated to the proteins from the disease pathway 
though experimental chemical-protein association data from ChEMBL, version 15 (Overington, 
2009). Canonical SMILES with no salts, isotopic or chiral center information 
(http://openbabel.org/wiki/Canonical_SMILES) were used as the unique molecular identifier 
for searching for common small compound entities between the phytochemical and ChEMBL 
lists. Colon cancer drugs were obtained from KEGG Disease Entry: H00020 
(http://www.genome.jp/dbget-bin/www_bget?ds:H00020) and their respective protein targets 
from the Therapeutic Targets (Zhu et al., 2012) (TTD Version 4.3.02).  
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Supplementary material 
 
 
Figure S1: Mapping the phytochemical space on the plant taxonomy. 37,351 phytochemicals 
were mapped on the plant taxonomy. Only 8% of the recorded phytochemicals 
show localized enrichment (p-value < 10-4). The taxonomy of land-plant species 
(embryophyta) was retrieved from NCBI taxonomy 
(http://www.ncbi.nlm.nih.gov/taxonomy). Nodes represent Classes (yellow), 
Orders (blue), Families (green) and Genera (pink) of the taxonomy tree. Links are 
placed between a parent and a child node, if they share conserved phytochemicals. 
A phytochemical is conserved, when it is overrepresented on both the parent and 
the child nodes. The width of the link corresponds to the number of conserved 
phytochemicals between parent and child nodes. The size of the node corresponds 
to the number of overrepresented phytochemicals on a given class, order, family or 
genus. 
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Table S1: 
 
List of phytochemicals described as SMILES that are localized on a taxonomy class, 
order, family or genus. 
Ref: http://www.ploscompbiol.org/article/fetchSingleRepresentation.action?uri=info:doi
/10.1371/journal.pcbi.1003432.s002, Accessed May 14 2014. 
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Abstract  
There is rising evidence of an inverse association between chronic diseases and diets 
characterized by rich fruit and vegetable consumption. Dietary components may act directly or 
indirectly on the human genome and modulate multiple processes involved in disease risk and 
disease progression. However, there is currently no exhaustive resource on the health benefits 
associated to specific dietary interventions and there is certainly no resource covering the broad 
molecular content of our food. Here we present the first release of NutriChem, a database 
generated by text mining of 21 million MEDLINE abstracts for collecting all available 
information that link plant-based foods with their small molecule components and human disease 
phenotypes. NutriChem contains text-mined data for 18,478 pairs of 1,772 plant-based foods and 
7,898 phytochemicals, and 6,242 pairs of 1,066 plant-based foods and 751 diseases. In addition, it 
includes predicted associations for 548 phytochemicals and 252 diseases. To the best of our 
knowledge this database is the only resource linking the chemical space of plant-based foods with 
human disease phenotypes and provides a fundamental foundation for understanding 
mechanistically the consequences of eating behaviors on health. NutriChem is available at 
http://cbs.dtu.dk/services/NutriChem-1.0 
 
Introduction  
Although both genetic and environmental factors contribute to the risks of developing 
chronic diseases, differences in environment are probably responsible for 70-90% of disease risks 
(Rakyan et al., 2011; Rappaport and Smith, 2010; Vineis et al., 2009). The numerous direct and 
indirect effects that environmental exposures display induce both immediate and long-term health 
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responses. Exposure in high doses of chemicals or vulnerability of individuals to particular 
chemicals, can lead to immediate health effects. On the other hand, repeated and prolonged 
exposures, like dietary habits, contribute to more general pathophysiological mechanisms and 
increase the potential health effects by influencing disease development over a lifetime. The term 
´´exposome´´, which is used to describe the totality of all environmental exposures (e.g. diet, air 
pollutants, lifestyle factors) over the life course of an individual, has been proposed to be a critical 
entity for disease etiology and to complement the genetic information (Brook et al., 2010; 
Heinrich, 2011; Wild, 2011). In order to avoid biased inferences regarding gene-environment 
interactions and to discover the major causes of chronic diseases a more comprehensive and 
quantitative view of the exposome is required (Paoloni-Giacobino, 2011; Rappaport, 2012). Since 
a full characterization of the human exposome is a daunting task, cutting the pie to smaller pieces 
could offer critical portions of disease associations of certain exposures. 
Diet is certainly one of the most dynamic expressions of the exposome and one of the most 
challenging to assess its effects in health homeostasis and disease development, as a consequence 
of its myriad components and their temporal variation. Recognize, understand and interpret the 
interplay between diet and biological responses to this exposure may contribute to the weight of 
evidence in assigning causality to a diet-disease association. Therefore, in order to open up new 
avenues to disease prevention through diet interventions is crucial to provide insights into the 
mechanisms by which an exposure to the chemical space of a food might be exerting its effects. 
Towards this direction we have developed a state-of-the art database with information on plant-
based food (referred to simply as “food” throughout the article), its small compound constituents 
(also known as phytochemicals) and human disease phenotypes associated with it. This database 
offers a unique platform for exploring the medicinal value of diet and elucidating the synergistic 
effects of natural bioactive compounds on disease phenotypes. 
 
Implementation 
Data ontologies 
The taxonomy of the plant species was retrieved from NCBI taxonomy 
(http://www.ncbi.nlm.nih.gov/taxonomy). Food names were retrieved from the Plant For A 
Future (PFAF) (http://www.pfaf.org) and the Food composition database 
(http://www.foodcomp.dk) and were mapped to NCBI IDs (TAXIDs). Human proteins were 
associated to diseases through the Therapeutic Targets Database (Zhu et al., 2012) (TTD Version 
4.3.02). Disease names were mapped to the OBO Foundry Human Disease Ontology (DOID) 
(Smith et al., 2007) and ordered in disease categories. 
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Chemical structures and corresponding IDs of small compounds were retrieved from PubChem 
(Bolton et al.) ChEBI (Hastings et al., 2013), CHEMLIST (Hettne et al., 2009), the Chinese 
Natural Product Database (Shen et al., 2003) (CNPD) and Ayurveda (Polur et al., 2011) 
ressources. Marvin 6.1.0 (http://www.chemaxon.com) was used for encoding the chemical 
structures in unique SMILES. 
 
Food-compound and food-disease associations 
We extracted by text-mining plant – phytochemical and plant - disease associations from 21 
million abstracts in PubMed/MEDLINE, covering the period 1908-2012, as described previously 
(Jensen et al., 2014). We subsequently filtered for pairs involving plant-based foods using Plant 
For A Future (PFAF) (http://www.pfaf.org) and the food composition database 
(http://www.foodcomp.dk). In total, NutriChem contains 18,478 pairs of 1,772 plant-based 
foods and 7,828 phytochemicals, and 6,242 pairs of 1,066 plant-based foods and 751 diseases. 
 
Association of diet to health benefit at molecular level 
Fisher’s exact test was used to systematically associate frequently occurring phytochemical-
disease pairs through the phytochemical-food and food-disease relations extracted by text mining, 
with the Benjamini-Hochberg procedure and a 5% false discovery rate (the method is described in 
detail previously (Jensen et al., 2014)). Chemical-protein interactions data were gathered in 
September 2013 from the open-source database ChEMBL (version 16). We associated 
phytochemicals that have no direct experimental bioactivity data with structurally similar 
compounds from ChEMBL (Tanimoto coefficient > 0.85) and their protein targets, when such 
data were available. For the calculation of the Tanimoto coefficient, chemical structures were 
encoded in 166 MACCS keys (Durant et al., 2002) using OpenBabel (O’Boyle et al., 2011). In 
total, NutriChem contains 1,549 predicted associations between 548 phytochemicals and 252 
diseases. 
 
Visual interface 
We implemented a visual interface in NutriChem to facilitate the visualization of the results 
using CytoscapeWeb (http://cytoscapeweb.cytoscape.org). At the left part of the screen a 
network is depicted, with the query input as the central node and the retrieved results connected 
to it through edges. The thickness of an edge indicates the number of references in support of the 
associations. By clicking on the icon “Apply layout” the user can apply the Force-directed layout 
on the network. At the right-hand side the results are shown as a list. The list items are 
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expandable upon click and detailed information about the association is shown. The list items are 
also expandable by clicking on the edges of the network at the left-hand side. 
By clicking on the icon “Export network” the user can download the network in 
Cytoscape/xml format and continue working offline in Cytoscape or download the list results as 
a “tab-separated file” by clicking on the “Export table” icon. The user can search by: i) food name 
or TAXID, ii) human disease name or DOID and iii) compound (i.e. phytochemical) name, ID 
(ChEMBL ID, CID, etc.) or SMILES string. The different functionalities of NutriChem. The user 
can query NutriChem by food, disease or compound name/ID are shown in Figure 10. 
 
 
 
Figure 10: The different functionalities of NutriChem. The user can query NutriChem by 
food, disease or compound name/ID. Outcomes from each query type are in cycles 
pointed by arrows. The available actions that can be subsequently performed are 
depicted next to each cycle. 
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Figure 11: (A) A search with “pomegranate” as the query, (B) The plant-compound network 
is shown by default and by using the top buttons the user can switch to the plant-
disease network or back to Home for submitting a new query. On the right-hand 
side the user can directly access the relevant references in PubMed in support of the 
pomegranate-compound associations, by clicking on the respective PMID. (C) If 
we select the compound “quercetin”, “Get compound protein activities” lists 15 
proteins with measured experimental activity. The user has the option to click 
either on the bioassay, the compound or the protein IDs on the right side of the 
panel, which will open in a new tab the respective ChEMBL and UniProt pages.  
(D) “Get compound activities to disease proteins” filters the above results for 
therapeutic proteins only (proteins annotated to a disease in TTD) and displays the 
disease-associated network for quercetin. (E) “Get predicted compound activities” 
shows predicted disease associations for quercetin as derived from Fisher’s test. 
The results are grouped in three categories, depending on the experimental 
evidence that supports each prediction. (F) The disease network of the query 
“pomegranate” returns 15 diseases in which pomegranate is known to have a 
preventive/beneficial effect. Blue edge: “preventive” association, red edge: 
“promoting”. On the right-hand side the user can directly access the relevant 
references in PubMed in support of the pomegranate-disease associations, by 
clicking on the respective PMID. 
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Applications 
a) Food as query 
When a food query is submitted to the server the user can specify the minimum number of 
references required for an edge and the maximum number of edges allowed to a query node. By 
default we use a limit of minimum 1 reference for an edge (can range from 1 to 10) and maximum 
15 edges for a node (can range from 1 to 20). However, regardless of the settings, all results are 
listed at the right-hand side. Figure 11 illustrates a search with “pomegranate” as the query. In the 
top of the interface two buttons are shown. The buttons allow the user to switch between the 
different result sections. The plant-compound network is shown by default and by using the top 
buttons the user can switch to the plant-disease network or back to Home for submitting a new 
query. The network at the left-hand side shows 15 compound associations. On the right-hand side 
the user can directly access the relevant references in PubMed in support of the pomegranate-
compound associations, by clicking on the respective PMID. 
When a compound node is selected on the food-compound network, the user has three 
special action buttons. The first action button is “Get compound protein activities”, the second 
“Get compound activities to disease proteins”, and the third “Get predicted compound 
activities”. For example, if we select the compound “quercetin”, “Get compound protein 
activities” lists 15 proteins in UniProtID (http://www.uniprot.org) with measured experimental 
activity (data from ChEMBL). The user has the option to click either on the bioassay, the 
compound or the protein IDs on the right side of the panel, which will open in a new tab the 
respective ChEMBL and UniProt pages.  “Get compound activities to disease proteins” filters the 
above results for therapeutic proteins only (proteins annotated to a disease in TTD) and displays 
the disease-associated network for quercetin. “Get predicted compound activities” shows 
predicted compound-disease associations as derived from Fisher’s test. The results are grouped in 
three categories, depending on the experimental evidence that supports each prediction. The first 
category “Disease with protein targeted by compound” includes predicted disease associations, 
where there exist experimental activity data for quercetin and a disease-related protein target. The 
second category “Disease with protein targeted by similar compound” includes predicted disease 
associations, where there exist experimental activity data for a compound similar to quercetin (Tc 
> 0.85) and a disease-related protein. The user has the option to click on one of the results on the 
right side of the panel, to open in a new tab the respective ChEMBL compound activity data or 
the protein information in UniProt.  The third category “Disease with no target information” 
includes predicted disease associations with no experimental activity data for quercetin or a 
structurally similar compound and a disease-related protein. 
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By clicking on the top right button, “Plant disease associations” the disease network of the 
query “pomegranate” is displayed, with 15 diseases in which pomegranate is known to have a 
preventive/beneficial effect. When the edge is blue, it indicates a “preventive” association (food 
associated with disease prevention or amelioration) and a red edge indicates a “promoting” 
association (food associated with disease progress). On the right-hand side the user can directly 
access the relevant references in PubMed in support of the pomegranate-disease associations, by 
clicking on the respective PMID. 
 
Figure 12: (A) Diabetes as query returns a network with 15 foods that have a preventive 
association against the disease. On the right-hand side the user can directly access 
the relevant references in PubMed in support of the diabetes-food associations, by 
clicking on the respective PMID. Clicking on any of food names on the network 
enables the action buttons “Get compound activities to disease proteins” and “Get 
predicted compound activities”. On the right side of the panel the user can click on 
an arrow, which expands the results and displays the experimental activity data 
related to each compound. The user has again the option to click either on the 
bioassay, the compound or the protein IDs, which will open in a new tab the 
respective ChEMBL and UniProt pages. (B) Ellagic acid as query returns 15 foods 
that have been associated with it in the literature. On the right-hand side the user 
can directly access the relevant references in PubMed in support of the Ellagic acid-
food associations, by clicking on the respective PMID. Clicking on any of the food 
names enables the three action buttons, as described above. 
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b) Disease as query 
The user can query “diabetes” which returns a network of 15 foods that have a preventive 
association with diabetes (Figure 12A). On the right-hand side the user can directly access the 
relevant references in PubMed in support of the diabetes-food associations, by clicking on the 
respective PMID. Clicking on any of the food names on the network enables the action buttons 
“Get compound activities to disease proteins” and “Get predicted compound activities”, as 
described above. Ginger, for example, has been associated in the literature with 10 compounds 
with experimental biological activity against a diabetes-related target. On the right side of the 
panel the user can click on an arrow, which expands the results and displays the experimental 
activity data related to each compound. For example, by expanding the results for Curcumin, we 
see that it targets P10253 (lysosomal alpha-glucosidase), a clinical trial target against diabetes 
mellitus type 2 according to TTD (Zhu et al., 2012). The user has again the option to click either 
on the bioassay, the compound or the protein IDs, which will open in a new tab the respective 
ChEMBL and UniProt pages. 
 
c) Compound as query 
The user can query “ellagic acid” which returns a network of 15 foods that have the 
compound associated (Figure 12B). Ellagic acid as query returns 15 foods that have been 
associated with it in the literature. On the right-hand side the user can directly access the relevant 
references in PubMed in support of the Ellagic acid-food associations, by clicking on the 
respective PMID. Clicking on any of the food names enables the three action buttons that allow 
the use to perform the steps described above. 
 
Conclusion 
The need for a more complete assessment of the environmental factors in epidemiological 
studies gave birth to a new –ome, the exposome. Here, we envisage elucidating the link between 
diet, molecular biological activity and diseases by developing a database source that translates the 
diet-exposome from concept to utility. Our methodology for better delineating the prevention of 
human diseases by nutritional interventions relies heavily on the availability of information 
related to the small molecule constituents of our diet. We expect to maintain and expand 
NutriChem regularly. As the next thing in the pipeline, we intend to integrate in NutriChem 
biological activity data of marketed drugs, which will make possible to study the effect of diet on 
drug properties related to their pharmacokinetics and pharmacodynamics.
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Abstract 
 
Recent research has demonstrated that consumption of food -especially fruits and vegetables- can 
alter the effects of drugs by interfering either with pharmacokinetic or pharmacodynamic 
processes. Despite the recognition of these drug-food associations as an important element for 
successful therapeutic interventions, a systematic approach for identifying, predicting and 
preventing potential interactions between food and marketed or novel drugs is not yet available. 
The overall objective of this work was to gain a global knowledge on the interference of ~ 4,000 
dietary components present in ~1800 plant-based foods with the pharmacokinetics and 
pharmacodynamics processes of medicine, with the purpose of elucidating the molecular 
mechanisms involved. By developing a systems chemical biology approach that integrates data 
from the scientific literature, online databases and a recently developed in-house database we 
revealed novel associations between diet and dietary molecules with drug effect targets, metabolic 
enzymes, drug transporters and carriers currently deposited in DrugBank. Moreover, we 
identified disease areas, e.g. cancer and neurological diseases, as well as drug effect targets e.g. 
carbonic anhydrase family, kappa- and delta- type opioid receptors and 5-hydroxytryptamine 
receptors, that are most prone to the negative effects of drug-food interactions, showcasing a 
platform for making recommendations in relation to foods that should be avoided under certain 
medications. Lastly, by investigating the correlation of gene expression signatures of foods and 
drugs we were able to generate a completely novel drug-diet interactome map. 
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Introduction 
 
Drugs and plant-based foods (i.e. fruits, vegetables and beverages derived from them, 
referred to simply as “food” throughout the rest of the document) share an intricate relationship 
in human health and have a complementary effect in disease prevention and therapy. In many 
diseases, such as hypertension, hyperlipidemia, and metabolic disorders, dietary interventions 
play a key part in the overall therapeutic strategy (Chan, 2013). But there are also cases, where 
food can have a negative impact on drug therapy and constitute a significant problem in clinical 
practice. Recent research has demonstrated that foods are capable of altering the effects of drugs 
by interfering either with pharmacokinetic or pharmacodynamic processes (Yamreudeewong et 
al., 1995). Pharmacokinetics includes the Absorption, Distribution, Metabolism and Excretion of 
drugs, commonly referred to jointly as ADME. Pharmacodynamic processes are related to the 
mechanisms of drug action, hence the therapeutic effect of drugs; interactions between food and 
drugs may inadvertently reduce or increase the drug therapeutic effect (Schmidt and Dalhoff, 
2002). Until not long ago, most knowledge about drug-food interactions derived mostly from 
anecdotal experience, but recent scientific research can demonstrate examples, where food is 
shown to interfere with the pharmacokinetics and pharmacodynamics of drugs via a known 
mechanism of interaction: an inhibitory effect of grapefruit juice on Cytochrome P450 
isoenzymes (e.g. CYP3A4) that leads to increased bioavailability of drugs e.g. felodipine, 
cyclosporin and saquinavir and potential symptomatic toxicity has been reported (Seden et al., 
2010); green tea reduces plasma concentrations of the β-blocker nadolol, possibly due to 
inhibition of Organic Anion Transporter Polypeptide 1A2 (OATP1A2) (Misaka et al., 2014); 
activity and expression of P-glycoprotein (P-gp), an ATP-driven efflux pump with broad substrate 
specificity, can be affected by food phytochemicals, such as quercetin, bergamottin and catechins, 
which results in altered absorption and bioavailability of drugs that are Pgp substrates (Zhou et 
al., 2004b); an antagonistic interaction of anticoagulant drug warfarin with vitamin K1 in green 
vegetables (e.g. broccoli, Brussels sprouts, kale, parsley, spinach), whereby the 
hypoprothrombinemic effect of warfarin is decreased and thromboembolic complications may 
develop (Yamreudeewong et al., 1995); sesame seeds have also been reported to negatively 
interfere with the tumor-inhibitory effect of Tamoxifen (Sacco et al., 2008). Judging from the 
examples above, under most in vitro drug-food interaction studies, food is either treated as a black 
box, or the study focuses on few, well-studied compounds, such as polyphenols, lipids and 
nutrients.  
Our main hypothesis in the current work is that the interference of food on drug 
pharmacokinetic or pharmacodynamic processes is mainly exerted at the molecular level via 
natural compounds in food that are biologically active towards a wide range of proteins involved 
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in drug ADME and drug action. The hypothesis is certainly supported by the large number of 
natural compounds that have reached the pharmacy shelves as marketed drugs. Hence, the more 
information we gather about these natural compounds, such as molecular structure, experimental 
and predicted bioactivity profile, the greater insight we will gain about the molecular mechanisms 
dictating drug-food interactions, which will help us identifying, predicting and preventing 
potential unwanted interactions between food and marketed or novel drugs. 
Unlike drug bioactivity information that has already been made available for system-level 
analyses via databases such as ChEMBL (www.ebi.ac.uk/chembldb/) and DrugBank 
(http://www.drugbank.ca/), biological activity data and source origin information of natural 
compounds present in food are scarce and unstructured. To this end, we have developed a 
database generated by text mining of 21 million MEDLINE abstracts that links plant-based foods 
with their small molecule components, experimental bioactivity data and human disease 
phenotypes (Jensen et al., 2014). In the present work, we are exploring this resource for links 
between the natural compound chemical-space of plant-based foods with the drug target space. 
By integrating protein-chemical interaction networks and gene expression signatures we provide 
the foundation for understanding mechanistically the effect of eating behaviors on therapeutic 
intervention strategies. 
 
Results 
 
The drug-like chemical space of the plant-based diet 
 
 Our in-house database (Jensen et al., 2014), consists of 1,772 plant-based foods associated 
with ~8,000 unique compounds. Information on the bioactivity profile exists for less than half of 
these food compounds (Figure 13A). Initially, in order to map the interactions associated with 
diet and drug treatment on the therapeutic target space, we studied the activity profile of the 3,799 
phytochemicals with experimental bioactivity data. We identified 463 phytochemicals with 
bioactivity at the range of drug activity against 207 drug targets, 18 enzymes, 7 transporters and 3 
carriers currently deposited in DrugBank. As shown in Figure 13B, foods that are routinely part 
of our diet, such as strawberry, tomato, celery and maize, are involved via the bioactive 
phytochemicals they contain in high number of interactions with targets within these four 
categories (Figure 13B). This illustrates that ignoring the complete phytochemical content of a 
food and focusing on a couple of “hot” molecules, a strategy widely applied in traditional food 
research, will never reveal the true magnitude of drug-food associations. 
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Figure 13: (A) Number of plant-based food compounds in our database with (blue) and 
without (green) experimental bioactivity information in ChEMBL. (B) Left: Total 
number of drug effect targets, enzymes, transporters and carriers from DrugBank 
targeted by food compounds, based on biological activity data deposited in 
ChEMBL. Right: The plant-based foods with the most interactions to drug carriers, 
transporters, enzymes and effect targets. The plot shows the 15 most interacting 
foods within these four categories. (C) Network of foods that share protein targets 
with drugs. Node size reflects the number of bioactive compounds 
(phytochemicals) and targeted proteins for a given food.  Edge width reflects the 
number of common targeted proteins between two foods. For visualization 
purposes, only the 5 strongest edges for each node are shown. The food network 
with the widest edges is highlighted.  
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 Ginger’s phytochemical profile appears as the most biologically active, targeting in total 151 
proteins, most of which are targets associated with drug pharmacodynamics. This comes with no 
surprise since ginger has been positively associated in the scientific literature with at least 87 
human disease phenotypes (Jensen et al., 2014). It should be pointed out that the 15 highly 
interacting foods shown in the figure are not necessarily the best characterized in terms of number 
of assigned phytochemicals. The number of bioactive phytochemicals in them ranges from 18 for 
mango to 42 for camellia-tea, while foods like licorice and rhubarb, for example, contain similar 
number of bioactive compounds (33 and 24 respectively) without, however, targeting as many 
proteins within these four categories. This indicates that specific structural characteristics of the 
food components are dictating drug-food interactions. 
 In order to further hone in the dietary habits that augment the impact on drug efficiency we 
created a network that relies on the number of protein targets shared between different foods. As 
shown in Figure 13C several sub-networks of foods target the same protein space, a property that 
could be taken into account when drugs targeting these proteins are prescribed. For example, 
safflower, lettuce and garlic are forming a small sub-network sharing more than 55 proteins 
targeted by their food compounds. The most highly influential food group consists of guava, 
mango, strawberry, beansprout, camellia-tea, swede and tomato, with the average number of 
shared protein targets to be more than 70. Papaya, orange, dill, tangerine, cress and chili pepper 
together with a few more foods form an isolated module targeting a separate protein target space. 
In all the food clusters of Figure 13C it is apparent that there is no phenotypic or higher level 
taxonomic characteristic of the foods that could be used to predict the shared interactions with the 
therapeutic space; this pattern has been revealed from the knowledge of their phytochemical 
space.  
Effect of drug-food interactions on drug pharmacodynamics and 
pharmacokinetics 
 
To get an insight of the pharmacodynamics processes that are mostly affected by the bioactive 
phytochemicals of our diet we zoomed in the interactions with the drug effect targets. Comparing 
Figure 14A, which presents the foods with the highest number of interactions with targets 
involved in drug pharmacodynamics, with Figure 13B that relies on all protein targets of a drug 
(effect target, transporter, carrier and metabolic enzyme), we notice that rice and avocado have 
replaced maize and licorice in the top-15 list. Furthermore, categorizing drug effect targets based 
on their human disease association, demonstrates the broad spectrum of disease treatments that 
may be affected by dietary habits. 
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As shown in Figure 14A, the drug effect targets for 13 disease categories, ranging from 
neurological and cardiovascular to infectious and immunological diseases, could be potentially 
altered by food components. It is particularly interesting that cancer-related proteins are highly 
targeted by dietary molecules; since cancer is still one of the most deadly diseases, patients are 
willing to follow alternative therapeutic approaches, most often concomitantly with standard drug 
treatment, such as adopting a “healthy diet” that usually consists of fruits and vegetables. While 
this approach could be beneficial prior the onset of disease as a preventive measure, it appears 
that it should be adopted with caution when a patient is under drug therapy, as it may interfere 
with the therapeutic effect of the drug. 
Another observation from Figure 14A, not surprising due to the well-known protective role of 
plant-based diet against these diseases, is that cardiovascular and gastrointestinal drug effect 
targets are highly associated with dietary molecules. Furthermore, looking into the association 
between food and drug effect targets at a biological process level reveals a wide range of functions 
that are targeted by food components (Figure 14B). Nevertheless, our analysis points to that food 
“shows a preference” towards a specific drug effect target space that is significantly 
overrepresented (Student’s t-test, p<0.05) with proteins involved in signal transduction, immune 
system and developmental processes (Figure 14B). 
Having identified the foods that interact the most with drug effect targets and the biological 
processes that these targets participate in, we took a step further and zoomed into the level of 
individual proteins. We constructed a network (Figure 14C) for each disease category, which 
links drug effect targets based on the drug-food pairs that they share. For example in cancer, drug 
targets of the carbonic anhydrase family are tightly connected, as they share a large number of 
drug-food pairs. Looking into the neurological diseases we could identify a tight connection 
between the kappa- and delta- type opioid receptors, while for cardiovascular diseases a network 
of the 5-hydroxytryptamine receptors is highly targeted by the same drug-food pairs. Naturally, 
since many of the drug effect targets are shared between different disease classes, some of these 
networks were observed in more than one disease category. Nevertheless, similarly to our 
observations above at the biological process level, our analysis here revealed that drugs developed 
for certain protein targets are more prone to be affected by diet than others.  
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Figure 14: (A) The plot shows the plant-based foods with the highest number of interactions 
with drug effect targets and their associated human disease classification. (B) The 
number of drug effect targets affected by food, annotated to different biological 
systems. The expected number of targets in each biological category was calculated 
as: exp = (tpc / tdt) * tpa, where, tpc: the total number of drug effect targets from 
DrugBank in a biological category, tdt: the total number of drug effect targets in all 
biological categories (1,806 proteins) and tpa: the total number of drug effect 
targets that participate in drug-food interactions based on our analysis (186 
proteins). (C) Networks of drug effect proteins affected by food, per human disease 
class, shown for the 6 most dominant classes. Two drug effect targets are connected 
when there are at least 3 drug-food pairs with biological activity against both 
proteins. We show only the 5 strongest edges for each node. The numbers for each 
disease class inside the pie correspond to the total number of drug effect targets that 
are affected by food. The bar-plot to the right shows the total number of foods and 
drugs interacting with drug effect targets in each disease class.  
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Figure 15: Disease-specific networks of drug-food interactions on proteins affecting drug 
pharmacodynamics. Node shape denotes drug effect target (circle), drug (triangle) 
and food (diamond). Edge color highlights the food compound (phytochemical) 
that shows the highest binding activity to the effect target. Edge width denotes the 
biological activity (Ki, IC50) and ranges between 1nM to 1000 nM. For 
visualization purposes, only 3 drugs and 3 foods with the highest biological 
activities are shown for each drug effect target. 
 
In order to attempt a molecular level understanding of identified drug-food interactions we 
selected case studies from five disease categories and highlighted the food components with the 
highest binding affinity to the drug effect targets. As shown in Figure 15, aromatase, a protein 
targeted by five anticancer drugs (Anastrozole, Testolactone, Exemestane, Letrozole and 
Aminoglutethiumide) is also targeted by naringenin (IC50=2.9nM), a compound found in 
licorice, beansprout and maize, among others. 
 
Cancer
Anastrozole
Licorice
Letrozole
Onion
Tamoxifen
Exemestane
Beansprout
Maize
Aromatase
Estrogen receptor beta
Testolactone
82 kDa matrix 
metalloproteinase-9
Celery
Guava
Swede
Olive
Sugar-pea
PEX
Aminoglutethimide
Wheat
Stromelysin-1
Tomato
Thalidomide
Grape
Currant
Strawberry
Estrogen receptor
Bosutinib
Rhubarb
Dasatinib
Prostaglandin G/H 
synthase 2 
Tyrosine-protein kinase 
ABL1
Imatinib
Lingonberry
Peanut
Flutamide
Androgen receptor
Tea
Nilutamide
Quinces
Bicalutamide
Passionfruit
Sweet-pepper
Watercress
Chives
Persimmon
LycheeVandetanib
Arachidonate
5-lipoxygenase
Masoprocol
Erlotinib
Gefitinib
Lapatinib
Epidermal growth factor 
receptor
Endive
Dandelion
Collagenase 3
DNA topoisomerase 
2-alpha
Marimastat
Amsacrine
Cardiovascular
Tomato
Potato
Safflower
Pindolol
5-hydroxytryptamine
receptor 1B 
5-hydroxytryptamine
receptor 1A 
Poppy-seed
Sprouted-lentilCoconut
Swede
Trichlormethiazide
Oat
Carbonic anhydrase 1
Currant
Peanut
Musculoskeletal
Grape
Diclofenac
Currant
Prostaglandin G/H 
synthase 2 Tomato
Ketoprofen
Etoricoxib
Lumiracoxib
Naproxen
Androgen receptor
Tea
Olive
Quinces
Sweet-pepper
Celery
Passionfruit
Testosterone
Watercress
Celecoxib
Estrogen receptor
Strawberry
Flurbiprofen
RaloxifeneLingonberry
Rhubarb
Peanut
Neurological
5-hydroxytryptamine
receptor 7 
Aripiprazole
Haloperidol
Fluphenazine
Quetiapine
5-hydroxytryptamine
receptor 1A 
Tacrine
Sweet-pepper
Sugar-pea
Passionfruit
Quinces
Loxapine
Rivastigmine
Watercress
Acetylcholinesterase
Donepezil
Tea
Galantamine
Endive
Dandelion
Celery
Wheat
Olive
Persimmon
Cholinesterase
Ziprasidone
Sulpiride
5-hydroxytryptamine
receptor 6 
Risperidone
Tomato
Buspirone
Olanzapine
Remoxipride
Clozapine
D(2) dopamine receptor
5-hydroxytryptamine
receptor 2C 
Potato
Sertindole
5-hydroxytryptamine
receptor 2A 
Safflower
Thioridazine
Chlorpromazine
Poppy-seed
Serotonin
Resveratrol
Quercetin
P-Hydroxybenzoic Acid
Naringenin
Aporphine
Apigenin
3,5-Dihydroxybenzoic Acid
Kaempferol
Edge width
Compound binding
strength
(IC50/Ki)
Drug Interaction
Plant-based food
Protein target
Drug
1 nM - 1000 nM
Chapter III: Developing a molecular roadmap of drug-food interactions 
 
81 
Kaempferol, present in lychee, onion, strawberry and other common foods has a high binding 
affinity (IC50=3.0nM) for the epidermal growth factor receptor, effect target for Lapatinib, 
Gefitinib, Vandetanib and Erlotinib anticancer drugs. For neurological diseases, serotonin, 
present in sunflower, potato and tomato interacts strongly (Ki=1.1nM) with the 5-
hydroxytryptamine receptors targeted by several drugs (e.g. Loxapine, Buspirone, etc.), whereas, 
aporphine, present in poppy-seed, binds to the D(2) dopamine receptor (Ki=527nM), drug effect 
target of Ofremoxipride, Sulpiride and other drugs (Figure 15).  
P-hydroxybenzoic acid, a compound naturally found in coconut, currant, sprouted lentil, 
swede and other foods, binds strongly (Ki=920nM) to carbonic anhydrase, effect target of the 
cardiovascular drug Trichlormethiazide. Lastly, resveratrol, a compound that earned its 
prophylactic reputation against cardiovascular diseases due to its presence in red wine 
(represented by grape in Figure 15), was found in our analysis to interfere with the activity of 
several drugs (Diclofenac, Raloxifene, etc.) that target either the estrogen receptor or 
prostaglandin G/H synthase 2 (involved in musculoskeletal diseases). 
Turning our focus to the effects of diet on the pharmacokinetics of drugs, we studied the 
interactions of food components with proteins involved in drug ADME. Figure 16 illustrates the 
corresponding drug-food interaction networks for metabolic enzymes and transporters, where 
apigenin, quercetin, naringenin, resveratrol and nicotinic acid are the food molecules with the 
strongest binding affinities. These compounds are found in more than 40 foods; hence, a complete 
understanding of their interaction profile with drug ADME proteins is of utmost importance. For 
acetylcholinesterase and cholinesterase, two proteins involved in the metabolism of several drugs, 
e.g. Neostigmine (myasthenia gravis), Isoflurophate (glaucoma), Donepezil (dementia), 
Galantamine (dementia) the binding affinity of food components quercetin and apigenin is lower 
than this of the drugs, but still in the range of measured activities for these metabolic targets. In 
other cases, such as aromatase, involved in the metabolism of Anastrozole, Letrozole, 
Exemestane and Aminoglutethimide, drugs used against breast cancer, we encounter bioactive 
food components with stronger activities. Naringenin, a compound found in licorice, sugar pea, 
guava and others, has a binding affinity of IC50=1000nM against aromatase, comparable with 
the actual drug’s. Similarly, the ribosyl-dihydronicotinamide dehydrogenase, involved in the 
metabolism of primaquine, is targeted from resveratrol with binding affinity higher than that of 
the respective drug (IC50=450nM) (Figure 16). Resveratrol interacts as well with the multidrug 
resistance protein 1, involved in the transport of several cancer drugs (Tamoxifen, Vinblastine) 
and other types of drugs, such as the antiretroviral drug Nelfinavir or Haloperidol an 
antipsychotic medication. 
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Figure 16: Networks of drug-food interactions affecting drug pharmacokinetics. Node shape 
denotes enzyme/transporter (circle), drug (triangle) and food (diamond). Edge 
color highlights the food compound (phytochemical) that shows the highest 
binding activity to the protein target. Edge width denotes the biological activity 
(Ki, IC50) and ranges between 1nM to 1000 nM. For visualization purposes, only 3 
drugs and 3 foods with the highest biological activities are shown for each protein 
target. 
 
Evaluation of drug-food interactions through their gene expression 
signatures 
 
 Despite a thorough investigation of the interaction network formed by the bioactive 
compound space of diet and the drug activity space, the obtained results of possible drug-food 
interactions heavily rely on the available data related to the phytochemical content of food as well 
as the activity of these molecules on human proteins. To overcome the barrier of data 
incompleteness we decided to compare the gene expression signatures of diet with the ones of 
FDA approved drugs, looking for correlated and anti-correlated profiles. The statistical analysis 
was performed using the Connectivity Map (Lamb et al., 2006) which includes gene expression 
signatures from 1,309 compounds, both FDA-approved drugs and bioactive compounds. We 
found gene expression data for 9 foods that are linked in our in-house database with 390 unique 
compounds (Figure 17). These 390 compounds are chemically similar to both CMap compounds 
as well as FDA approved drugs currently present in DrugBank (Figure 17A). We could retrieve 
5,171 protein targets (direct and indirect) for these compounds, where “disease” is the most 
enriched pathway with 538 protein targets involved (Figure 17B). Other significantly enriched 
pathways include cell cycle, developmental biology and apoptosis. Looking into the gene 
expression profiles of these 9 foods, we notice that 9,072 genes are significantly differentially 
expressed (FDA corrected moderated t-test, p<0.05) between the control samples and the diet 
interventions. 
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Interestingly, when these gene targets were further analyzed, the biological processes that were 
found significantly enriched have a high similarity with the protein space targeted by the food 
compounds (Figure 17B vs Figure 17C). However, what we also observed was that from the 
5,171 proteins targeted by the food components, only 2,653 were found in the significantly 
differentially expressed (DE) gene list. In our attempt to understand the reasons behind this 
discrepancy we selected a sub-set of 56 food molecules that were targeting proteins from both 
groups; the ones that showed a significantly different expression level and the ones that did not 
(non-DE). We compared the binding affinity for those compounds having both DE targets and 
non-DE targets as well as the protein connectivity of their targets. While the protein connectivity 
analysis did not yield a statistically significant difference between the two groups, the IC50 values 
were significantly lower (Wilcoxon rank-sum test p value< 0.05) for the compounds targeting the 
non-DE group of genes.  
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Figure 17: Comparative analysis of food and drug gene expression signatures. In total 9 
high-quality gene expression signatures of plant-based foods could be retrieved 
(A) Chemical similarity comparison between the food compounds (390), the 
bioactive compounds present in ConnectivityMap (1,309) and FDA-approved 
drugs in DrugBank. (B) Pathway enrichment analysis of the proteins targeted 
(directly and indirectly, see Materials and Methods) by the food compounds. (C) 
Pathway enrichment analysis of the 9,072 genes that were found collectively 
significantly differentially expressed in the pair-wise comparisons of each food 
with the respective control. (D) Drug-food interactions based on the food gene 
expression signatures submitted to CMap. Foods (yellow nodes) and drugs 
(squares with different colors based on disease classification) are connected if 
they show a correlated (grey edge) or anti-correlated (orange edge) gene 
expression signature. The width of the edge indicates the significance level of the 
observed correlation. 
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 Using as an input the gene expression signatures of each of the nine foods, we retrieved 133 
CMap compounds, of which, 46 FDA approved drugs that have a significant correlated or anti-
correlated profile (Figure 17D). These 46 FDA approved drugs were further mapped to disease 
categories showing that mostly drugs used against infectious diseases (13), cancer (9) and 
neurological diseases (9) induce a gene expression signature that can be either enhanced or 
reversed by diet. In the drug-food interaction network shown in Figure 17D, broccoli has the 
highest number of connections with drugs. Interestingly, all connections between broccoli and 
drugs are correlation-based, most of which display strong correlation coefficients. This finding 
sheds some additional light -from a mechanistic point of view- on the well-known beneficial effect 
of broccoli on human health. Orange and garlic induce a gene expression profile that is highly 
correlated with drugs used in cancer (Carmustine, Mercaptopurine) and reproductive disorders 
(Dydrogesterone, Diethylstilbestrol); orange specifically, is highly correlated with the activity of 
Orciprenaline (drug against a metabolic disease), Pyrimethamine (drug against an infectious 
disease) and Hydroxyzine (drug against a neurological disease). One notable case is olive oil; 
olive oil induces a gene expression signature highly anti-correlated with the anticancer drugs 
Mitoxanthrone, Irinotecan and Daunorubicin. Mitoxanthrone and Daunorubicin are typically 
used against leukemia, where olive oil has not demonstrated any beneficial effect. Irinotecan, on 
the other hand, is a drug used against colon cancer, a disease which several studies suggest that 
olive oil has actually a prophylactic effect on. This seemingly contradictory observation could be 
interpreted from another angle; foods that have the potentially to reverse -to some degree- the 
global effect of drugs, especially anticancer drugs that trigger severe side effects, without reducing 
the therapeutic action of the drug, could play a significant role in the life-quality of patients under 
treatment. 
 
Discussion  
 
Herbal therapies have been used for a variety of symptoms for thousands of years while 
recently there has been a drastic growth in the consumption of herbs and natural supplements 
with health benefits. In relation to AIDS and cancer patients especially, two life-threatening 
diseases where classical drug treatment does not always have a guaranteed effect, the use of both 
multiple prescription drugs and herbal supplements is very prevalent (Richardson et al., 2000; 
Sparber et al., 2000). Given that components of herbs and natural supplements interact with 
human proteins in a similar manner as drugs, there is a high potential for altering drug efficiency. 
Furthermore, phytochemicals are abundant in our diet and have been shown in vitro to influence 
human proteins and cell-cultures. 
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Several have demonstrated activity against the same proteins and biological systems as drugs, and 
thus, potentially influence their pharmacokinetics and pharmacodynamics behavior when 
consumed concomitantly. In example of sesame seed that has been reported to negatively 
interfere with the tumor-inhibitory effect of Tamoxifen (Sacco et al., 2008), the protein 
responsible for the therapeutic effect of Tamoxifen is the estrogen receptor (P003372), which is 
also targeted by a number of different bioactive phytochemicals present in sesame, including beta-
sitosterol (Chang et al., 2005; Hu et al., 2007). According to our in-house database, which links 
food with its molecular components, besides sesame seed, beta-sitosterol is a phytochemical 
component of guava, onion, pomegranate, turnip, fennel, celery and kiwifruit - all common foods 
of our diet that could also be potentially involved in interactions with Tamoxifen negatively 
affecting its therapeutic activity. As another example, health professionals recommend to patients 
under medication against high blood pressure to avoid consumption of licorice 
(http://www.ehow.com/list_5798754_foods-avoid-taking-beta_blockers.html, Accessed May 
30). The mechanism of this drug-food interaction is not yet clarified, although it has been 
occasionally attributed to the presence of glycyrrhizin. Our analysis points though towards the 
phytochemical liquiritin contained in licorice. Liquiritin has been found to interact with the beta-2 
adrenergic receptor (P07550; Bioassay CHEMBL1738166), which is the primary target of beta-
blockers, such as Penbutolol, a drug against hypertension.  
The overall objective of this work was to gain knowledge on the interference of dietary 
components with the pharmacokinetics and pharmacodynamics processes of medicine, with the 
purpose of elucidating the molecular mechanisms involved. To the best of our knowledge this is 
the first time of such a scale integration of data from the literature, online public and in-house 
databases coupled with gene expression analysis to study the effect of natural bioactive 
compounds from foods on proteins related to drug bioavailability and therapeutic effect. The 
novelty of this platform is that it takes into account the global effects of food, propelled by its rich 
natural compound content, increasing the level of confidence of the scientific community and 
medical professionals when making recommendations for foods that should be avoided under 
certain medications. We identified clusters of foods that target the same therapeutic space as 
drugs, a property that could potentially increase the chances for severe alterations of the drug 
activity if these foods are consumed concomitantly. We also identified a large number of food 
components that are potentially involved in yet not documented drug-food interactions 
supporting the notion that ignoring the complete chemical background of a food is a missing link 
for obtaining a holistic view of the effect of dietary habits. From a methodological point of view 
we believe that including the actual bioactivity values of the food components against drug targets 
allowed us to go beyond a simple enumeration of interactions to a more comprehensive and 
possibly accurate mapping of food-drug associations. Our food-drug interaction network also 
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revealed that therapeutic interventions for every disease category could be potentially affected to 
some degree by diet, even though specific disease areas, e.g. cancer and neurological diseases, are 
most prone to the negative effects of drug-food interactions than others. Lastly, we believe that we 
have demonstrated with several examples the power of a systems-level analysis to answer the two 
most important questions for patients and clinicians: (1) which foods should be potentially 
avoided from a patient under treatment, and (2) which is the underlying mechanism behind these 
drug-food interactions. However we should also keep in mind that, since many of the food 
compounds that are strong binders to therapeutic targets are very common in our diet, it will 
certainly be a daunting task to actually design diets that will not include such compounds. Thus, 
adding in the network analysis the actual concentration in food of each bioactive compound 
would give a more accurate picture of the extent and severity of these drug-food interactions. 
 
Materials and Methods 
 
The food-drug interaction space 
 
The plant-based food compounds and their chemical structures were retrieved form our in-
house database (Jensen et al., 2014). FDA-approved small molecule drugs were retrieved from 
DrugBank v.3. Food compounds and drugs were mapped to their protein interactions using 
ChEMBL v.16. Binding activities were retrieved from ChEMBL Bioassays. Protein targets were 
categorized into “Drug effect target”, “Enzyme”, “Transporter” and “Carrier”, following the 
DrugBank categorization. For a food compound to be considered active against a protein target, 
it had to bind within the range of the drugs targeting the same protein. For proteins were the 
binding activity of the drugs is unknown, the binding activity of the food compound was 
compared to the binding activities of proteins from the same category (i.e. drug effect target, 
enzyme, transporter or carrier). Drug effect proteins were mapped to disease categories using the 
Therapeutic Target Database (Zhu et al., 2012) and the Human Disease Ontology (LePendu et 
al., 2011). Categories were selected as the third level in the human disease ontology. Drug effect 
proteins were assigned to biological systems using Reactome (http://www.reactome.org). 
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Gene expression signature comparison 
 
Chemical similarity between food compounds, CMap bioactive compounds and FDA-
approved drugs 
 
SMILES strings of food compounds were retrieved from PubChem (Bolton et al.), while 
SMILES of the CMap bioactive compounds and FDA-approved small molecule drugs were 
retrieved from Connectivity Map build 02 (Lamb et al., 2006) and DrugBank 3.0 (Knox et al., 
2011), respectively. Based on the chemical structures, molecular or physical descriptors were 
calculated for each compound using the RDKit plugin (http://www.rdkit.org) in KNIME 
(Berthold et al., 2008), including a 1024-bit Morgan circular fingerprint, Topological Polar 
Surface Area (TPSA), octanol/water partition coefficient (SlogP), Molecular Weight (MW), 
number of Lipinski hydrogen bond acceptors (HBA) and donors (HBD). Afterwards, a matrix of 
compound descriptors with 1029 columns was constructed, in which each row represented a food 
compound, a CMap bioactive compound, or an FDA-approved drug and a principle component 
analysis (PCA) using R was performed. 
 
Retrieval of direct and indirect protein targets of the food compounds 
 
Firstly, food compounds were mapped to exact InChI key matches in ChEMBL and similar 
ChEMBL compounds using the Morgan circular fingerprint. The Tanimoto Coefficient (TC) was 
calculated based on Morgan fingerprint. Two of the compounds were similar if TC ≥0.85 and 
their difference in molecular weight was lower than 50 g/mol. Next, the interactions of food 
compounds and proteins were built by searching in ChEMBL the protein targets of those exactly 
matched or similar ChEMBL compounds. The bioactivities were filtered based on the following 
thresholds: for Ki, Kd, IC50 and EC50, pchembl_value larger than 6; for inhibition, measurement 
value greater than 30%; for potency, measurement value lower than 50 μM. To deal with the 
multiple measurements of the same compound on the same protein, we calculated a frequency of 
“positive” measurements (served as evidence of compound-protein interaction) among all 
candidate measurements. Only chemical-protein interactions with a frequency of higher than 0.5 
were considered confident and were used for further analysis. In addition to chemical-protein 
interactions from ChEMBL, we also included first-degree protein-protein interaction (PPI) 
partners (a confidence score higher than 400) from STRING 9.1 (Franceschini et al., 2013), to 
expand further our protein target space of food compounds. Note that this was only done for the 
protein targets of food compounds matching exactly to ChEMBL compounds. Only those PPI 
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from human, rats and mice were included. After obtaining protein targets for food compounds, 
protein targets in rats and mice were mapped to their human orthologous proteins through 
Ensembl Biomart Homolog Service (Flicek et al., 2014). 
Microarray data extraction and analysis 
 
ArrayExpress database (Rustici et al., 2013) was first queried with the list of 126 edible 
plants. Besides microarray data from human, experiments from rats and mice were also included. 
After manual inspection and quality check, 17 gene expression microarray experiments remained 
for downstream analysis, which corresponded to 12 unique foods that had available chemical 
composition information in the in-house database. Differential expression analysis of microarray 
data was conducted with R Bioconductor limma package (Smyth, 2004). A p-value of 0.05 was 
used as the cutoff when selecting significantly differentially expressed (DE) genes (Yoav and 
Hochberg, 1995). For each food, the list of DE genes was split into two lists of up and down-
regulated genes, referred to as “tag lists” in Connectivity Map (Lamb et al., 2006). The genes in 
tag lists were converted to the CMap-compatible probe-set IDs from Affymetrix GeneChip 
Human Genome U133A Array. For DE genes in rats and mice, the human homolog genes were 
obtained through Ensembl Biomart Homolog Service (Flicek et al., 2014) before mapping to 
probe-set IDs. The paired tag lists were used to query Connectivity Map to reveal the correlation 
or anti-correlation relationship between foods and drugs. Based on the output from Connectivity 
Map, CMap drugs or bioactive compounds were considered to correlate or anti-correlate with 
foods if they had an absolute enrichment score higher than 0.75, permutation p-value less than 
0.01 and a non-null percentage above 80%. 
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Abstract 
Background: Epidemiological studies in the recent years have investigated the relationship 
between dietary habits and disease risk demonstrating that diet has a direct effect on public 
health. Especially plant-based diets -fruits, vegetables and herbs- are known as a source of 
molecules with pharmacological properties for treatment of several malignancies. 
Unquestionably, for developing specific intervention strategies to reduce cancer risk there is a 
need for a more extensive and holistic examination of the dietary components for exploring the 
mechanisms of action and understanding the nutrient-nutrient interactions. Here, we used colon 
cancer as a proof-of-concept for understanding key regulatory sites of diet on the disease pathway. 
Results: We started from a unique vantage point by having a database of 158 plants positively 
associated to colon cancer reduction and their molecular composition (~3,500 unique 
compounds). We generated a comprehensive picture of the interaction profile of these edible and 
non-edible plants with a predefined candidate colon cancer target space consisting of ~1,900 
proteins. This knowledge allowed us to study systematically the key components in colon cancer 
that are targeted synergistically by phytochemicals and identify statistically significant and highly 
correlated protein networks that could be perturbed by dietary habits. 
Conclusion: We propose here a framework for interrogating the critical targets in colon cancer 
process and identifying plant-based dietary interventions as important modifiers using a systems 
chemical biology approach. 
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Our methodology for better delineating prevention of colon cancer by nutritional interventions 
relies heavily on the availability of information about the small molecule constituents of our diet 
and it can be expanded to any other disease class that previous evidence has linked to lifestyle. 
  
Introduction 
Nutrition is the cornerstone of an individual’s lifestyle, thus, understanding how diet 
influences metabolic regulation and how dietary interventions can improve health is a key 
scientific goal. At the same time, diet has a major influence on the overall quality of life beyond 
the prevention of diseases. Thus, even though the personalized approach to diet is the logical 
transition – much like the transition from pharmacology to personalized medicine – this task is 
extraordinary complex (Kaput, 2008; Kussmann and Fay, 2008). Most foods are composed of 
hundreds of bioactive compounds, often interacting synergistically, with varied concentrations 
and several biological targets with different affinities and specificities. However, since nutritional 
trials are not designed as mechanism-based preclinical studies little is known about these 
molecular targets. Observational studies performed on populations with distinct diet preferences, 
often coupled with sophisticated statistical analyses, have offered some associations between 
certain diseases and foods (Hutter et al., 2012; Nanri et al., 2011; Shiels et al., 2011). Even though 
in some cases, these kind of studies have led to further mechanistic investigations that resulted in 
elucidation of the bioactive natural compounds, they suffer in two ways: (a) they are 
phenomenological in nature, (b) they are very restricted in the confined disease phenotype space 
that is under study. 
On the other hand, numerous successful stories of FDA-approved therapeutic agents 
derived from phytochemicals: Hycamtin (GlaxoSmithKline), Navelbine (Pierre Fabre 
Pharmaceuticals Inc.), Taxol (Bristol-Myers Squibb), Taxotere (Sanofi-aventis) among others, have 
propelled the research on how dietary bioactive compounds interact with target proteins and 
perturb key signaling pathways. Thus, the second approach that we often encounter in nutritional 
studies is the in vivo or in vitro investigation of the beneficial effects of common phytochemicals, 
such as specific polyphenols that are present in a variety of fruits, vegetables, and other dietary 
botanicals. An abundant literature has shown that polyphenols can, among others, trigger 
apoptosis in cancer cells through the modulation of a number of key elements in cellular signal 
transduction pathways linked to apoptosis (caspases, bcl-2 genes) (Manson, 2003) and modulate 
epigenetic alterations in cancer cells (Katada et al., 2012). However, in such studies the major 
limitation is that the possible therapeutic value of the phenolic compound of interest is evaluated 
while ignoring the chemical background of the diet, which is probably one of the reasons for 
contradictory results from different research groups on the same compounds.  
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Therefore, there is a clear need for more systematic studies to identify those dietary factors 
that influence the most, reveal their synergistic interactions, and uncover the mechanisms of 
action. 
Cancer research in the last 20 years has brought to the fore a dramatic amount of 
information at the molecular level, leading to an overwhelming number of possible 
pharmaceutical targets for drug discovery. However, the redundancy and interconnection of the 
many regulatory pathways that are involved in cell replication, growth and apoptosis, as well as 
the capacity of mutations in cancer cells, is a significant barrier for drug development using 
targeted approaches.  
These hard limitations encountered with the targeted approach are contributing to prompt 
us to reconsider the global fight against cancer, especially for cancers that are proven to be 
intrinsically or partly related to lifestyle die). Beyond the specific aspect of cancer prevention, 
understanding the capacity of the body to maintain health homeostasis is a genuine subject of 
study for which a methodological approach needs to be considered. Taken separately each 
regulatory cascade interaction may not help framing an operational understanding of health 
homeostasis whereas a more global view, where the concomitant activity of the largest number of 
targets with respect to the wave of external agent exposure, such as dietary molecules, could be 
scrutinized as a complex interaction network. There is a general consensus that in the new era of 
nutritional research, systems analysis of normal and nutrient-perturbed signaling networks is 
required for identifying critical network nodes targeted through nutritional intervention of either 
preventive or therapeutic fashion (Fu et al., 2010). Borrowing chemoinformatics methods, well 
established and widely used in drug discovery research, could help us understand the complex 
interaction network between dietary small molecules and biological systems. In line with this, we 
present here a systems chemical biology approach that provides a fundamental foundation for 
understanding, which processes involved in the onset, incidence, progression and severity of 
colon cancer are modulated by dietary components. We selected colon cancer as a case study not 
only because it is one of the most aggressive cancers and the fourth most commonly diagnosed, 
but also because colon cancer seems not to be a consequence of aging but of eating behavior 
(Hambly et al., 2002; Tammariello and Milner, 2010). Nevertheless, the methodology proposed 
here is applicable to any large-scale diet-disease association study, where information about the 
small molecule constituents of the diet is available.  
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Results 
The chemical space of diet associated with colon cancer  
Using an in-house database developed by Jensen et al., (2014) (Jensen et al., 2014) through 
text mining of 21 million abstracts present in PubMed, we investigated here the role of dietary 
small molecules present in plants (edible and non-edible) with an established phenotype against 
colon cancer. As shown in Figure 18A 158 plants that have been positively associated in the 
literature with colon cancer, with 39 of them being part of a common diet, e.g. celery, garlic, 
thyme, among others (Figure 18A). From our in-house database we could also retrieve molecular 
information for these plants for 3,526 unique phytochemicals. It is quite interesting that despite 
the fact that all these plants have been positively associated with colon cancer reduction, the 
majority of phytochemicals (2,023) are plant specific (found only in one plant). The number of 
compounds associated with each plant varied considerably (Figure 18A), with a median value of 
41 compounds per plant and reaching as high as 392 compounds for ginseng. Not surprisingly, as 
shown in Figure 18A, common foods have been studied more thoroughly than other plants and 
have a median value of 129 compounds per food. Nevertheless, a group of phytochemicals has 
been detected in a very large number of plants associated with colon cancer; quercetin (N=51), 
gallic acid (N=43), vitamin P (N=43), gamma-sitosterol (N=42) and kaempferol-3-O-rutinoside 
(N=38). Since our objective was to obtain a mechanistic understanding of the association between 
plants and colon cancer we examined how many of the 3,526 phytochemicals are present an 
exact match in the ChEMBL database, one of the largest repositories of chemical-protein 
interaction data. As shown in Figure 18A, roughly for one third of the compounds present in each 
plant there are available experimental data for their interactions with the human protein space. 
We could find, in total, an exact match in ChEMBL for 1,663 phytochemicals, while 887 have a 
chemical similarity (TC > 0.85 & a difference in molecular weight less than 50 g/mol) with at 
least one other chemical in ChEMBL. For the remaining 976 compounds no information is 
available for possible protein targets. The chemical space of the phytochemicals from plants 
associated with colon cancer was evaluated using 1,027 chemical descriptors. To obtain a holistic 
view of this chemical space we compared it with FDA approved drugs and the human 
metabolites involved in the colon metabolic network developed by Agren et al. (Agren et al., 
2012). Interestingly, a large percentage of the plant phytochemicals shows a high degree of 
chemical similarity with metabolites of the human colon metabolic network pointing out that the 
therapeutic effect of these plants could be mediated at a metabolic level (Figure 18B); however, 
we should not overlook the high similarity between FDA drugs and plant phytochemicals and 
especially anticancer drugs (Figure 18B). 
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Figure 18: (A) A sub list containing 39 plants that are considered typical for western diet; the 
embedded figure shows the compound distribution as found in the 159 edible and 
non-edible plants. Green indicates total number of compounds, while orange 
indicates compounds that were found as exact match in CHEMBL; (B) Clustering 
of the plant compounds (green), human colon metabolites (yellow), FDA approved 
drugs (purple) and anticancer FDA approved drugs (black cross) based on 1027 
chemical descriptors. Selected compounds ((i)-(vii)) from the plants chemical space 
that show no or low chemical similarity with the other groups of compounds are 
shown on the left. 
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On the other hand a large number of phytochemicals (left upper corner of Figure 18B) has a 
very unique chemical profile with no similarities to either the drug space or the colon metabolic 
network. Examples of such compounds (Figure 18B) are glycyrrhizic acid (in rosemary), beta-
solamarine (in potato), tomatine (in tomato), transsylvanoside C (in liquorice) and diocine (in 
pomegranate). The above compounds are present in just a handful of edible and non-edible plants 
that have been associated to colon cancer. In the lower right part of Figure 18B we find 
compounds with structural similarities solely with approved drugs, e.g. 3-hydroxy-3-
methylglutaryl-coenzyme A (in potato), cinnamoyl-coenzyme A (in soybean) and oleoyl-
coenzyme A (in coriander). The source of these compounds is again restricted to a few edible and 
non-edible plants. 
 
 
Figure 19: (A) (i) The pie chart offers information for the compounds present in these edible 
plants; phytochemicals found as exact match in ChEMBL (orange), 
phytochemicals having at least one similar small molecule present in ChEMBL 
that do not fulfill any of the above criteria (green); (ii) A graphical representation of 
how the interactome map between edible plants and candidate colon cancer protein 
targets was generated: (a) an edible plant (orange circle; Px) contains a 
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phytochemical (box; Cx) which interacts directly with a target protein (green 
diamond; TPx) or through a first-degree neighbor (yellow diamond; Py) of TPx, (b) 
the phytochemical Cx is structurally similar with a compound (Cy) that interacts 
with the target protein (TPx). Straight lines represent verified interactions while 
dashed lines represent predictions; (iii) The Venn diagram shows the overlap 
between the proteins in the three candidate colon cancer target sets; (B) A plant-
protein interaction network based on the interactions between phytochemicals, 
FDA approved colon cancer drug targets and their first-degree neighbors. The size 
of the plant node is proportional to the number of proteins that its molecular 
components target. The width of the edge connecting two plants reflects how many 
protein targets the plants share. (C) A plant-protein interaction network using as a 
candidate target space the KEGG colon cancer pathway. (D) A plant-protein 
interaction network using as a candidate target space the colon cancer prognostic 
gene signatures (Oh et al., 2012). The color of the nodes in (B)-(D) is according to 
(Aii). 
 
An interactome map of candidate colon cancer targets and diet 
To unravel the interactions associated with diet and colon cancer we studied the complex 
interaction networks of the small molecules present in the 158 plants and the candidate colon 
cancer target space. By “candidate” here we mean proteins that are potentially involved in the 
onset and development of colon cancer and fall in one of the following categories (Figure 19A), 
(i) proteins that are established targets of the FDA approved colon cancer drugs (N=20) and their 
first degree neighbors (N=1,224); ii) proteins that participate in the KEGG colon cancer pathway 
(N=62) and their first degree neighbors (N=1,588); iii) proteins characterized by Oh et al., (Oh et 
al., 2012) as colon cancer prognostic signature (N=87) and their first degree neighbors (N=870). 
First-degree protein neighbors were included since cancer-related proteins are more likely to act as 
hubs in protein interaction networks. This feature of cancer proteins makes them amenable to 
activity disturbances through ligand binding to their protein neighbors. To ensure the biological 
validity of the interactions in the context of colon cancer only proteins for which there is positive 
evidence of expression in the colon according to the Human Protein Atlas (Uhlen et al., 2010) 
were included. As shown by the Venn diagram in Figure 19A there is very low overlap between 
the three categories (not taking into account the first-degree neighbors). The total number of 
unique proteins is 181 (and 1,708 unique first degree neighbors).  
 For the association of the plants with the candidate colon cancer protein space through 
their molecular components we considered direct (a) and indirect (b) interactions: (a) a plant 
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contains a compound that was found as an exact match in ChEMBL to interact with either the set 
of 181 or 1708 proteins; (b) a plant contains a compound structurally similar to a compound in 
ChEMBL that interacts with the set of 181 proteins. Only high confidence interactions, either 
chemical-protein or protein-protein, were kept (see Materials and Methods). 
(i) In total, 105 plants (33 edible) were found to interact with 4 target proteins (TEK, KDR, 
FGR1 and TOP1) of the FDA approved colon cancer drugs and 43 of their first-degree neighbors. 
The mean number of proteins from this category targeted by each plant was 6 (9 if we restrict the 
analysis to the common edible). The most targeted proteins of the compounds from edible plants 
were EGFR (targeted by 26 edible plants or 79% of the total edible plants in our database), NT5E 
(24 edible plants), ESR2 (20 edible plants), CSNK2A1 (17 edible plants) and FYN (17 edible 
plants). None of the above is an FDA colon cancer drug target but all are first degree neighbors of 
the drug targets. Similar results were observed when looking into the most targeted proteins of the 
non-edible plants. The interaction network between common edible plants and proteins from this 
category is shown in Figure 19B. The FDA approved drugs used against 4 proteins that are 
targeted by small molecules present in the edible plants, are irinotecan (TOP1) and regorafenib 
(TEK, KDR, FGR1). Pomegranate (Nsmall molecules=13, targeting Nproteins=23), rosemary (Nsmall 
molecules=13, targeting Nproteins=20), black tea (Nsmall molecules=12, targeting Nproteins=16), ginseng (Nsmall 
molecules=14, targeting Nproteins=17) and wheat (Nsmall molecules=10, targeting Nproteins=11) are the 
common foods of our diet with small molecules targeting the most this protein space. The mean 
connectivity ratio for the edible plants of Figure 19B is 3.7 (calculated as the sum of all edge 
weights divided by the number of edge weights). 
(ii) Similarly, we explored the interaction pattern of the phytochemicals in the 158 plants 
with the proteins in the KEGG colon cancer pathway and their first-degree neighbors. In total 12 
proteins are targeted by 73 plants through 32 unique small molecules. From the common edible 
plants (Figure 19C) 11 were found to have compounds targeting 3 proteins (MARK1, SMAD3, 
GSK3B) of the KEGG colon cancer pathway and 28 targeting the remaining 9, which are first-
degree neighbors of the proteins in the KEGG colon cancer pathway. Black tea (Nsmall molecules=5, 
targeting Nproteins=7), ginger (Nsmall molecules=4, targeting Nproteins=5), rosemary (Nsmall molecules=5, 
targeting Nproteins=6) and pomegranate (Nsmall molecules=4, targeting Nproteins=6) are the common foods 
of our diet with small molecules targeting the most this protein space. Interestingly, the pattern 
we observe in Figure 19B,C does not depend on the actual number of compounds present in each 
plant. Soybean, tomato, potato and guava, among others, are edible common plants with a large 
number of compounds however, none of them appears to target a large part of the candidate 
colon cancer protein space. 
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 The proteins from this category that are targeted the most from the edible common plants 
are HSD17B1 (43% of edible plants), TOP1 (37%), GSK3B (37%), SMAD3 (27%) and PRKACG 
(27%). GSK3B and SMAD3 are proteins involved in the KEGG colon cancer pathway and the 
remaining three are first-degree neighbors. The mean connectivity ratio of the network of Figure 
19C is 1.7. 
(iii) The last candidate colon cancer protein space under study was the prognostic signatures 
based on gene expression data (Oh et al., 2012). From the 87 proteins and their 870 first-degree 
neighbors that this targeted space consists of, only 5 proteins designated as prognostic signatures 
and 17 of their first-degree neighbors are targeted by the chemical space of the plants. In this 
category we found most of the edible plants: 41 small molecules from 37 edible plants target 4 
proteins that constitute colon cancer prognostic signatures and 14 that are their first-degree 
neighbors. The edible plants with the highest activity in this target space are black tea, ginger, 
tomato and grape, which interestingly share none of the active compounds. The most targeted 
proteins are CYP1B1, ALOX5 and FABP1 and the mean connectivity ratio of the network of 
Figure 19D is 3.9. 
The candidate colon cancer protein space that is targeted by plants with an established 
phenotypic effect against colon cancer allowed us to get a better insight on the biological and 
network properties of these 79 proteins. By using the Database for Annotation, Visualization and 
Integrated Discovery (DAVID) (Huang et al., 2009), the 79 proteins were annotated according to 
the protein domains as found in the InterPro database (Hunter et al., 2012), and subsequently 
tested for enrichment. Then these domains were clustered using the integrated functional 
clustering in DAVID (default settings). Only clusters in which at least one InterPro family had a 
p-value < 0.05 (corrected for multiple testing using the Benjamini-Hochberg approach) were 
considered significantly enriched. We found three enriched clusters, in which the cluster with the 
highest enrichment score consisted mostly of kinase domains. The other two domains are related 
to cell division (Cyclin domains) and growth (EGF receptor domain). We also computed the 
intra-cluster distance between two proteins as the average shortest path distance between all pairs 
in this set of 79 proteins and we found a value of 2.2 (with the longest to be 5). Even though we 
started with three discrete candidate colon cancer target sets, the topological coefficients reveal a 
strong communication between the proteins, which may offer an explanation why, despite the 
differences in the observed candidate target space of each plant, they all produce the same 
phenotypic effect.  
Seventy-two (72) plants, of which 28 edible (e.g. celery, thyme, coriander, oregano, olive, 
ginger among others) were found to contain compounds that target proteins from all three 
candidate colon cancer protein space. 97 plants; 35 edible- target proteins from two protein spaces 
and 117 plants; 37 edible target proteins from one. For 41 of the plants, of which 2 were common 
Chapter IV: Exploring Mechanisms of Diet-Colon Cancer Associations through Candidate 
Molecular Interaction Networks 
 
100 
edible plants (chickpea and sugar maple). We found no compounds to interact with any of the 
four categories of the candidate colon cancer target space. The number of the chemical 
compounds associated to chickpea and sugar maple could not explain this observation since these 
two edible plants are not the least characterized (Figure 18B). On the other hand, the average 
number of compounds (14.6) assigned to the non-edible plants showing no interactions with the 
colon cancer targets was significantly lower than the rest of the plant space of our study. 
 
 
Figure 20: Phytochemicals present in edible and non-edible plants with significant interest in 
connection to the candidate colon cancer target space. 
*: Target also found in KEGG Pathway 
+: Protein is a Px (see Figure 19)  
 
The “hot” colon cancer space 
 
The next step was to take a closer look on these phytochemicals and proteins that could 
hold the key for understanding the mechanism behind the positive phenotype of the particular 
edible and non-edible plants against colon cancer. In Figure 20 we present some of the chemical 
structures that caught our attention in this analysis. For example, rutin, is a compound present in 
19 edible (olive, thyme, strawberry, among others) and 24 non-edible plants. Rutin targets two 
proteins, namely NT5E and EGFR, which both interact with established colon cancer drug 
targets and two proteins that are part of the colon cancer prognostic signature gene set (CYP1B1 
and ALOX5). Another interesting compound is luteolin, a compound found in 11 edible (black 
tea, celery, rosemary, among others) and 12 non-edible plants. Luteolin has an interesting 
Chapter IV: Exploring Mechanisms of Diet-Colon Cancer Associations through Candidate 
Molecular Interaction Networks 
 
101 
interaction network that includes 15 proteins from three candidate colon cancer target spaces, 
making it undoubtedly one of the most “hot” dietary compounds. Ellagic acid, present in 5 edible 
(strawberry, guava, ginger, rosemary and cranberry) and 2 non-edible plants targets as well 
proteins from all three candidate protein sets (Figure 20). Another interesting compound is 
camptothecin that was found in 2 non-edible plants. Camptothecin is actually a precursor of 
irinotecan, a drug primarily used for the treatment of colon cancer. 
 
 
Figure 21: The two tables show the efficacy of each plant (for details see Materials and 
Methods) calculated using either (A): a binary index; 0 = no phytochemicals in the 
plant interact with the protein (protein in the tables are indicated as X1-Xn), 1 = at 
least one phytochemical in the plant interacts with the protein, or (B): the number 
of unique phytochemicals present in the plant that interact with the protein. (C): A 
network of candidate colon cancer proteins connected by the phi correlation 
coefficient. Labels on the edges are the phi correlation coefficients. The network 
shows only significant correlations (p < 0.05, Bonferonni corrected). Correlation 
coefficients are calculated using the knowledge of plant-protein interactions, and 
thus a large correlation coefficient indicates that these two proteins are targeted by 
a common set of plants. The node size of is proportional to the actual number of 
plants targeting the protein. The equations used to calculate is shown on the right, 
in which the squared phi coefficient is related to the Chi-squared test statistic by the 
number of samples. 
 
  
 


	

	

	
	
	
	
 	
	
	
	
	

	
 


	

	

	

	
	



	






 


 






	
	



		








		




	



	




















	
	
	
	 


	
	
		




	
	






	





























	



	








	

	

	





 


	





	























 
 

	
 







!"











!



"


! 
Chapter IV: Exploring Mechanisms of Diet-Colon Cancer Associations through Candidate 
Molecular Interaction Networks 
 
102 
Subsequently we calculated the efficacy E(P) of each plant as the ratio of the number of 
candidate colon cancer proteins targeted by plant P to the total number of candidate colon cancer 
proteins targeted by all plants (79 in total). As shown in Figure 21A the highest efficacy was 
observed for pomegranate (59 targeted proteins, E=0.75), rosemary (54 targeted proteins, 
E=0.68), black tea (51 targeted proteins, E=0.65) and ginger (46 targeted proteins, E=0.58) from 
the edible plant space and Gingo biloba (E=1), Butea monosperma (E=0.48), Withania somnifera 
(E=0.48) and Galphimia glauca (E=0.43) from the non-edible plant space. If we take into 
consideration the actual number of compounds present in the plants that target each of these 
proteins the picture is slightly different (Figure 21B). The most promising edible plant interacting 
with the candidate colon cancer protein space now appears to be black tea with an efficacy of 
E=0.45, while ginseng reaches an efficacy of E=0.35. From the non-edible plants Ginkgo biloba 
shows the highest weighted efficacy followed by Withania somnifera and Butea monosperma. 
In the last part of the analysis we tried to develop the necessary statistical framework in 
order to achieve the main objective of our study; to actually reveal the protein space that may 
explain the observed anti-cancer phenotype of these edible and non-edible plants. Due to its 
complex chemical background the way that diet induces particular phenotypes must be 
fundamentally different from the drug mode of action (one compound - one, or more target(s)). 
We calculated the correlation coefficients based on the plant-protein interaction patterns of Figure 
21A. In Figure 21C we have only included the significant correlations (p < 0.05, Bonferonni 
corrected) that show some very interesting patterns in the candidate colon cancer target space. 
There are several small networks of proteins that are consistently targeted, or avoided by these 
plants. The significance of this analysis is not that it further reduces the candidate colon cancer 
target space to 55 proteins (Figure 21C) but mainly that it allows to formulate hypotheses on the 
sets of proteins that could be of significant interest as potential targets, either through dietary 
interventions or polypharmacology. The smallest networks consist of only three proteins (e.g. 
MAPK1/FYN/MAPK14, HNRNPA1/SSTR1/TACR2), whereas the largest one of 41 proteins. 
However, as shown in Figure 21C, this large network could be viewed as five sub-networks that 
was bridged via PDE4A (connecting three sub-networks) and PRKACA (connecting two sub-
networks). As can also be seen in Figure 21C, there are a lot of edges with high correlation 
coefficients, but when taking the node size into account (the number of plants actually targeting a 
protein) the number of interesting clusters decreases. For instance, in the TOP1/GSK3A/GSK3B 
cluster all edges have correlation coefficients > 0.923 and a relatively large node size, indicating 
that these three proteins are targeted by a lot of plants as a group (indicated by the high 
correlation coefficient).  
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Another cluster in Figure 21C with high correlation coefficients and a relatively large node 
size is the NT5E/ALOX5/EGFR. CYP1B1, despite being the largest node in this network, 
shows very poor correlation (max(phi_CYP1B1)=0.563). This is probably due to the fact that 
nearly all compounds in the drug development pipeline are screened against this target in ADME 
assays. In that sense this target is most likely not as interesting as the aforementioned protein 
clusters when it comes to explaining the observed colon cancer phenotypes of particular plants as 
the result of synergistic interactions of small molecules. 
Metabolic regulation by dietary components 
 
Two of our previous observations, the fact that the majority of the plant phytochemicals 
appear structurally similar to the assigned metabolites in the human colon metabolic network 
(Figure 18B) and that 43 plants with a known phenotype against colon cancer have no 
compounds interacting with the candidate colon cancer protein space, was the motivation to 
study the possible metabolic regulation triggered by dietary components. The colon metabolic 
network consists of 2,934 metabolites and 1,773 enzymes involved in 3,060 reactions. In the 158 
plants that have been positively associated with colon cancer reduction there are 122 
phytochemicals that are exact match to one human metabolite and 13 more that are structurally 
similar to 10 human metabolites. We make the assumption that these phytochemicals perturb a 
human metabolic reaction in the colon only if they appear in the enzymatic reaction as substrates. 
Based on this, we found in total 570 metabolic reactions in colon to be affected by plants. From 
the edible plant space, soybean, rapeseed, potato and ginseng was the ones with the highest 
influence in the colon metabolic regulation by perturbing 421, 225, 210 and 196 of metabolic 
reactions, respectively. If we look specifically at the 43 plants that was not linked with any of the 
candidate colon cancer protein space, we see that only chickpea contains phytochemicals that are 
involved in 76 metabolic reactions in the colon. 
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Figure 22: The metabolic pathways of the human colon metabolic network (Agren et al., 2012) 
influenced mostly by phytochemicals present in plants associated with colon 
cancer. We highlighted the reactions in pathways that contain metabolites as 
substrates present in more than 20 plants. The width of the edge is proportional to 
the number of plants targeting a reaction in that pathway. We have zoomed in on 
lipid metabolism (A), fatty acid (B), pyruvate metabolism and TCA cycle (C). 
 
The observation that the regulation of the human metabolic network is under the control of 
signaling pathways often altered in cancer has shifted a lot of attention to cancer metabolism (Hsu 
and Sabatini, 2008). This has actually revealed the therapeutic potential of metabolic targets in 
cancer with important implications in the development of anticancer drugs. From Figure 22 we 
could actually get a visual representation of the metabolic processes in colon that are mostly 
targeted by the plants associated with colon cancer. Interestingly, the most targeted parts of the 
colon metabolic network are the lipid, fatty acid and pyruvate metabolism as well as the TCA 
cycle. Our findings are to a great extent in agreement with the analysis performed recently by Hu 
et al. (Hu et al., 2013), who used gene expression profiles gathered over the last decade to 
investigate the global shift in metabolic gene expression between and within cancers, including 
colon cancer. In their study, tumor-induced mRNA expression changes in lipid metabolism and 
fatty acid biosynthesis were associated with several cancer types. Even more interesting were the 
findings on colon cancer that were further validated by measurement of metabolite levels; there 
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was observed a significant decrease in citrate concentration in tumor samples as well as a down-
regulation of the pyruvate dehydrogenase complex that controls the majority of glucose carbon 
flux into the TCA cycle. Monitoring the levels of the TCA cycle intermediates in colon cancer 
patients after introducing specific dietary interventions could offer additional evidence for the 
mechanism that associates plants with colon cancer. 
 
Discussion 
The term ´´exposome´´, which is used to describe the totality of environmental exposures 
(e.g. diet, air pollutants, lifestyle factors) over the life course of an individual, has been proposed 
as a critical entity for disease etiology that complements genome information (Brook et al., 2010; 
Heinrich, 2011; Wild, 2011). Diet is certainly one of the most dynamic expressions of the 
exposome and one of the most challenging to assess its effects in health homeostasis and disease 
development, due to its many components and their temporal variation. Recognize, understand 
and interpret the interplay between diet and biological systems may contribute to the weight of 
evidence for assigning causality to a diet-disease association. Therefore, in order to open up new 
avenues to disease prevention through diet interventions it is crucial to provide insights into the 
mechanisms by which exposure to the chemical space of food might be exerting its effects. 
Towards this direction we used colon cancer as a proof-of-concept for developing the 
necessary toolbox for a more cohesive view of diet exposure. From our systematic analysis of the 
candidate colon cancer target space, consisting of ~1,900 proteins, we identified a sub-set of 79 
and further reduced it to 55 proteins that may reflect the mechanism by which the small molecule 
constituents synergistically define a food’s anti-cancer activity. This is in our opinion the most 
important contribution of our study; we go beyond the one compound-one target paradigm that 
has been extensively used in drug discovery and is often borrowed to explain the mode of action 
of dietary interventions. In contrast, here we identified statistically significant small protein 
clusters, from a pre-defined candidate colon cancer related space (avoiding in that way noise from 
uncurated protein interactions), that are targeted by dietary small molecules in a highly correlated 
manner. We have demonstrated that plants with different molecular profile can be associated to 
colon anticancer activity, as long as their protein targets are part of the same disease space. 
Furthermore, we attempted to rank the efficacy of the plants associated to colon cancer 
using a simple scoring system. Taking again into consideration all the compounds present in each 
plant and their interaction profile with what we called “the hot” protein colon cancer space 
(consisting of 79 proteins) we found black tea, rosemary, pomegranate and ginseng leading the list 
of edible plants. It would certainly be very interesting to perform a comparative study, using a 
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model animal system for colon cancer with edible plants that are ranked high and low in our list 
and verify in what degree these predictions stand true. 
Actually this list can be further expanded to any other edible or non-edible plant without 
known association to colon cancer as long as the chemical profile of the plant is adequately 
defined. One of the major limitations in phenotypic screening studies is that it is practically 
impossible to test all foods against all disease phenotypes. However, analyses like the one 
performed here can lead to the identification of more foods with similar phenotypic effect based 
on the protein target space of their molecular components. Thus, our methodology for better 
delineating the prevention of human diseases by nutritional interventions relies heavily on 
knowing the small molecule constituents of our diet. While until recently this was a major 
obstacle to perform nutritional systems chemical biology studies, we have contributed 
significantly in this direction (Jensen et al., 2014) by developing a state-of-the art database 
(currently in-house but soon part of it will be publicly available) with information on 16,102 plants, 
their small molecules constituents (20,654) and the human disease phenotypes (1,592) associated 
with these plants. This database offers a unique platform for performing global analysis of our 
diet-exposome for elucidating the synergistic interactions of the small molecules that yield specific 
phenotypes and their protein targets and hopefully will contribute in the future towards 
personalized nutrition based on the disease risk of the individual.  
Last but not least, we should acknowledge the limitations of our study, mainly attributed to 
data incompleteness in relation to the phytochemical content of plants, their therapeutic effect on 
diseases, as well as the activity of phytochemicals on human proteins. Even though our database 
contains 20,000 phytochemicals, this is still just a fraction of the natural compound space, which 
is estimated to be more than 150,000 compounds. Few plants have undergone a complete 
phytochemical profiling, while the majority has either been studied for specific compounds, if at 
all. In addition, the biological activity of natural compounds and plants is typically tested 
experimentally against few, selected proteins or disease phenotypes. Thus, the protein space and 
the phytochemicals identified in our study as the major players in the colon cancer interaction 
network, are based on the to date available information in PubMed and may be further revised in 
the future, as new knowledge on the medicinal properties of plants and their natural compound 
constituents is going to emerge. 
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Materials and Methods 
Plant, phytochemical and protein target data  
In the study of Jensen et al. (Jensen et al., 2014)  we applied text mining and Naïve Bayes 
classification to assemble the plant-phytochemical and plant-disease associations. The 158 plants 
that were used in this study are the ones showing the highest probability (p=1) of a positive 
association with colon cancer. From the same in-house database we extracted the chemical 
composition of each plant (3,526 unique phytochemicals) and after standardization, by removing 
salts, ions and hydrogen atoms, an InChi key was generated for unique identification. Proteins 
forming the candidate colon cancer target space were retrieved from three different sources: (i) 
from the National Cancer Institute we retrieved all drugs approved by the FDA for treatment of 
colon cancer (http://www.cancer.gov/cancertopics/druginfo/colorectalcancer). The protein 
target of each drug was extracted from DrugBank database (Knox et al., 2011); (ii) from the 
KEGG Pathway Database (Kanehisa et al., 2012) all proteins from the colon cancer pathway 
(KEGG Pathway id: hsadd05210) were retrieved; (iii) the colon cancer prognostic signature gene 
set of 87 mRNA transcripts was taken from Oh et al., (Oh et al., 2012). In addition, we included 
first-degree neighbors of all the proteins falling in (i) to (iii) using STRING 9.1 (Franceschini et 
al., 2013). In STRING each interaction is assigned a score based on evidence; here we applied a 
medium confidence threshold (score > 400). To ensure the biological validity of the interactions 
in the context of colon cancer only proteins for which there was positive evidence of expression in 
the colon according to the Human Protein Atlas (Uhlen et al., 2010) were included. Protein-
protein interactions not derived from Homo sapiens, Rattus norvegicus and Mus musculus were 
removed. 
 
Chemical-protein interactions 
ChEMBL (Bento et al., 2014), a database of manually curated small molecule-protein 
bioactivities, quantified by a measured experimental value, was used for retrieving interactions of 
phytochemicals with proteins. The bioactivities were filtered according to (Kramer et al., 2012). 
In the present study, only Ki, IC50, potency, inhibition, EC50 and Kd from experiments performed 
on proteins from Homo sapiens, Rattus norvegicus and Mus musculus were included. To 
accommodate for multiple measurements of the compound on the same protein, we calculated a 
probability (based on frequency) that the compound had an effect on the protein using the 
equation below: 
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𝑃 = 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒  𝑒𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑠𝐴𝑙𝑙  𝑒𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑠  
A threshold was set as follows for the various kinds of pharmacological measurements: for 
Ki, EC50, IC50 and Kd, a compound was deemed to interact with the protein if the pChembl 
value (corresponding to the log10([M]) value) was greater than 5.5; for inhibition, a compound 
was deemed to interact with the target if the percentage value was greater than 20; for potency, a 
compound was deemed to interact with the target if the micro molar value was lower than 
500μM. A single experiment was defined as “positive”, i.e. the compound interacts with the 
protein, if the measured value was above the threshold. Only compounds for which the positive 
evidence outweighed the negative evidence (i.e. P ≥ 0.5) were included for further analysis. The 
ChEMBL database was searched for both exact compounds using the InChI key and similar 
compounds using a Morgan circular based fingerprint and comparing compounds by the 
Tanimoto coefficient (Tc). Two compounds were deemed similar if Tc ≥ 0.85 with a difference in 
molecular weight lower than 50 g/mol and were thus expected to show approximately the same 
behavior against the same set of proteins. 
 
Chemical similarity between phytochemicals, drugs and metabolites of 
the colon metabolic network 
The phytochemical space was compared to all approved drugs (retrieved from DrugBank 
(Knox et al., 2011) and human metabolites involved in reactions in the colon (Agren et al., 2012). 
For every compound, we computed a 1024 bit Morgan circular fingerprint, Molecular Weight 
(MW), Topological Polar Surface Area (TPSA) (Ertl et al., 2000) and Octanol/Water coefficient 
(SlogP) using the KNIME (Berthold et al., 2008) RDKit plugin. Using each descriptor, a matrix 
of 1027 columns was constructed, in which each row represented a drug, a human metabolite or a 
phytochemical. Each individual column was scaled to have mean = 0 and standard deviation = 1, 
to ensure no bias for further distance calculations. We calculated the Euclidian distance between 
each small molecule, and performed a classical multidimensional scaling (MDS) using the R 
built-in package cmdscale. Classical MDS is a dimensionality reduction technique, which aims to 
place objects in a lower dimensional space, keeping the between-object distance as close as 
possible to the original space. In this case, we choose to represent our 1027 dimensions (molecule 
features) in a 2 dimensional space. 
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Highly targeted protein space and plant efficacy 
The pairwise correlation between each pair of proteins was calculated as the ϕ-coefficient. 
The ϕ-coefficient is a measure between -1 and 1 of correlation between two binary variables, and 
is related to the χ2, as shown below: 𝜒! = 𝜙!𝑛 
Where n is the total sample size. P-values were adjusted for multiple testing using the Bonferonni 
correction. Only correlations with adjusted p-value ≤ 0.05 were considered significant, however 
biological conclusions that rely on p-values, especially so close to the arbitrary cut-off of 
significance, should be interpreted with caution and the actual effect size should also be carefully 
examined before definitive conclusions are made. 
For each plant P, the efficacy, E, of the plant was calculated as: 𝐸(𝑃) = 𝑃𝑟𝑜𝑡𝑒𝑖𝑛𝑠  𝑤𝑖𝑡ℎ𝑖𝑛  𝑡ℎ𝑒  𝑐𝑜𝑙𝑜𝑛  𝑐𝑎𝑛𝑐𝑒𝑟  𝑠𝑝𝑎𝑐𝑒  𝑡𝑎𝑟𝑔𝑒𝑡𝑒𝑑  𝑏𝑦  𝑝𝑙𝑎𝑛𝑡  𝑃𝑇𝑜𝑡𝑎𝑙  𝑝𝑟𝑜𝑡𝑒𝑖𝑛𝑠   79   𝑖𝑛  𝑡𝑎𝑟𝑔𝑒𝑡  𝑝𝑟𝑜𝑡𝑒𝑖𝑛  𝑠𝑝𝑎𝑐𝑒  
Furthermore, we calculated a weighted efficacy, Ew, which takes into account the number of 
compounds targeting each protein: 𝐸!(𝑃) = 𝐸(𝑃) ∗ #𝐶𝑜𝑚𝑝𝑜𝑢𝑛𝑑𝑠 
We scaled both the weighted and un-weighted efficacy values between 0 and 1, keeping the 
relative difference between plants. 
Conclusion 
 
In conclusion, by developing a systems chemical biology platform that integrates data from 
the scientific literature as well as online and in-house databases we revealed novel associations 
between dietary molecules with candidate colon cancer targets. Nevertheless, the methodology 
proposed here for understanding, which processes involved in the onset, incidence, progression 
and severity of colon cancer, are modulated by dietary components, and is applicable to any 
large-scale diet-disease association study, where information about the small molecule 
constituents of the diet is available. 
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Chapter V: Discovering novel anti-ovarian cancer 
compounds from our diet 
 
Introduction 
 
Ovarian cancer is the leading cause of death from gynecological disorders with an 
increasingly high incidence, especially in the western world (Hanna and Adams). It is among the 
five leading causes of death for women in developed countries (Kushi et al., 2012; La Vecchia, 
2001). Epithelial ovarian cancer (EOC) comprises about 90% of all ovarian cancers and is 
associated with the epithelial cells on external surface of the ovary. The other 10% are stromal 
ovarian cancers (Schulz et al., 2004). With the diagnostic methods available today ovarian cancer 
is still hard to detect, thus many cases are discovered too late. We know only little about the 
biology of ovarian cancer. We do however know that hormonal, environmental and genetic 
factors have been implicated in the development. Several studies has shown that most ovarian 
cancers are environmental and avoidable (Kushi et al., 2012; La Vecchia, 2001). 
Epidemiological studies suggests that some dietary factors may play a role in the 
development of ovarian cancer, so far most studies have shown up inconclusive (Bandera et al., 
2009). The understanding of modifiable, contributing factors to reducing the incidence of the 
disease is therefore of outmost importance (Bandera et al., 2009; McCann et al., 2003). Little is 
known about the impact that lifestyle factors, such as diet, may have in the development of 
ovarian cancer (Bandera et al., 2009). It has been known for some time and shown in several 
epidemiologic studies that women have a significantly lower risk of developing ovarian cancer 
after having given birth (Hanna and Adams; Schulz et al., 2004). It is known that women in 
western culture are having babies much later in life then Asian women. Therefore one could 
speculate that the higher rate of ovarian cancer in the western world could be explained, to some 
extent, by women having children later in life. There are several studies that have shown a higher 
ovarian cancer risk for women with polycystic ovary syndrome or irregular menopause (Barry et 
al., 2014; Galazis et al., 2012; Smith et al., 2014). This has led to a different hypothesis; built 
upon the observation that phytoestrogen at doses typical of vegetarian or Asian diets influences 
the female menstrual cycle and could be an influencer of cancer risk. However, so far conducted 
clinical studies have shown considerable variation in the outcomes (Whitten and Naftolin, 1998). 
Phytoestrogens can change the ovarian cycle through ovarian, pituitary or hypothalamic actions. 
In addition, it has been shown that several bioflavonoids can affect the ovary, although the 
potential for direct ovarian effects may be limited (Whitten and Naftolin, 1998). 
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The literature on dietary components and ovarian cancer is limited. In general, reduced 
risks of ovarian cancer have been associated with higher intakes of vegetables (McCann et al., 
2003). Especially green-leaf vegetable intake is more strongly associated with a decreased risk 
(Kushi et al., 1999; Zhang et al., 2002). Evidence that vegetable and fruit consumption reduces 
cancer risk has led to attempts to isolate the bioactive phytochemicals from these foods (Kushi et 
al., 2012). Phytoestrogens, bioflavonoids and lignans are known to have estrogenic as well as 
anti-estrogenic activity (McCann et al., 2003). However, studies on ovarian responses to 
phytoestrogens suggest suppression of estrogen and progesterone secretion in some cases and 
enhanced estradiol secretion in others (Whitten and Naftolin, 1998). This applies to most studies 
to date, where the effect of dietary components on ovarian cancer has been inconclusive (Chang 
et al., 2007). An issue for most of the studies is that their outcome is associated with relatively few 
phytochemicals such as isoflavones and isothiocyanates. 
Many studies have concluded that even though a compound inhibits the development of 
many different cancer types, it may not be significantly associated with cancer of the ovary 
(Chang et al., 2007). The intake of isothiocyanates or foods high in isothiocyanates has not yet 
been significantly associated with ovarian cancer risk, neither has intake of macronutrients, 
antioxidant vitamins, or other micronutrients (Chang et al., 2007). For example, a study has 
shown that, compared with the risk for women who consumed less than 1 mg of total isoflavones 
per day, the relative risk of ovarian cancer associated with consumption of more than 3 mg/day 
was about half (Chang et al., 2007). It is however hard to determine with certainty that this 
difference is significant since there could be several other contributing factors (Chang et al., 2007). 
Bioflavonoids such as quercetin have been shown to have anti-oxidant, anti-bacterial, anti-
thrombotic, anti-inflammatory and anti-carcinogenic properties (McCann et al., 2003). For 
kaempferol consumption a significant 40% decrease in ovarian cancer incidence has been found 
for the highest compared to lowest quintile of kaempferol intake and a 34% decrease in incidence 
for the highest compared to lowest quintile of luteolin (Gates et al., 2007). Quercetin has also 
been shown to reduce the size of solid cancer cells line of the ovary, the amount required for an 
effect is however high -in the 2000 mg range-, and the length of treatment hard to determine 
(Thomasset et al., 2007). 
It is hard to determine whether quercetin could be the phytochemical in the vegetarian-diet 
that reduces the risk of ovarian cancer. Some studies have shown that certain phytochemicals in 
our diet cause hormonal changes on the female menstrual cycle (Whitten and Naftolin, 1998): 
flaxseed lignans increased testosterone levels; soy-isoflavones decreases estrogen level together 
with the progesterone testerone levels; zearalenone decreases luteinizing while bourdon 
congeners decreases luteinizing and sex hormone binding globulin (Whitten and Naftolin, 1998). 
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Genistein action has been associated with precocious vaginal opening, follicles and fewer corpora 
luteal. However, high-doses are required for an effect (Whitten and Naftolin, 1998). The findings 
of clinical studies are mixed, and it is unclear whether isoflavones substantially reduce 
menopausal symptoms (Whitten and Naftolin, 1998). Although, several rat models have shown 
promising effects of phytochemicals on ovarian cancer, these findings have been hard to 
reproduce in humans. Human responses to phytoestrogens are highly variable in both quality and 
incidence of response (Whitten and Naftolin, 1998). 
In the present study we search for novel phytochemicals from plant-based foods with 
activity against ovarian cancer, through text mining and a system-wide association of 
phytochemicals, foods and health benefits on human ovarian cancer, following the methodology 
described in our previously study (Jensen et al., 2014). In addition we evaluate the anti-ovarian 
cancer effects of some of the most significant compounds in a cell line study. 
 
Methods 
Prediction of phytochemicals’ biological activity against ovarian 
cancer 
 
Phytochemicals active against ovarian cancer were predicted using a fisher’s exact test as 
described previously (Jensen et al., 2014). The compound composition of the plant-based foods of 
our diet and the health effect from their consumption were extracted from free textual data of 
MEDLINE abstracts. The plant – compound and plant – health benefit associations were 
extracted using natural language processing (Jensen et al., 2014). We then identified potential 
phytochemicals against ovarian cancer using a fisher’s exact test and a 5% false discovery rate 
(Yoav and Hochberg, 1995). The likelihood of a plant compound to have biological activity 
against ovarian cancer is calculated based on the number of times the compound and the human 
health effect (in this case, ovarian cancer) are mentioned together with the same plant. Support 
for the predictions of bioactive compounds against ovarian cancer were sought through three 
different routes, as shown in Figure 23. i) We searched PubMed manually for reported 
bioactivities supporting the predicted health benefit. ii) We searched ChEMBL (Overington, 
2009) using the structure of the compounds, for information about known protein targets linked 
to ovarian cancer in the therapeutic target database (Zhu et al., 2012). iii) We searched ChEMBL 
for compounds structurally similar to our predictions, with activity against ovarian cancer targets. 
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Figure 23: A flow diagram showing the discovery process and prioritization of novel anti-
ovarian cancer compounds. 
 
In-vitro evaluation of compounds 
 
Melatonin, Protocathechuic acid, Curcumene, 6-O-alpha-L-Rhamnopyranosyl-Hyperin, 3-
O-Sophorotrioside-3,4,5,7-tetrahydroxyflavone were purchased from Chengdu MUST bio-
technology, China). D-(+)-Trehalose dehydrate, (-)-β-Pinene, (+)-Arabinogalactan, Abscisic acid 
were purchased from Sigma-Aldrich (USA). Tannic acid from our laboratory stock. All other 
chemical were purchased from Sigma-Aldrich (USA). 
Growth inhibition effect of tested compounds on SKOV3 (ovarian cancer cell line) and 
HOSE6.3 (immortalized ovarian epithelial cell line) were determined by MTT assay. Briefly, 
1,500 cells of each cell line were seeded into 96-well plates. After 24 hours, cells were treated with 
100μl of fresh growth medium containing tested with designated concentrations for 48 hours. 
Cells were harvested for MTT assay. 20μl of MTT reagent containing 2.5 mg/ml MTT, and the 
plates were incubated for additional 4 hours to develop insoluble formazan product at 37oC. 
DMSO was added to each well to dissolve the formazan crystal formed in viable for 
spectrophotometric analysis at 570nm. 
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Compound composition of  
plants 
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from plant consumption + 
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Results 
Prediction of the phytochemicals’ biological activity against ovarian 
cancer 
 
We found several compounds with a p-value within the 5% false discovery rate.  The 
predicted hits are divided in three categories: a) compounds that are structurally similar to a 
compound in ChEMBL targeting a known anti-ovarian cancer protein, b) compounds with no 
similar compounds in ChEMBL with such a target, c) compounds from plants used in Traditional 
Chinese Medicine, included in the Chinese Natural Product Database (Shen et al., 2003). 
a) Compounds structurally similar to a compound with an anti-ovarian cancer target 
 
The predicted anti-ovarian cancer activity of several of the compounds from the top 20 most 
significant hits could be verified in literature. Trilinolein is one compound with predicted anti-
ovarian cancer activity at a low p-value (p-value < 10-11). The compound is similar to fumaric 
acid, which interacts with the PPAR-gamma protein (P37231). Diphosphatidylglycerol has also 
predicted anti-ovarian cancer activity with a low p-value (p-value < 10-8). This compound is 
similar to octanoic acid, which interacts with the LPA receptor-1 protein (Q92633). 
A third example, the compound beta-sitostanol has predicted anti-ovarian cancer activity 
with p-value < 10-8. This compound is similar to ChEMBL compound CHEMBL69891, which 
interacts with Cytochrome P450 19A1 (P11511). From a) group, were selected 5 compounds for 
experimental validation of the predicted activities shown in Table 4. 
b) Compounds not similar to any compound with a known anti-ovarian cancer target  
 
In the top 20 of most significant compounds, we find several compounds whose activities 
are confirmed in literature: anthocyanin (p-value < 10-11), beta-glucan (p-value <10-9), Saponin (p-
value <10-3) (Jafaar et al., 2014; Podolak et al., 2010; Schmitt and Stopper, 2001). From the two 
categories above we selected 10 compounds for experimental validation. From b) group, were 
selected 5 compounds for experimental validation of the predicted activities shown in Table 4. 
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c) Compounds from plants used in Traditional Chinese Medicine  
 
We also identified several potential candidate compounds from the Chinese Natural 
Product Database (Shen et al., 2003) with potential anti-ovarian cancer activity. The identified 
compounds are shown in Table 5. Melatonin is one such compound from the Chinese Natural 
Product database predicted with anti-ovarian cancer activity (p-value < 10-10). The compound is 
found in 8 plants, among others, in grape and ginkgo biloba, that are concomitantly mentioned in 
the literature to have anti-ovarian cancer activity, Gelseverine is another compound that we also 
find significantly associated with anti-ovarian cancer activity (p-value < 10-10). The compound is 
found in 6 plants associated with anti-ovarian cancer activity (Abdul Wahab et al., 2004). 
Abscisic acid is another compound that we have associated with anti-ovarian cancer activity (p-
value < 10-10). The compound is found in 18 plants with known with anti-ovarian cancer activity 
(Nagle et al., 2010). The compound itself is also known to have anti-cancer activity (2010b). 
However, no activity on ovarian cancer has yet been reported. 
Table 4 shows the compounds that are predicted associated with anti-ovarian cancer 
activity. The compound Arabinogalactan significantly associated with anti-ovarian cancer 
activity. The compound is structurally similar to the CHEMBL P16581, a compound that binds 
to the protein E-selectin (P16581). This compound is found in 9 foods, 3 medical plants and 1 
other plant associated with ovarian cancer. The compound is proposed immune-stimulatory 
(Gannabathula et al., 2012). alpha,alpha-trehalose was found with anti-ovarian cancer activity. 
The compound is structurally similar with the compound CHEMBL461727 that binds to the 
protein E-selectin (P16581). The compound is found in 9 foods, 1 medical plant and 1 other plant 
associated with ovarian cancer. 
Tannic acid was found with anti-ovarian cancer activity. The compound has features similar 
with CHEMBL1399656 that binds to hypoxia-inducible factor 1-alpha (Q16665). The compound 
is found in 12 foods, 5 medicinal plants and 5 other plants associated with anti-ovarian cancer 
activity. The table also shows some novel compounds, which no structural similarity with 
compounds has known to target proteins with anti-ovarian cancer activity. The compound beta-
damascenone is one such compound found associated with anti-ovarian cancer activity (p-value < 
10-7). For this compound we find no structurally similarity with compound targeting known anti-
ovarian cancer targets. The compound is found in 6 foods associated with anti-ovarian cancer 
activity. Ethyl-2-(diethoxyphosphinyl)-3-oxobutanoate (p-value < 10-6) is another such compound 
found in 5 foods associated with anti-ovarian cancer activity. Beta-Pinene, is another compound 
found which associated with anti-ovarian cancer activity (p-value <10-3). This compound is not 
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found structurally similar to compounds with known anti-ovarian cancer activity. It is found in 12 
foods, 7 medicinal plants and 2 other plants associated with anti-ovarian cancer activity. 
Table 5 shows the compounds associated with anti-ovarian cancer activity and with no 
structural similarity. Melatonin from the Chinese Natural Product database was associated with 
anti-ovarian cancer activity (p-value < 10-10). The compound is found in 8 plants, among others, 
in grape and ginkgo biloba, that are concomitantly mentioned in the literature to have anti-
ovarian cancer activity, Gelseverine is another compound that we also find significantly 
associated with anti-ovarian cancer activity (p-value < 10-10). The compound is found in 6 plants 
associated with anti-ovarian cancer activity (Abdul Wahab et al., 2004). Abscisic acid is another 
compound that we have associated with anti-ovarian cancer activity (p-value < 10-10). The 
compound is found in 18 plants with known with anti-ovarian cancer activity (Nagle et al., 2010). 
The compound itself is also known to have anti-cancer activity (2010b). However, no activity on 
ovarian cancer has yet been reported. 
 
In vitro evaluation of compounds 
 
Figure 24 shows the results of the in-vitro assays. Four of the 11 compounds tested showed 
a lower cell viability then control (HOSE6.2). The compound Curcumene showed activity at 
92,91uM (SKOV3) compared to 131.2 uM (HOSE6.3). 3-O-Sophorotrioside-3,4,5,7-
tetrahydroxyflavone showed 18.88 uM (SKOV3) compared to 19.99 uM (HOSE6.3). Tannic acid 
showed 50.7 uM (SKOV3) compared to 98.2 uM (HOSE6.3) and Damascenone showed 32 uM 
(SKOV3) compared to 57.8 uM (HOSE6.3). The compounds have now been scheduled for mice 
studies.  
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Table 4: The table shows the top compounds that are associated with anti-ovarian cancer 
activity from group a) and b). The 5 last compounds has “No data” listed as 
evidence because we find no structural similarity with compounds known to target 
anti-ovarian cancer compounds (group b). 
 
  
Name Structure Compound evidence Plant evidence 
Arabinogalactan 
 
Similar structural features 
with CHEMBL311181** that 
binds to P16581 
Found in 9 foods, 3 
medicinal plants and 1 other 
plant associated with OC  
alpha,alpha-
trehalose 
 
 
Similar structural features 
with CHEMBL461727** that 
binds to P16581 
Found in 9 foods, 1 
medicinal plant and 1 other 
plant associated with OC 
Tannic acid 
 
Similar structural features 
with CHEMBL1399656** 
that binds to Q16665 
Found in 12 foods, 5 
medicinal plants and 5 other 
plants associated with OC 
Dammarenediol 
II 
  
Similar structural features 
with CHEMBL1610940** 
that binds to Q16665 
Found in 1 food, 4 medicinal 
plants and 1 other plant 
associated with OC 
24-
methylcholestero
l 
 
 
Similar structural features 
with CHEMBL69891** that 
binds to P11511 
Found in 4 foods, 4 
medicinal plants and 1 other 
plant associated with OC 
beta-
damascenone 
 
No data Found in 6 foods associated 
with OC 
Ethyl-2-
(diethoxyphosph
inyl)-3-
oxobutanoate  
No data Found in 5 foods associated 
with OC 
beta-pinene 
 
No data Found in 12 foods, 7 
medicinal plants and 2 other 
plants associated with OC 
4-
methylthiobutylg
lucosinolate  
No data Found in 1 food and 1 
medicinal plant associated 
with OC 
Curcumene 
 
No data Found in 1 food, 2 medicinal 
plants and 2 other plants 
associated with OC 
* Search with this ID PubChem (http://pubchem.ncbi.nlm.nih.gov/) to see chemical structure 
** Search with this ID ChEMBL (https://www.ebi.ac.uk/chembl/) to see chemical structure 
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Table 5: The table shows the compounds predicted associated with anti-ovarian cancer activity 
from group c). 
  Name Structure Plants (food or/and TCM) associated in the literature (PubMed) with 
ovarian cancer 
melatonin 
 
grape (TAXID:29760);ginkgo biloba f. epiphylla 
(TAXID:3311);azadirachta indica (TAXID:124943);ninjin 
(TAXID:4054);st. johns wort (TAXID:65561);rice 
(TAXID:4530);solanum tuberosum l. (TAXID:4113);olea europaea l. 
(TAXID:4146) 
gelseverine 
 
goetzea elegans (TAXID:70013);garovaglia elegans 
(TAXID:94572);goniothalamus elegans ast (TAXID:497607);gypsophila 
elegans m. bieb. (TAXID:146095);gomphrena elegans 
(TAXID:240060);gelsemium elegans (gardner and champ.) benth. 
(TAXID:427660) 
abscisic acid 
 
brassica rapa l. (TAXID:3711);grape (TAXID:29760);radish 
(TAXID:3726);brassica oleracea (TAXID:3712);ginkgo biloba f. 
epiphylla (TAXID:3311);ninjin (TAXID:4054);livistona chinensis 
(TAXID:115492);tea plant (TAXID:4442);camptotheca acuminata 
(TAXID:16922);salvia mihiorrhiza (TAXID:226208);dodonaea viscosa 
(TAXID:151065);solanum tuberosum l. (TAXID:4113);nicotiana 
benthamania (TAXID:4100);rice (TAXID:4530);cocos nucifera l. 
(TAXID:13894);pyrus malus (TAXID:3750);soya bean 
(TAXID:3847);olea europaea l. (TAXID:4146) 
3-O-
Sophorotriosi
de-3,4',5,7-
Tetrahydroxyf
lavone  
radish (TAXID:3726);ginkgo biloba f. epiphylla (TAXID:3311);ninjin 
(TAXID:4054);dodonaea viscosa (TAXID:151065);lentils 
(TAXID:3864);soya bean (TAXID:3847);grape (TAXID:29760);acacia 
nilotica (TAXID:138033);curcuma domestica valeton 
(TAXID:136217);common oleander (TAXID:63479);tea plant 
(TAXID:4442);st. johns wort (TAXID:65561);cordyla madagascariensis 
r.vig. (TAXID:149643);pyrus malus (TAXID:3750);podophyllum 
hexandrum (TAXID:93608);brassica rapa l. (TAXID:3711);azadirachta 
indica (TAXID:124943);brassica oleracea (TAXID:3712);zingiber 
officinale (TAXID:94328);rice (TAXID:4530);olea europaea l. 
(TAXID:4146);rhodiola rosea (TAXID:203015);red stem pokeweed 
(TAXID:3527);pyrus balansae decne. (TAXID:23211) 
6-O-alpha-L-
Rhamnopyran
osyl-Hyperin 
 
radish (TAXID:3726);ginkgo biloba f. epiphylla (TAXID:3311);manioc 
(TAXID:3983);asparagus officinalis l. (TAXID:4686);solanum 
tuberosum l. (TAXID:4113);lentils (TAXID:3864);soya bean 
(TAXID:3847);grape (TAXID:29760);curcuma domestica valeton 
(TAXID:136217);common oleander (TAXID:63479);tea plant 
(TAXID:4442);st. johns wort (TAXID:65561);pyrus malus 
(TAXID:3750);podophyllum hexandrum (TAXID:93608);brassica rapa 
l. (TAXID:3711);azadirachta indica (TAXID:124943);brassica oleracea 
(TAXID:3712);zingiber officinale (TAXID:94328);platycodon 
grandiflorum (TAXID:94286);rice (TAXID:4530);olea europaea l. 
(TAXID:4146);rhodiola rosea (TAXID:203015);dodonaea viscosa 
(TAXID:151065);scutellaria barbata (TAXID:396367);pyrus balansae 
decne. (TAXID:23211) 
 
protocathechu
ic acid 
 
garden rhubarb (TAXID:3621);brassica rapa l. (TAXID:3711);soya bean 
(TAXID:3847);brassica oleracea (TAXID:3712);ginkgo biloba f. 
epiphylla (TAXID:3311);manioc (TAXID:3983);grape 
(TAXID:29760);st. johns wort (TAXID:65561);salvia mihiorrhiza 
(TAXID:226208);rice (TAXID:4530);solanum tuberosum l. 
(TAXID:4113);cremastra appendiculata (TAXID:459596);red stem 
pokeweed (TAXID:3527);cocos nucifera l. (TAXID:13894);pyrus malus 
(TAXID:3750);pyrus balansae decne. (TAXID:23211);olea europaea l. 
(TAXID:4146) 
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Figure 24: The figure shows the results of the in-vitro assays. Four of the 11 compounds tested 
showed a lower cell viability then control (HOSE6.2). The compound Curcumene 
showed activity at 92,91uM (SKOV3) compared to 131.2 uM (HOSE6.3). 3-O-
Sophorotrioside-3,4,5,7-tetrahydroxyflavone showed 18.88 uM (SKOV3) 
compared to 19.99 uM (HOSE6.3). Tannic acid showed 50.7 uM (SKOV3) 
compared to 98.2 uM (HOSE6.3) and Damascenone showed 32 uM (SKOV3) 
compared to 57.8 uM (HOSE6.3). 
 
  
Melatonin
Protocathechuic acid 
Curcumene
6-O-alpha-L-Rhamnopyranosyl-Hyperin
3-O-Sophorotrioside-3,4,5,7-tetrahydroxyflavone
D-(+)-Trehalose dihydrate
(-)-β-Pinene
(+)-Arabinogalactan 
Tannic acid 
Abscisic Acid 
Damascenone 
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Conclusion 
 
We found several compounds with predicted biological activity at a p-value within the 5% 
false discovery rate. The predicted hits are divided in three categories: i) Compounds that are 
structurally similar to a compound in ChEMBL targeting a known anti-ovarian cancer protein. ii) 
Compounds with no similar compounds in ChEMBL with such a target. iii) Compounds from 
plants used in Traditional Chinese Medicine, included in the Chinese Natural Product Database. 
We found the compounds Arabinogalactan, alpha,alpha-trehalose and Tannic acid as compounds 
with potential anti-ovarian cancer activity. These compounds are structurally similar to 
compounds known to target anti-ovarian cancer targets. The compounds beta-damascenone, 
Ethyl-2-(diethoxyphosphinyl)-3-oxobutanoate and Beta-Pinene are compounds found potentially 
active on ovarian cancer with no structural similarity to compounds with known anti-ovarian 
cancer targets. From the Chinese Natural Product database we estimate that melatonin, 
Gelseverine and Abscisic acid with potential anti-ovarian cancer activity. 
Four of the 11 compounds tested showed a lower cell viability then control (HOSE6.2). The 
compound Curcumene showed activity at 92,91uM (SKOV3) compared to 131.2 uM (HOSE6.3). 
3-O-Sophorotrioside-3,4,5,7-tetrahydroxyflavone showed 18.88 uM (SKOV3) compared to 19.99 
uM (HOSE6.3). Tannic acid showed 50.7 uM (SKOV3) compared to 98.2 uM (HOSE6.3) and 
Damascenone showed 32 uM (SKOV3) compared to 57.8 uM (HOSE6.3). The compounds have 
now been scheduled for mice studies.
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Conclusion 
In the first chapter we developed and described the method on which the data for the thesis 
was extracted from the raw textual data of MEDLINE. Food is a factor that exerts influence on 
human health on a daily basis. With this study we provide the molecular basis of the effect of 
food on health in the complete spectrum of human diseases and to suggest why and how diet and 
dietary molecules may represent a valuable tool to reinforce the effect of therapies and protect 
from relapse. Modulating the expression and the activity of enzymes, transcription factors, 
hormones and nuclear receptors is how food and its bioactive constituents modulate metabolic 
and signaling processes. Our systematized approach for connecting foods and their molecular 
components to diseases makes possible similar analyses as the one illustrated for colon cancer for 
approximately 2,300 disease phenotypes. In addition, it provides the phytochemical layer of 
information for nutritional systems biology studies with the aim to assess the systemic impact of 
food on health and make personalized nutritional recommendations. 
In the second chapter we developed a systems chemical biology resource, NutriChem, to 
explore the medicinal value of diet. The need for a more complete assessment of the 
environmental factors in epidemiological studies gave birth to a new –ome, the exposome. We 
envisage elucidating the link between diet, molecular biological activity and diseases by 
developing a database source that translates the diet-exposome from concept to utility. Our 
methodology for better delineating the prevention of human diseases by nutritional interventions 
relies heavily on the availability of information related to the small molecule constituents of our 
diet. 
In the third chapter we developed a molecular roadmap of drug-food interactions. The 
importance of drug-food interactions has long been recognized; a systematic approach for 
identifying, predicting and preventing potential interactions between food and marketed or novel 
drugs is not yet available. The overall objective of this work was to gain knowledge on the 
interference of dietary components with the pharmacokinetics and pharmacodynamics processes 
of medicine, with the purpose of elucidating the molecular mechanisms involved. We integrated 
data from the scientific literature, our in-house database, NutriChem, and online databases and 
using systems chemical biology approaches for the study of the effect of natural bioactive 
compounds from plant-based foods on proteins related to drug bioavailability and therapeutic 
effect. We identified phytochemicals and foods that are potentially involved in yet not 
documented drug-food interactions. Moreover, we identified disease areas that are most prone to 
the negative effects of drug-food interactions and made recommendation in relation to foods that 
should be avoided under certain medications. 
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In the fourth chapter of the thesis we proposed a framework for interrogating the critical 
targets in colon cancer progression and identifying plant-based dietary interventions as important 
modifiers of this process using a systems chemical biology approach. Our methodology for better 
delineating the prevention of colon cancer by nutritional interventions relies heavily on the 
availability of information about the small molecule constituents of our diet and it can be 
expanded to any other disease class that previous evidence has linked to lifestyle. 
In the fifth chapter of the thesis is on the discovering of novel anti-ovarian cancer 
compounds. Here, we found the compounds Arabinogalactan, alpha,alpha-trehalose and Tannic 
acid as compounds with potential anti-ovarian cancer activity. In addition, we find beta-
damascenone, Ethyl-2-(diethoxyphosphinyl)-3-oxobutanoate and Beta-Pinene potentially active 
on ovarian cancer. We estimate, from the Chinese Natural Product database, that Melatonin, 
Gelseverine and Abscisic acid could be active as well. Interestingly, 4 of the 11 compounds we 
tested in vitro, showed considerable lower cell viability then the control. This includes the 
compounds Curcumene, 3-O-Sophorotrioside-3,4,5,7-tetrahydroxyflavone, Tannic acid and 
Damascenone. 
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Future perspectives 
A future perspective for this work is definitely to extent our work to cover the complete diet, 
i.e. to include meat, fish and their products. In this thesis we have focused on plant-based diets, 
due to our limited time and our limited resources. With more time and resources we should be 
able to extent the present work from covering plant-based diets to covering the complete human 
diet. It would also be interesting to investigate how diet affects our blood. Recently, interesting 
discoveries have been made about the role of blood in human health: young blood reverses age-
related impairments in cognitive function and synaptic plasticity in mice (Villeda et al., 2014). In 
this perspective a better understanding of how diet affects our blood at a molecular level could be 
extremely interesting. It would also be interesting to investigate the molecular mechanisms 
underlying the relation between diets, calorie restriction and health (Testa et al., 2013). 
This thesis represents current state-of-the-art nutritional systems biology. We believe our 
work in time will benefit people that suffer from chronic disorders and non-communicable 
diseases. In the thesis we demonstrate that the components of our diet function in many aspects 
similar to those of drugs. The concentration of the bioactive components in our diet is, however, 
less than when taking medicine. Diet cannot be used directly as a medical treatment but the 
components of our diet may however, modulate disease states and limit the need of medication. 
We also believe that our present work provides important mechanistic insight into the interaction 
of dietary components and drugs, useful for both the development of new drugs and treatment 
strategies.  
We imagine a future where you could monitor your health condition from your blood using 
a nano/bio-chip. The chip could be connected with the internet through e.g. your smartphone 
providing health information on the go. From the knowledge developed in this thesis you could 
have an App that could tell you what to eat and when to eat it. This could be particularly useful 
for patients with chronic disorders, helping to move treatment of patients from hospitals to their 
homes and through diet limit the need of medication. This kind of service could also be useful 
during hospital treatment, as well as consist an important tool for the elderly under multiple 
prescription drugs, with which a wrong diet may interfere unfavorably. 
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